{"prompt": "Unknown Title", "completion": "Dousing the \ufb02ame: reviewing the\nmechanisms of in \ufb02ammatory\nprogramming during\nstress-induced intrauterinegrowth restriction and the\npotential for \u03c9-3 polyunsaturated\nfatty acid intervention\nMelanie R. White and Dustin T. Yates*\nStress Physiology Laboratory, Department of Animal Science, University of Nebraska-Lincoln, Lincoln, NE,\nUnited States\nIntrauterine growth restriction (IUGR) arises when maternal stressors coincide\nwith peak placental development, leading to placental insuf \ufb01ciency. When the\nexpanding nutrient demands of the growing fetus subsequently exceed thecapacity of the stunted placenta, fetal hypoxemia and hypoglycemia result.Poor fetal nutrient status stimulates greater release of in \ufb02ammatory cytokines\nand catecholamines, which in turn lead to thrifty growth and metabolicprogramming that bene \ufb01ts fetal survival but is maladaptive after birth.\nSpeci \ufb01cally, some IUGR fetal tissues develop enriched expression of\nin\ufb02ammatory cytokine receptors and other signaling cascade components,\nwhich increases in \ufb02ammatory sensitivity even when circulating in \ufb02ammatory\ncytokines are no longer elevated after birth. Recent evidence indicates thatgreater in \ufb02ammatory tone contributes to de \ufb01cits in skeletal muscle growth and\nmetabolism that are characteristic of IUGR offspring. These de \ufb01cits underlie the\nmetabolic dysfunction that markedly increases risk for metabolic diseases inIUGR-born individuals. The same programming mechanisms yield reduced\nmetabolic ef \ufb01ciency, poor body composition, and inferior carcass quality in\nIUGR-born livestock. The \u03c9-3 polyunsaturated fatty acids (PUFA) are diet-\nderived nutraceuticals with anti-in \ufb02ammatory effects that have been used to\nimprove conditions of chronic systemic in \ufb02ammation, including intrauterine\nstress. In this review, we highlight the role of sustained systemic in \ufb02ammation\nin the development of IUGR pathologies. We then discuss the potential for \u03c9-3\nPUFA supplementation to improve in \ufb02ammation-mediated growth and metabolic\nde\ufb01cits in IUGR offspring, along with potential barriers that must be considered\nwhen developing a supplementation strategy.\nKEYWORDS\nadaptive fetal programming, developmental origins of health and disease, DOHAD, fetal\ngrowth restriction, intrauterine growth restriction, IUGR, low birthweight, metabolic\nprogrammingOPEN ACCESS\nEDITED BY\nClaire Stenhouse,\nThe Pennsylvania State University (PSU),United States\nREVIEWED BY\nAmelia Tanner,University of Colorado Anschutz MedicalCampus, United States\nAlice Brandao,\nTexas A&M University, United States\n*CORRESPONDENCE\nDustin T. Yates,\ndustin.yates@unl.edu\nRECEIVED 29 June 2023\nACCEPTED 14 August 2023\nPUBLISHED 01 September 2023\nCITATION\nWhite MR and Yates DT (2023), Dousingthe\ufb02ame: reviewing the mechanisms of\nin\ufb02ammatory programming during\nstress-induced intrauterine growth\nrestriction and the potential for \u03c9-3\npolyunsaturated fatty acid intervention.Front. Physiol. 14:1250134.\ndoi: 10.3389/fphys.2023.1250134\nCOPYRIGHT\n\u00a9 2023 White and Yates. This is an open-access article distributed under the termsof the Creative Commons Attribution\nLicense (CC BY) . The use, distribution or\nreproduction in other forums is\npermitted, provided the original author(s)and the copyright owner(s) are creditedand that the original publication in thisjournal is cited, in accordance withaccepted academic practice. No use,\ndistribution or reproduction is permitted\nwhich does not comply with these terms.\nFrontiers in Physiology frontiersin.org 01TYPE Review\nPUBLISHED 01 September 2023\nDOI10.3389/fphys.2023.1250134\n1 Introduction\nFetal intrauterine growth restriction (IUGR) occurs in an\nestimated 1 out of every 5 pregnancies worldwide, resulting inalmost 30 million babies being affected by the condition eachyear ( Kesavan and Devaskar, 2019 ). Asymmetrical IUGR is a\npathological cause of low birth weight and small-for-gestational-\nage (SGA) newborns. Unlike genetic causes of SGA, IUGR is anadaptive response to chronic fetal hypoxemia, hypoglycemia, andother sustained nutritional stresses, since slower fetal growth ratesrequire less nutrients ( Sharma et al., 2016 ;Kesavan and Devaskar,\n2019 ). However, these adaptations also reduce newborn vigor and\nsubstantially increases the risk for early morbidity and mortality(Garite et al., 2004 ). Globally, IUGR-born infants suffer 3-fold\ngreater perinatal demise than babies born at appropriate size for\ntheir gestational age ( Garite et al., 2004 ). Most commonly, IUGR-\nborn babies survive but are at much greater risk for chronicmetabolic disorders, including obesity, hyperlipidemia, and type2 diabetes ( Hales and Barker, 2001 ;Hicks and Yates, 2021 ). This is\nbecause the programmed metabolic thrift that underlies IUGR andbene\ufb01ts the nutrient-deprived fetus becomes an environmental\nmismatch after birth, as offspring are no longer hypoxemic and\ntypically have better nutritional opportunities ( Gibbs et al., 2020 ;\nPosont et al., 2021 ). Hales and Barker were the \ufb01rst to link IUGR-\ninduced low birthweight to lifelong metabolic dysfunction and themyriad associated health disorders ( Hales et al., 1991 ;Hales and\nBarker, 1992 ). In the decades since, research has begun to identify\nthe root causes for this link. For example, IUGR-born infantstypically undergo compensatory catch-up growth prior toadolescence that is driven more so by fat deposition than by lean\ntissue growth ( Ong et al., 2000 ;Dulloo et al., 2012 ). Greater adiposity\ncompounds programmed metabolic thrift and further increases therisk for insulin resistance, high blood pressure, and greater bodymass index ( Ong and Dunger, 2000 ;Mericq et al., 2005 ;Lurbe et al.,\n2009 ). In adulthood, these risks often manifest in diabetes,\nhypertension, central obesity, hyperlipidemia, and heart disease(Barker et al., 1993 ;Barker et al., 2002 ). Although modern\nmedical advances have markedly improved global IUGR infant\nsurvival rates, prevalence of the condition has remained static for\ndecades ( Goldenberg and Culhane, 2007 ;Mathews and Driscoll,\n2017 ). Developing countries in South Asia and Sub-Saharan Africa\nremain at the highest risk for IUGR pregnancies, but rates indeveloped countries have also increased since 1981 ( Gurung\net al., 2022 ). Moreover, rates among African-Americans and\namong individuals from low-income areas have increaseddisproportionately in the US ( Goldenberg and Culhane, 2007 ).\nPrenatal stressors in livestock and mammalian wildlife species\ninduce the same fetal programming mechanisms responsible forIUGR in humans ( De Blasio et al., 2007a ;Yates et al., 2019 ). The lack\nof perinatal vigor makes IUGR-born animals more susceptible tostarvation and predation, which is a major animal welfare issue thatcosts the US livestock industry on average about 8% of its annualproduct ( Milligan BNF and Kramer, 2002 ;Wu et al., 2006 ). Like\nhumans, most IUGR-born animals survive but exhibit inef \ufb01cient\ngrowth and less desirable carcasses that create a great economic\nburden ( Greenwood et al., 1998 ;Ogata et al., 1999 ;Milligan BNF\nand Kramer, 2002 ). There is an explicitly-recognized need for more\nef\ufb01cient livestock production to feed the world \u2019\ns rapidly increasingpopulation, which is expected to double by 2050 ( Godfray et al.,\n2010 ). Improving growth ef \ufb01ciency in IUGR-born livestock would\nallow more food to be produced from the same number of animalswithout overgrowing normal animals. The clear impact of IUGR onlifelong health in humans and on sustainability for the livestockindustry makes strategies to target maladaptive fetal programming a\nfundamental need. This review presents the evidence for the role of\nin\ufb02ammatory programming in IUGR-associated metabolic\npathologies and discusses the potential nutraceutical ef \ufb01cacy of\nanti-in \ufb02ammatory omega-3 polyunsaturated fatty acids ( \u03c9-\n3 PUFA) in mitigating those outcomes.\n2 Characteristics of IUGR\n2.1 Placental insuf \ufb01ciency: the common\nculprit for IUGR\nFetal IUGR can result from any maternofetal stressor that stunts\nplacental development or otherwise limits fetal nutrient supply. Forhumans, environmental and social stresses, nutritional imbalancedue to poor or limited diet, unhealthy lifestyle choices, and\npregnancies occurring after the age of 35 are some of the many\nfactors that increase the risk of impaired placental development andgrowth ( Beard et al., 2009 ;Nardozza et al., 2017 ). For livestock,\ncommon causes of fetal and placental growth restriction includechronic heat stress, restricted feed intake due to drought ormismanagement, and grazing of noxious forages ( Greenwood and\nCafe, 2007 ;Robinson et al., 2013 ). Placental insuf \ufb01ciency is also\ncommon in small ruminants carrying multi-fetal pregnancies and in\nswine carrying large litters ( Milligan BNF and Kramer, 2002 ;De\nBlasio et al., 2007a ). Inadequate blood \ufb02ow and/or nutrient supply\nduring the critical window for placental development (mid-gestationfor most species) causes stunting that ultimately prevents theplacenta from ful \ufb01lling the expanding nutritional needs of the\ngrowing fetus, even when the cause of stunting has been resolved(Burton and Jauniaux, 2018 ). As the fetus outgrows the stunted\nplacenta in late gestation, progressive IUGR ensues in a predictable\npattern ( Nardozza et al., 2017 ). Several animal models have been\ndeveloped to study IUGR, from pigs ( Tang and Xiong, 2022 ) to non-\nhuman primates ( Chassen et al., 2020 ). Sheep are particularly good\nfor IUGR research. The clinical characteristics and developmentalmilestones of sheep pregnancies are remarkably comparable tohumans and other ruminant livestock, as previously described indetail ( Yates et al., 2018 ;Beede et al., 2019 ). Sheep fetuses are\nuncommonly resilient, and ewes are typically easy to obtain and\nhouse ( Beede et al., 2019 ). A popular model for natural IUGR\ninduction is to expose pregnant ewes to chronic heat stress duringpeak placental growth, which reliably induces placental insuf \ufb01ciency\nand in turn fetal IUGR ( Beede et al., 2019 ). Other natural IUGR\nsheep models include maternal nutrient restriction, maternofetalin\ufb02ammation, high-altitude hypoxemia, and behavioral stress\n(Zhang et al., 1998 ;Beede et al., 2019 ). Placental insuf \ufb01ciency\ncan also be created arti \ufb01cially via placental embolization,\numbilical artery ligation, or carunclectomy ( Beede et al., 2019 ).\nPlacental stunting is the result of stress-induced alterations in\nmaternal nutrient \ufb02ux. Normally, robust repartitioning of maternal\nnutrients occurs to support the gravid uterus, which is facilitated in\nFrontiers in Physiology frontiersin.org 02White and Yates 10.3389/fphys.2023.1250134\npart by greater uterine blood \ufb02ow ( Thaler et al., 1990 ). Chronic\nstress reduces maternal nutrient repartitioning to the uterus byslowing uterine blood \ufb02ow up to 50% in sheep models ( Thureen\net al., 1992 ;Lang et al., 2000 ;Wallace et al., 2008 ). Reduced uterine\nO\n2delivery is particularly damaging, as a rodent model of maternal\nhypoxemia yielded placental and fetal IUGR despite a compensatory\nincrease in uterine blood \ufb02ow ( Lane et al., 2020 ). Placental\nvasculature expands rapidly beginning about 0.3 of pregnancy,and stress-induced suppression of vasculogenesis during thiscritical window cannot be recovered later in pregnancy ( Burton\nand Jauniaux, 2018 ). Underdeveloped placental villi and poor\nfetoplacental angiogenesis in IUGR pregnancies culminate in asmuch as two-fold reductions of placentome volume andmaternofetal vascular interface ( Mayhew et al., 2004 ;Edwards\net al., 2020 ). Indeed, reduced peripheral capillary and villous\nsurface areas are hallmarks of the IUGR placenta ( Teasdale,\n1984 ). Not surprisingly, two key angiogenic factors are\ndysregulated in IUGR placental tissues: vascular endothelialgrowth factor (VEGF) and placental growth factor (PlGF)(Regnault et al., 2002 ;Regnault et al., 2003 ). Diminished\nmaternofetal interface slows the movement of O\n2, glucose, and\nother molecules that cross the placenta via simple or facilitated\ndiffusion ( Regnault et al., 2003 ). Studies in IUGR sheep indicate a\n50%\u201370% disparity in maternofetal O 2gradients ( Limesand et al.,\n2007 ;Beer et al., 2021 ). Nutrients that cross via facilitated diffusion\nor active transport are also slowed by reduced placental expressionof transporters. For example, sheep pregnancies made IUGR bymaternal overfeeding or heat stress had reduced placental glucosetransport ( Wallace et al., 2003 ;Brown et al., 2015 ) that coincided\nwith less of the Glut1, Glut3, and Glut8 glucose transporters\n(Wallace et al., 2005 ). Placental transport of amino acids was also\nreduced in IUGR sheep pregnancies ( Brown et al., 2012 ). In humans\nand rodents, this coincided with downregulation of the Na\n+-\ndependent neutral amino acid transporter A system, whichmoves alanine, serine, glutamine and glycine ( Jansson et al.,\n2006 ;Shibata et al., 2008 ;Alkhalefah et al., 2021 ). Conversely,\nplacental fatty acid transporters were downregulated in IUGRmice but increased in the placenta of nutrient-restricted baboons\nand in human pregnancies complicated by IUGR ( Assumpcao et al.,\n2017 ;Xu et al., 2019 ;Chassen et al., 2020 ).\n2.2 The hallmark IUGR fetal phenotype\n2.2.1 Fetal pathophysiology\nStress-stunted placentas can typically ful \ufb01ll the relatively modest\nfetal nutrient demands in early and mid-gestation, but exponential\nfetal growth during late gestation pushes O 2and nutrient\nrequirements beyond the capacity of the stunted placenta(Limesand et al., 2013 ;Macko et al., 2013 ). As the fetus\ncontinues to grow, nutrient de \ufb01cits progressively worsen. Natural\nsheep models for IUGR produce up to 50% reductions in fetal bloodglucose near term ( Saker et al., 1999 ;Limesand et al., 2007 ;Yates\net al., 2016 ;Edwards et al., 2020 ). Endogenous hepatic glucose\nproduction is engaged in the IUGR fetus but only partially\ncompensates for its hypoglycemia ( Fowden and Silver, 1995 ;\nLimesand et al., 2007 ;Thorn et al., 2009 ;Thorn et al., 2013 ). In\nresponse to limited nutrient availability, the fetus engages its ownnutrient repartitioning adaptations that prioritize vital nervous and\nendocrine tissues over others, particularly skeletal muscle ( Poudel\net al., 2015 ). Greater circulating lactate concentrations observed\nwhen IUGR fetal sheep were experimentally made hyperglycemicwere consistent with a shift in muscle glucose metabolism fromoxidative phosphorylation to anerobic glycolysis ( Thorn et al., 2013 ;\nLacey et al., 2021 ). Such shift coincides with and is perhaps\nnecessitated by the hypoxemic state of the fetus ( Regnault et al.,\n2003 ;Brown et al., 2015 ). However, less oxidative phosphorylation\ndiminishes energy status by reducing production of ATP ( Cree-\nGreen et al., 2018 ). Despite this, IUGR fetuses exhibited greater\ncirculating CO\n2due to compromised placental gas transfer, which\ncan affect acid-base balance ( Macko et al., 2013 ;Lacey et al., 2021 ).\nDisruptions in lipid homeostasis included 10% \u201325% lower\ncirculating cholesterol, which were reported in IUGR human and\nrodent fetuses at term despite markedly higher precursorconcentrations and slower clearance rates ( Cadaret et al., 2019a ;\nPecks et al., 2019 ). This indicates that de \ufb01cits were due at least\npartially to impaired de novo cholesterol synthesis by the IUGR fetal\nliver rather than solely due to de \ufb01cient placental transport.\nConversely, ~15% reductions in circulating triglycerides coincidedwith less placental fatty acid transporter expression and greater\ndisparity in maternofetal triglyceride gradients in IUGR fetal models\n(Meyer et al., 2010 ;Cadaret et al., 2019a ;Xu et al., 2019 ). Diminished\nplacental amino acid transporter expression together with lesseffective Na\n+/K+-ATPase support is re \ufb02ected in circulating amino\nacid pro \ufb01les in IUGR fetuses ( Stremming et al., 2020 ;Rosario et al.,\n2021 ).Brown et al. (2012) observed reduced placental transport of\nisoleucine, leucine, phenylalanine, tryptophan, methionine, andtyrosine, which notably lowered fetal circulating arginine and\nmethionine and muscle protein synthesis patterns in IUGR fetal\nsheep. Interestingly, concentrations of some amino acids wereactually increased in these fetuses, which was presumably abyproduct of reduced protein synthesis ( Armstrong, 1973 ). Even\nelectrolyte homeostasis can be disrupted by placental insuf \ufb01ciency,\nas fetal blood concentrations of Na\n+,K+,C a++, and Cl\u2212were\nincreased in IUGR fetal sheep ( Jansson et al., 2006 ;Bacchetta\net al., 2009 ;Beer et al., 2021 ;Lacey et al., 2021 ).\nNutrient and O 2paucities stimulate fetal stress responses that\ninclude systemic in \ufb02ammatory and adrenergic components ( Yates\net al., 2012a ;Berbets et al., 2021 ). Hypoxemia, and to a lesser extent\nhypoglycemia, stimulate secretion of the catecholaminesnorepinephrine and epinephrine from the fetal adrenal medulla(Gardner et al., 2002 ;Ly et al., 2011 ;Yates et al., 2012a ). Circulating\nnorepinephrine (the primary fetal adrenal catecholamine) waselevated by as much as 8-fold in IUGR fetal sheep, and\nhypercatecholaminemia was among the earliest indicators of\nplacental insuf \ufb01ciency ( Macko et al., 2013 ;Chang et al., 2019a ).\nCatecholamines are most associated with physiological mechanismsaimed at immediate survival, and sustained exposure of tissues candisrupt \u03b2adrenergic programming, the details and implications of\nwhich have been reviewed elsewhere ( Yates et al., 2011 ;Posont et al.,\n2017 ;Gibbs and Yates, 2021 ). Perhaps the most consequential effect\nof fetal hypercatecholaminemia is suppressed insulin activity. Basal\ncirculating insulin concentrations were often modestly decreased in\nIUGR fetal sheep, but glucose-stimulated insulin secretion wasalmost completely suppressed ( Leos et al., 2010 ;Macko et al.,\n2013 ;Cadaret et al., 2019b ). In contrast, maternal nutrient\nFrontiers in Physiology frontiersin.org 03White and Yates 10.3389/fphys.2023.1250134\nrestriction-induced IUGR did not affect insulin concentrations\n(Edwards et al., 2020 ), which indicates that hypoxemia and\nhypercatecholaminemia are the suppressors of insulin secretion.Not surprisingly, circulating IGF-1 concentrations were likewisereduced in IUGR fetal sheep during mid- and late-gestation ( Thorn\net al., 2009 ;Macko et al., 2013 ;Rozance et al., 2018 ). As hypoxemia\nstimulates the adrenal medulla, hypoglycemic conditions stimulate\nthe adrenal cortex to secrete cortisol, a steroid stress hormoneassociated with changes in intermediary metabolism ( Thorn\net al., 2013 ;Jonker et al., 2018 ). This has been documented\nacross many IUGR models and among several species(Sutherland et al., 2012 ;Li et al., 2013 ;Thorn et al., 2013 ), and it\nmay ultimately lead to reduced sensitivity of the cortisol axis ( Iwata\net al., 2019 ). Despite the anti-in \ufb02ammatory effects of cortisol, IUGR\nfetuses exhibited elevated circulating in \ufb02ammatory cytokines,\nincluding tumor necrosis factor \u03b1(TNF \u03b1),interleukin-1 \u03b2(IL-1 \u03b2),\nand IL-6 ( Cadaret et al., 2019b ;Zhang et al., 2021 ), and lower\nconcentrations of anti-in \ufb02ammatory IL-10 and IL-12 ( Huang et al.,\n2019 ). Cytokines mediate in \ufb02ammatory responses to pathogens,\nreactive oxygen species, and toxins, but they are also responsive tohypoxemia and other physiological stressors ( Lacy and Stow, 2011 ;\nHicks and Yates, 2021 ). They are released in greatest volume from\ncirculating white blood cells and resident tissue macrophages and\nmast cells, and they act on tissues throughout the body ( Tracey and\nCerami, 1993 ;Lacy and Stow, 2011 ). Elevated in \ufb02ammatory\ncytokines in IUGR fetuses can increase catabolism of skeletalmuscle and affect mobilization of nutrient stores ( Hicks and\nYates, 2021 ). The concurrent appearance of systemic\nin\ufb02ammation and hypercatecholaminemia in near-term IUGR\nfetuses is somewhat paradoxical, as macrophagic release of TNF \u03b1\nand IL-6 is suppressed by adrenergic stimulation under normal\nconditions ( Donnelly et al., 2010 ;Papandreou et al., 2016 ).\nNonetheless, the combined heightened in \ufb02ammatory and\nadrenergic tones mediate many of the changes in metabolismand growth that IUGR fetuses exhibit ( Macko et al., 2013 ;Hicks\nand Yates, 2021 ).\n2.2.2 Fetal growth restriction\nThe bodyweights of IUGR fetal sheep and pigs were reduced by\nas much as 55% near term ( Tree et al., 2016 ;Cadaret et al., 2019c ;\nTang and Xiong, 2022 ), and IUGR-born offspring remained lighter\nwell into the neonatal period ( Gibbs et al., 2020 ;Shoji et al., 2020 ).\nHowever, growth restriction is not equivalent among all fetal tissues.In fact, sustained nutrient insuf \ufb01ciency and the resulting fetal stress\nresponse yields hallmark asymmetric growth by disproportionallyslowing muscle accretion relative to cranial and skeletal growth\n(Lapillonne et al., 1997 ). This was re \ufb02ected in reduced muscle\nprotein accretion rates, muscle morphometrics, and body length-to-mass ratios of IUGR fetal sheep ( Yates et al., 2016 ;Rozance et al.,\n2018 ;Cadaret et al., 2019b ). In human fetuses for whom adiposity is\nnaturally high, disproportionally slower fat deposition was alsoapparent from ultrasound diagnosis of IUGR ( Padoan et al.,\n2004 ;Ikenoue et al., 2021 ). The fetal hypoxemia-\nhypercatecholaminemia-hypoinsulinemia cascade appears\ninstrumental in muscle growth restriction, as experimental\ninduction of each factor individually produced some degree ofIUGR in sheep ( Philipps et al., 1991 ;Bassett and Hanson, 1998 ;\nRozance et al., 2018 ). Hypoxemia-induced in \ufb02ammation alsolimited muscle mass by increasing protein catabolism, reducing\nprotein accretion, and altering muscle stem cell function ( Li W.\net al., 2009 ;Wang et al., 2014 ;Madaro et al., 2018 ;Posont et al.,\n2022 ). Less severe reductions in body length, head circumference,\nand cannon bone length observed in IUGR fetal lambs re \ufb02ected the\nmodest nature of structural growth restriction ( Rozance et al., 2018 ;\nCadaret et al., 2019c ;Sandoval et al., 2020 ). As with bodyweight,\nhowever, these mild de \ufb01cits in structural metrics persisted postnatal\n(Gibbs et al., 2020 ;Shoji et al., 2020 ). Ultimately, most IUGR-born\noffspring undergo a period of catch-up growth that diminishes oreliminates their weight disparity ( Dulloo et al., 2006 ). However, this\ncompensatory weight gain results from greater fat accumulation anddoes not re \ufb02ect recovery of muscle mass ( Ong et al., 2000 ;Gibbs\net al., 2020 ). Consequently, IUGR-born adolescents and adults are\nmore likely to develop high body mass indices ( Fagerberg et al.,\n2004 ;Zinkhan et al., 2018 ). For humans, altered body composition\nwas associated with a higher risk for metabolic and cardiovasculardysfunction later in life ( Ong et al., 2000 ;Fagerberg et al., 2004 ). In\nfood animals, IUGR-altered body composition resulted in smallerand less valuable carcasses ( Greenwood et al., 2005\n;Greenwood and\nBell, 2019 ).\nPreferential reappropriation of fetal nutrients from muscle and\nother peripheral soft tissues to vital brain and endocrine tissues is\nre\ufb02ected in blood \ufb02ow patterns. In IUGR fetal sheep, blood \ufb02ow was\nmaintained or increased in every region of the brain, and pancreaticand adrenal blood \ufb02ow increased by up to 2-fold ( Poudel et al.,\n2015 ). Conversely, blood \ufb02ow to the hindlimb, which is about 45%\nskeletal muscle ( Hicks et al., 2021 ), was reduced by half ( Poudel\net al., 2015 ;Hicks et al., 2021 ). In a baboon model of IUGR, less\nhindlimb blood \ufb02ow was associated with decreased size and\ndistensibility of the external iliac and femoral arteries, which was\nsustained into adulthood ( Kuo et al., 2018 ). In contrast, lower\nultrasound-estimated resistance in the carotid artery of humanIUGR fetuses re \ufb02ected the brain-sparing characteristic of\nasymmetric growth restriction ( Groenenberg et al., 1989 ).\nPreferential delivery of blood and nutrients maintained brainweights across sheep models for IUGR ( Yates et al., 2016 ;\nRozance et al., 2018 ;Wallace et al., 2020 ;Posont et al., 2021 )\neven when heart, lung, and liver weights were reduced ( Hyatt\net al., 2007 ;Cadaret et al., 2019b ;Wallace et al., 2020 ). Not\nsurprisingly, weights of individual hindlimb muscles relative tofetal weight or hindlimb length were reduced in IUGR fetalsheep by up to 40% ( Rozance et al., 2018 ;Lacey et al., 2021 ).\nImpaired myoblast function and slower protein synthesis each\ncontributed to reduced IUGR muscle mass ( Yates et al., 2014 ;Soto\net al., 2017 ;Rozance et al., 2018 ;Felicioni et al., 2020 ), which\npersisted after birth ( De Blasio et al., 2007a ;Gosby et al., 2009 ;\nGibbs et al., 2020 ). Myoblasts are the myogenic stem cells that\nfacilitate muscle \ufb01ber hypertrophy in late gestation and after birth\nwhen \ufb01ber numbers have become largely static ( Maier et al., 1992 ;\nWilson et al., 1992 ). Myoblasts undergo rate-limiting proliferation\nand differentiation steps before fusing with existing muscle \ufb01bers to\nincrease the myonuclear content/protein capacity of the \ufb01ber (Allen\net al., 1979 ;\nYates et al., 2012b ). Histological and ex vivo assessments\nindicated that differentiation capacity was impaired in myoblasts\nfrom IUGR fetal lambs ( Yates et al., 2014 ;Yates et al., 2016 ;Soto\net al., 2017 ;Posont et al., 2022 ). Myoblast proliferation was also\ntypically reduced by IUGR intrauterine conditions, although\nFrontiers in Physiology frontiersin.org 04White and Yates 10.3389/fphys.2023.1250134\nTABLE 1 Summary of literature reporting stress-induced placental and fetal growth restriction.\nAge Species Placental weight Body weight Organ/Muscle weight Study\nSpontaneous IUGR\nNewborns Humans \u219334% Krajewski et al. (2014)\n\u219333% Miranda et al. (2018)\n\u219369% \u219380% Paolini et al. (2001)\n\u219334% Pecks et al. (2019)\n\u219313% Sharma et al. (2007)\n\u219312% Xiao and Li (2005)\n\u219312% \u219314% Souza et al. (2016)\nMaternal Nutrient Restriction\nFetus Baboon \u219310% \u21937% Brain, ND Chassen et al. (2020)\nMouse \u219338% \u219348% Ganguly et al. (2016)\nRat \u219312% \u219321% Jansson et al. (2006)\n\u219326% Brain, ND Liver, \u219326% Sadiq et al. (1999)\n\u21939% \u219315% Brain, ND Kidney, ND Alkhalefah et al. (2021)\nLiver, ND Heart, ND\nSheep \u21930%\u201332% Brain, \u21930%\u20139% Kidney, \u21930%\u201324% Sandoval et al. (2020)\nLiver, \u219311%\u201343% Heart, \u21930%\u201322%\nGastrocnemius ,\u21930%\u201330% Soleus ,\u21930%\u201333%\nL. dorsi ,\u21930%\u201338% Fiber CSA, \u21930%\u201331%\n\u219321% Liver, \u219315% Zhang et al. (2021)\nNeonate Baboon \u219310% Heart, ND Kuo et al. (2018)\nRat \u219311% Chen et al. (2016)\nND Brain, ND Liver, ND Sadiq et al. (1999)\n\u219314% Desai et al. (2009)\n\u219311% Liver, \u219314% He et al. (2018)\n\u21934% Gosby et al. (2009)\n\u219312% Tree et al. (2016)\n\u219336% Xing et al. (2019)\nMouse \u21938% Chisaka et al. (2015)\nMaternal Overnutrition\nFetus Sheep \u219346% \u219334% Brain, \u21939% Liver, \u219336% Wallace et al. (2003)\n\u219326% Wallace et al. (2008)\nNeonate Sheep \u219333% Wallace et al. (2008)\n\u219343% \u219342% Wallace et al. (2020)\nMaternofetal In \ufb02ammation\nFetus Rat \u21938% Hindlimb CSA, \u219314% Cadaret et al. (2019a)\nSheep \u219322% Brain, ND Kidney, \u219323% Cadaret et al. (2019b)\nLiver, \u21938% Lungs, \u21939%\nHeart, \u21938%\n(Continued on following page)\nFrontiers in Physiology frontiersin.org 05White and Yates 10.3389/fphys.2023.1250134\nTABLE 1 ( Continued ) Summary of literature reporting stress-induced placental and fetal growth restriction.\nAge Species Placental weight Body weight Organ/Muscle weight Study\nNeonate Sheep \u219318% Brain, ND Kidney, \u219316% Posont et al. (2021)\nLiver, \u21939% Lungs, \u219314%\nHeart, \u219324%\nMaternal Heat Stress\nFetus Sheep \u219355% \u219343% Brain, \u219314% Liver, \u219347% Brown et al. (2012)\nCarcass, \u219348%\n\u219347% \u219340% Brown et al. (2015)\n\u219340% Biceps femoris ,\u219345% Tibialis anterior ,\u219348% Chang et al. (2019a)\nFlexor dig. super \ufb01cialis ,\u219348% Fiber CSA, \u219337%\nFiber no., \u219332%\n\u219336% \u219336% Brain, \u219311% Kidney, \u219329% Chang et al. (2021)\nLiver, \u219327% Lungs, \u219334%\nHeart, \u219328% Pancreas, \u219321%\nSpleen, \u219332% Tibialis anterior ,\u219335%\nFlexor dig. super \ufb01cialis ,\u219333% Gastrocnemius ,\u219337%\nExtensor dig. longus ,\u219357% Soleus ,\u219358%\nFiber CSA, \u219336% Fiber no., \u219340%\n\u219326% Brain, \u21939% Kidney, \u219324% Lacey et al. (2021)\nLiver, \u21939% Lungs, \u219325%\nHeart, \u219322% Hindlimb, \u219323%\nSemitendinosus ,\u219326% Soleus ,\u219342%\nFlexor dig. super \ufb01cialis ,\u219336% L. dorsi ,\u219325%\n\u219358% Pancreas, \u219359% Limesand et al. (2005)\n\u219360% \u219355% Limesand et al. (2006)\n\u219340% \u219315% Brain, ND Liver, \u219322% Limesand et al. (2013)\nPancreas, \u21938%\n\u219338% \u21933% Brain, ND Liver, ND Macko et al. (2013)\n\u219368% \u219353% Brain, \u219315% Semitendinosus ,\u219351% Pendleton et al. (2019)\nBiceps femoris ,\u219350%\nMaternal Heat Stress (Cont \u2019d)\nFetus Sheep \u219351% \u219342% Regnault et al. (2003)\n\u219354% \u219356% Pancreas, \u219342% Rozance et al. (2015)\n\u219342% \u219341% Brain, \u219314% Hindlimb, \u219346% Rozance et al. (2018)\nBiceps femoris ,\u219345% Gastrocnemius .,\u219345%\nFlexor dig. super \ufb01cialis ,\u219348% Tibialis anterior ,\u219348%\nExtensor dig. longus ,\u219345%\n\u219336% Bicpes femoris ,\u219332% Gastrocnemius .,\u219332% Soto et al. (2017)\nTibialis anterior ,\u219323% Soleus ,\u219325%\n(Continued on following page)\nFrontiers in Physiology frontiersin.org 06White and Yates 10.3389/fphys.2023.1250134\nTABLE 1 ( Continued ) Summary of literature reporting stress-induced placental and fetal growth restriction.\nAge Species Placental weight Body weight Organ/Muscle weight Study\n\u219360% \u219356% Liver, \u219362% Thorn et al. (2009)\n\u219341% \u219338% Thorn et al. (2013)\n\u219353% \u219335% Liver, \u219343% Heart, \u219338% Wai et al. (2018)\nKidney, \u219347% Pancreas, \u219314%\nSpleen, \u219343% Biceps femoris ,\u219334%\nFlexor dig. super \ufb01cialis ,\u219348% Tibialis anterior ,\u219335%\nExtensor dig. longus ,\u219333% Gastrocnemius ,\u219337%\n\u219370% \u219368% Yates et al. (2014)\n\u219356% \u219355% Yates et al. (2016)\nNeonate Sheep \u219350% \u219321% Chen et al. (2010)\n\u219333% Yates et al. (2019)\n\u219321% Brain, ND Liver, ND Cadaret et al. (2022)\nHeart, \u219337% Lungs, \u21939%\nKidney, \u219313% Hindlimb, \u219332%\nFlexor dig. super \ufb01cialis ,\u219319%\nJuvenile Sheep \u219312% Brain, ND Liver, \u219313% Gibbs et al. (2021)\nHeart, \u219329% Lungs, \u219329%\nKidney, \u219315% Hindlimb, \u219317%\nFlexor dig. super \ufb01cialis ,\u219322% L. dorsi CSA, \u219314%\nFiber CSA, \u219321%\nCarunclectomy\nFetus Sheep \u219365% \u219333% Brain, \u21939% Liver, \u219351% Poudel et al. (2015)\nHeart, \u219336% Kidney, \u219329%\nLungs, \u219340% Pancreas, \u219332%\nSpleen, \u219352%\nNeonate Sheep \u219326% Fat, ND Adipocyte CSA, ND Duf\ufb01eld et al. (2009)\n\u219339% \u219325% Fat, \u219140% Semitendinosus ,\u219318% De Blasio et al. (2007a)\nBiceps femoris ,N D Flexor capri ,\u219349%\nGastrocnemius ,\u219318% Tibialis anterior ,\u219332%\nSoleus ,N D Vastus lateralis ,\u219330%\nExtensor dig. longus ,N D\nJuvenile Sheep ND Fat, \u219149% De Blasio et al. (2007b)\nUterine Artery Ligation\nFetus Rat \u219326% Brain, ND Liver, \u219326% Sadiq et al. (1999)\nSheep \u219327%\u201334% \u219315%\u201333% Brain, \u21930%\u20136% Liver, \u219328%\u201336% Lang et al. (2000)\nHeart, \u219316%\u201331% Lungs, \u219311%\u201327%\n(Continued on following page)\nFrontiers in Physiology frontiersin.org 07White and Yates 10.3389/fphys.2023.1250134\nproliferation was increased in one model induced by maternofetal\nin\ufb02ammation ( Soto et al., 2017 ;Cadaret et al., 2019a ;Posont et al.,\n2022 ). Myoblast dysfunction is re \ufb02ected in expression of key\nmyogenic transcription factors, which hint at mechanisms forIUGR myoblast de \ufb01cits. Speci \ufb01cally, differentiation factors myoD\nand myogenin were reduced in IUGR fetal myoblasts near term,whether assessed in vivo orex vivo (Yates et al., 2014 ;Chang et al.,\n2019b ;Rozance et al., 2021 ;Posont et al., 2022 ). Reduced myoblast\nproliferation, differentiation, and fusion slowed myonuclear\naccumulation in all muscle \ufb01ber types, which in IUGR fetal\nlambs restricted cross-sectional \ufb01ber area by as much as 60%\n(Yates et al., 2016 ;Chang et al., 2019b ). Smaller muscle \ufb01bers\nhave also been documented in IUGR piglets and rats ( Cadaret\net al., 2019a ;Felicioni et al., 2020 ). Although some variation\nexists among IUGR models, species, and even speci \ufb01c muscles,\ndisproportional reduction of muscle and other soft tissues as ameans of sparing brain and structural growth is a well-conserved\nphenotype. Table 1 illustrates the distinct size reductions of speci \ufb01c\ntissues and organs that yield asymmetric body composition.\n2.2.3 Fetal metabolic adaptations: muscle glucose\nmetabolism\nLimiting skeletal muscle growth contributes to fetal nutrient\nsparing necessitated by placental insuf \ufb01ciency ( Brown, 2014 ).\nAdditionally, the IUGR fetus alters tissue-speci \ufb01c utilization,\nmetabolism, and storage of nutrients ( Rozance and Wolfsdorf,\n2019 ;Yates et al., 2019 ;Zhang et al., 2021 ). As with growth\nrestriction, these changes disproportionally affect muscle. SeveralIUGR fetal sheep models found that muscle-speci \ufb01c glucose\noxidation rates were reduced by up to 80% near term, whichalong with reduced hepatic oxidative metabolism produced a~50% reduction in whole-fetus glucose oxidation ( Peterside et al.,\n2003 ;Limesand et al., 2007 ;Brown et al., 2015 ;Cadaret et al., 2019b ).\nThis de \ufb01cit was observed under normal resting conditions and\nexperimental hyperinsulinemia, and it persisted well after birth(Gibbs et al., 2021 ;Posont et al., 2021 ;Cadaret et al., 2022 ).\nImpaired glucose oxidation also occurred despite normal rates ofglucose uptake by muscle, which has been observed before ( Rozance\net al., 2018 ;Cadaret et al., 2019c ) and after birth ( Gibbs et al., 2021 ;\nPosont et al., 2021 ;Cadaret et al., 2022 ). Although IUGR muscle\nexpressed less of the insulin-dependent glucose transporter Glut4 insome studies ( De Blasio et al., 2012 ;Duan et al., 2016 ;Yates et al.,\n2019 ;Jones et al., 2022 ), glucose uptake may have been rescued by an\nincrease in the insulin-independent transporter Glut1 ( Brown et al.,\n2015 ;Yates et al., 2019 ). Moreover, it should be noted that some\nstudies found no changes in IUGR muscle content of Glut1 or Glut4(Limesand et al., 2007 ;Garg et al., 2009 ). Not surprisingly,\nGlut1 expression in the brain was increased by over 60% inIUGR fetal lambs and rats as well as in IUGR-born neonatal rats(Sadiq et al., 1999 ;Limesand et al., 2007 ), which is consistent with\nbrain sparing during chronic hypoglycemia ( Gibbs and Yates, 2021 ).\nReduced skeletal muscle glucose oxidation rates coincided with\nlower proportions of slow oxidative (type I) \ufb01bers relative to\nintermediate (type IIa) and fast glycolytic (type IIx) \ufb01bers in\nhindlimb muscles of IUGR fetal sheep and loin muscles of IUGRfetal pigs ( Wang et al., 2013 ;Yates et al., 2016 ;Stremming et al.,\n2022 ). Furthermore, IUGR muscle exhibited reduced activity of\npyruvate dehydrogenase and citrate synthase enzymes that generate\nKrebs cycle intermediates, as well as increased expression of\n(inhibitory) pyruvate dehydrogenase kinase and impairedfunction of Electron Transport Chain Complex I ( Brown et al.,\n2015 ;Pendleton et al., 2019 ;Stremming et al., 2022 ). These\nobservations, combined with reduced O 2utilization, normal\nglucose utilization, and greater lactate dehydrogenase B content(Brown et al., 2015 ;Pendleton et al., 2019 ), indicated that much of\nthe reduction in glucose oxidative phosphorylation was replaced by\ngreater glycolytic lactate production. This is evident in elevated\ncirculating lactate concentrations, which were as much as 3-foldgreater in IUGR fetuses, particularly during experimentalhyperglycemia or hyperinsulinemia ( Limesand et al., 2007 ;Davis\net al., 2021 ;Camacho et al., 2022 ). Lactate-O\n2quotient was also 2-\nfold greater, meaning that more lactate was produced from eachmole of O\n2consumed ( Rozance et al., 2018 ). Like other IUGR\npathologies, hyperlactatemia appears to be driven primarily by\nhypoxemia-induced hypercatecholaminemia. In fetal sheep made\nexperimentally hypoxemic (but not hypoglycemic) for 9 days, the 3-fold increase in circulating norepinephrine resulted in 20% lessglucose oxidation, 3.5-fold greater circulating lactate, and 2-foldgreater fetal lactate production ( Jones et al., 2022 ). This model also\ndemonstrated that hyperlactatemia may indicate condition severity,as circulating lactate concentrations were elevated by robust fetalhypercatecholaminemia (3-fold or greater increase) but not by aTABLE 1 ( Continued ) Summary of literature reporting stress-induced placental and fetal growth restriction.\nAge Species Placental weight Body weight Organ/Muscle weight Study\n\u219316% Lungs, \u219310% Sutherland et al. (2012)\nNeonate Rat ND Brain, ND Liver, \u21937% Sadiq et al. (1999)\nUterine Overcrowding\nNeonate Pig \u219340% Brain, \u219312% Liver, \u219345% Felicioni et al. (2020)\nHeart, \u219336% Semitendinosus ,\u219352%\nSemitendinosus CSA, \u219314% Fiber CSA, \u219316%\nFiber no., \u219332%\n\u219347% Niu et al. (2019)\nCSA, cross-sectional area; ND, not different.\nFrontiers in Physiology frontiersin.org 08White and Yates 10.3389/fphys.2023.1250134\nmore modest 1.4-fold increase in norepinephrine ( Jones et al., 2019 ;\nRozance et al., 2021 ;Jones et al., 2022 ). Catecholamine-induced\nhyperlactatemia also persisted in IUGR-born neonates ( Chen et al.,\n2010 ). Some studies have reported normal blood lactate in IUGR\nfetuses ( Wai et al., 2018 ;Cadaret et al., 2019b ;Pendleton et al., 2020 ),\nbut this does not necessarily mean that lactate was produced at\nnormal rates. Rather, IUGR fetuses were shown to engage hepatic\ngluconeogenesis that converts lactate and other substrates toglucose, a mechanism that is largely idle under normalintrauterine conditions ( Limesand et al., 2007 ). This was re \ufb02ected\nin elevated expression of gluconeogenic enzymes such asphosphoenolpyruvate carboxykinase and glucose 6-phosphataseand their transcriptional promoters in IUGR sheep, pigs, androdents in late gestation and after birth ( Peterside et al., 2003 ;\nVuguin et al., 2004 ;Limesand et al., 2007 ;Thorn et al., 2009 ;\nBrown et al., 2015 ;Ying et al., 2017 ). Hepatic gluconeogenesis\nallows the IUGR fetus to utilize greater skeletal muscle lactateproduction to partially offset poor glucose supply via the Coricycle ( Soeters et al., 2021 ).\n2.2.4 Fetal metabolic adaptations: amino acids and\nprotein cycling\nThe IUGR fetus \u2019s diminished protein supply affects utilization of\namino acids for tissue accretion and for energy production.Foundational work by researchers at the University of ColoradoSchool of Medicine found that hindlimb protein accretion wasreduced by 55% in IUGR fetal sheep ( Rozance et al., 2018 ;Wai\net al., 2018 ). This coincided with a comparable reduction in total\namino acid uptake rates by the hindlimb, although rates amongindividual amino acids were not affected uniformly ( Rozance et al.,\n2018 ). For example, hindlimb uptake rates of the essential branched-\nchain amino acids leucine, valine, and isoleucine, were reduced byup to 73% in IUGR fetal sheep, whereas alanine, glutamine, andglycine were actually secreted from the hindlimb, despite slightly lessprotein breakdown ( Chang et al., 2019a ). These differential \ufb02uxes\nare presumably an attempt at metabolic thrift, as branched-chainamino acids can be converted into alanine, glutamine, and glycine,which are substrates for hepatic gluconeogenesis ( Chang et al.,\n2019a ). Indeed, expression of enzymes that facilitate this\nconversion was greater for IUGR fetal rats and sheep ( Kloesz\net al., 2001 ;Chang et al., 2019a ). Interestingly, long-term infusion\nof essential amino acids into IUGR fetal sheep did not consistentlyincrease protein accretion, indicating that amino acid utilization wasrestricted by more than just the short supply ( Wai et al., 2018 ).\nTogether, these studies show de \ufb01nitively that protein accretion in\nthe IUGR fetus is impeded primarily by slower protein synthesis and\nnot by greater protein breakdown. Like amino acid uptake, the\nimpact of IUGR on individual amino acid oxidation rates is notuniform. For example, IUGR fetal sheep oxidized 47% less threonine(Anderson et al., 1997 ) but 2-fold more lysine ( Limesand et al.,\n2009 ). Leucine oxidation rates were reduced by 34% in one early\nstudy of IUGR fetal sheep ( Ross et al., 1996 ) but were normal in\nothers ( Rozance et al., 2018 ;Wai et al., 2018 ). Moreover, leucine\noxidation was not affected in fetal sheep made chronically\nhypoxemic ( Rozance et al., 2021 ), hypoglycemic ( Carver et al.,\n1997 ), hyperglucagonemic ( Cilvik et al., 2021 ), or\nhyperinsulinemic ( Brown et al., 2016 ) late in gestation, but it was\nmarkedly reduced by elevated circulating IGF-1 ( Stremming et al.,2021 ). A greater amount of leucine was oxidized when normal\nfetuses were experimentally administered excess amino acids(Rozance et al., 2009 ;Maliszewski et al., 2012 ), but this effect was\nblunted in IUGR fetuses ( Brown et al., 2012 ). Amino acids and\nglucose are normally competitive oxidative substrates ( Brown et al.,\n2017 ). However, the apparent lack of compensatory amino acid\noxidation in IUGR fetuses despite substantial de \ufb01cits in glucose\noxidation may have been the result of mitochondrial de \ufb01cits. Indeed,\nIUGR fetal skeletal muscle had less citrate synthase, which is anindicator of intact and functional mitochondria ( Stremming et al.,\n2022 ). It also expressed less BCAT1 and BCAT2, the transaminase\nenzymes that convert leucine and isoleucine into the Krebs cycleintermediate succinate, and less ALT, the enzyme that convertsalanine to pyruvate ( Chang et al., 2019a ). The coincident de \ufb01cits in\nglucose and amino acid oxidation ultimately diminished ATP\ncontent in IUGR fetal muscle ( Stremming et al., 2020 ).\n2.2.5 Fetal metabolic adaptations: lipid\nhomeostasis\nThe impact of IUGR on lipid homeostasis is perhaps less clear.\nElevated triglycerides and non-esteri \ufb01ed (or free) fatty acids (NEFA)\nin cord blood at birth is a hallmark of IUGR in humans ( Youssef\net al., 2021 ;Chassen et al., 2022 ) and has been used for decades as a\nclinical indicator of fetal stress ( Elphick et al., 1978 ). High blood\nlipid concentrations in late gestation and after birth have also beendocumented in piglets with spontaneous IUGR (i.e., litter runts) ( Li\net al., 2018 ) and in several IUGR sheep models ( Wallace et al., 2014 ;\nWallace et al., 2020 ;Posont et al., 2021 ;Zhang et al., 2021 ), although\nwe are aware of at least one study that found reduced circulating\nNEFA in young IUGR-born lambs ( Duf\ufb01eld et al., 2009 ). The impact\nof IUGR on circulating cholesterol is similarly inconsistent and may\ndepend in part upon the lipoprotein to which cholesterol is bound.For example, Youssef et al. (2021) observed 23% greater total\ncholesterol but 20% less HDL-C in cord blood from IUGRbabies, whereas Pecks et al. (2012) reported reductions in both\ntotal cholesterol and HDL-C. Circulating cholesterol was elevated inseveral IUGR fetal sheep studies and correlated tightly with fetalweights ( Meyer et al., 2010 ;Zywicki et al., 2016 ;Sun et al., 2018 ;\nZhang et al., 2021 ). As neonates, however, IUGR-born lambs had\nnormal or even reduced circulating cholesterol, although HDL-Cwas still elevated ( Wallace et al., 2014 ;Posont et al., 2021 ). Changes\nin intracellular lipids within IUGR tissues may also differ betweenprenatal and postnatal stages. In fetal sheep, for example, IUGR dueto nutrient restriction or fetal crowding increased blood NEFA andtriglycerides by as much as 50% but reduced liver triglycerides andhepatic lipase, the enzyme responsible for their hydrolysis ( Meyer\net al., 2010 ;Zywicki et al., 2016 ;Sun et al., 2018 ;Zhang et al., 2021 ).\nIn IUGR fetal guinea pigs, hepatic utilization of palmitate (the mostcommon saturated fatty acid in animals and plants) was reduced byabout 50% ( Detmer et al., 1992 ). Conversely, IUGR-born neonatal\ngoats had greater liver accumulation of NEFA, triglycerides, andcholesterol ( Liu et al., 2022 ), and IUGR-born runt piglets had more\nexpansive hepatic lipid droplets, particularly after undergoing catch-up growth ( Wang et al., 2022 ). IUGR-induced changes in lipid\nmetabolism were largely tissue-speci \ufb01c, as were changes in de novo\nsynthesis. Shortly after birth, IUGR infants exhibited greater rates ofwhole-body triglyceride mobilization and fatty acid oxidation ( Patel\nand Kalhan, 1992 ). Moreover, gene expression for the key \u03b2-\nFrontiers in Physiology frontiersin.org 09White and Yates 10.3389/fphys.2023.1250134\noxidation facilitator PPAR \u03b1was increased in liver tissue from\nIUGR-born runt piglets ( Wang et al., 2022 ) and in cardiac\nmuscle from IUGR-born adult guinea pigs ( Botting et al., 2018 ).\nGene expression for CPT1 and HADHA, which play rate-limitingroles for fatty acid \u03b2-oxidation, was reduced in liver tissues of IUGR-\nborn rats ( Lane et al., 2001a ). However, skeletal muscle from these\nrats had greater CPT1 and HADHA expression along with greater\ntriglyceride content ( Lane et al., 2001b ). Cardiac muscle from IUGR\nfetal sheep also expressed less mRNA for CPT1 and for enzymesassociated with \u03b2-oxidation and esteri \ufb01cation of fatty acids ( Drake\net al., 2022 ). This coincided with greater circulating acylcarnitines,\nwhich are indicative of impaired or incomplete fatty acid oxidation(Drake et al., 2022 ). Fatty acid synthesis rates were reduced in liver\nand lung tissues of IUGR rat fetuses, but not in brain tissue ( Vileisis\net al., 1982 ). Interestingly, maternofetal O\n2supplementation did not\nrecover fatty acid synthesis in these fetuses, which indicates that thede\ufb01cit was not a product of hypoxemia ( Vileisis, 1985 ). As adults,\nfatty acid synthesis was normal in liver and muscle from IUGR-bornrats but was elevated in adipose tissues ( Yee et al., 2016 ). Disruptions\nin lipid homeostasis almost certainly contribute to greater adiposityin IUGR-born offspring ( Ong et al., 2000 ;Zinkhan et al., 2018 ).\nIndeed, IUGR-born lambs exhibited markedly greater insulin\nsensitivity for fat deposition ( De Blasio et al., 2007b ). They also\nproduced muted increases in circulating NEFA in response toepinephrine challenge, indicating a reduced capacity for lipidmobilization ( Harwell et al., 1990 ;Chen et al., 2010 ).\n2.2.6 Fetal metabolic adaptations: insulin secretion\nDe\ufb01cient insulin production and secretion is a key contributor\nto poor growth and metabolic dysfunction in IUGR fetuses and\noffspring ( Limesand et al., 2006 ;Xing et al., 2019 ). Large reductions\nin basal circulating insulin and complete inhibition of nutrient-stimulated insulin secretion observed in IUGR fetal sheep(Limesand et al., 2007 ;Cadaret et al., 2019b ) were the direct\nresult of fetal hypoxemia and hypoglycemia. To illustrate, whennormoxemia and euglycemia were experimentally restored for a 5-day period in IUGR fetal sheep, basal insulin concentrationsnormalized and glucose-stimulated insulin secretion was rescued\n(Camacho et al., 2022 ). Conversely, acute or chronic experimental\nhypoxemia or hypoglycemia in otherwise uncompromised fetalsheep reduced insulin secretion ( Rozance et al., 2006 ;Yates et al.,\n2012a ;Benjamin et al., 2017 ). Basal hypoinsulinemia was also\nresolved postnatal, as IUGR-born offspring were no longerhypoxemic or hypoglycemic after birth ( Posont et al., 2021 ;\nCadaret et al., 2022 ). The suppressive effects of these conditions,\nparticularly hypoxemia, on pancreatic \u03b2cell function are mediated\nin large part by adrenergic signaling. In fact, blocking the adrenergic\nresponse to IUGR conditions via pharmaceutical antagonists oradrenal demedullation not only rescued insulin secretion, but inmost cases revealed a compensatory enhancement in \u03b2cell stimulus-\nsecretion coupling ( Leos et al., 2010 ;Yates et al., 2012a ;Macko et al.,\n2013 ;Macko et al., 2016 ). Comparable enhancements in \u03b2cell\nfunction were observed following chronic norepinephrineinfusion into otherwise normal fetal sheep or rats ( Chen et al.,\n2014 ;Chen et al., 2017 ;Li et al., 2021 ). Despite greater sensitivity of \u03b2\ncells, IUGR pancreatic islets are poorly developed. Speci \ufb01c islet\nde\ufb01cits are reviewed in detail elsewhere ( Boehmer et al., 2017 ) but\ninclude smaller size with fewer \u03b2cells/islet, less production andsensitivity to growth factors, and poor vascularity ( Limesand et al.,\n2005 ;Styrud et al., 2005 ;Limesand et al., 2006 ;Ham et al., 2009 ;\nRozance et al., 2015 ).\n2.3 In \ufb02ammatory contributions to IUGR\npathologies\nSystemic in \ufb02ammation has been observed in IUGR fetuses of\nseveral species. Although the role of in \ufb02ammation in IUGR\npathologies are not fully characterized, overexposure toin\ufb02ammatory cytokines is known to disrupt progenitor cell\nfunction, tissue growth, and metabolism, as detailed in previousreviews ( Joanisse and Parise, 2016 ;Hicks and Yates, 2021 ;Most and\nYates, 2021 ). In\ufb02ammatory cytokines such as TNF \u03b1, IL-1 \u03b2, and IL-6\nwere increased in blood and liver of IUGR fetal lambs and mice(Hudalla et al., 2018 ;Cadaret et al., 2019b ;Zhang et al., 2021 ) and in\ncord blood of IUGR infants ( Amarilyo et al., 2011 ). In humans,\npiglets, and rats, circulating in \ufb02ammatory cytokines remained\nelevated for the \ufb01rst few hours, days, or even weeks after birth\n(Krajewski et al., 2014 ;Riddle et al., 2014 ;Chisaka et al., 2015 ;\nHuang et al., 2019 ). Eventually, however, high circulating cytokine\nconcentrations subsided and in many cases even fell below normal;\nplasma TNF \u03b1was reduced by 50% in IUGR-born neonatal lambs\n(Posont et al., 2021 ), and IFN \u03b3, IL-1 \u03b2, IL-4, and IL-8 concentrations\nwere reduced in young IUGR-born piglets ( Zhong et al., 2012 ).\nResting blood TNF \u03b1, IL-6, and IL-1 \u03b2concentrations were normal in\nIUGR-born adult rats but were 25% \u201340% less elevated in response to\nimmune challenge ( Desai et al., 2009 ;Rueda-Clausen et al., 2011 ).\nWe should note that at least one study of IUGR-born adult rats\nobserved modestly greater circulating in \ufb02ammatory cytokines ( He\net al., 2018 ), although the reason for this unusual \ufb01nding was not\nclear. Moreover, when these researchers produced IUGR pigletsusing the same model of maternal nutrient restriction, they foundpostnatal circulating cytokine concentrations that were indeedbelow normal ( Dong et al., 2015 ).\nPostnatal reductions in circulating in \ufb02ammatory cytokines are\nlikely a compensatory response to heightened in \ufb02ammatory\nsensitivity that develops in several IUGR fetal tissues and persists\nafter birth ( Hicks and Yates, 2021 ). In a landmark example from\nhumans, the soluble form of the TNF \u03b1receptor, TNFR1, was\nobserved to be 2.5-fold greater in the umbilical cord of IUGR\nnewborn infants ( Laskowska et al., 2007 ). Enhanced\nin\ufb02ammatory sensitivity is also apparent in IUGR skeletal\nmuscle, as hindlimb muscles from IUGR fetal sheep and ratsexhibited greater gene expression for TNFR1, the IL-6 receptor\n(IL6R), and even the TWEAK receptor (Fn14) near term ( Cadaret\net al., 2019a ;Posont et al., 2022 ). Muscle from these IUGR fetal\nsheep also contained less of the NF \u03baB arrest protein, I \u03baB\u03b1(Posont\net al., 2022 ). As neonates, IUGR-born lambs continued to exhibit\ngreater skeletal muscle TNFR1 content, although I \u03baB\u03b1content was\nincreased, perhaps in compensation ( Posont et al., 2021 ). Adaptive\nenrichment of in \ufb02ammatory signaling components in the muscle of\nIUGR-born offspring may arise in part from intrauterine\nprogramming of muscle progenitors, which are established\nprenatal but are incorporated into muscle over the entire lifespan(Allen et al., 1979 ). Indeed, myoblasts isolated from IUGR fetal\nsheep had greater gene expression for TNFR1, IL6R, and TLR4 and\nFrontiers in Physiology frontiersin.org 10White and Yates 10.3389/fphys.2023.1250134\nalso had more c-Fos, a cytokine-responsive protein that can disrupt\ncellular differentiation ( Posont et al., 2022 ). In culture, these IUGR\nfetal myoblasts exhibited greater phosphorylation of NF \u03baB when\nstimulated with TNF \u03b1and were more sensitive to inhibitors of the\ncanonical signaling enzyme, I \u03baB kinase, under basal conditions\n(Posont et al., 2022 ). The impact of enhanced in \ufb02ammatory\nsensitivity in skeletal muscle on growth and metabolichomeostasis is substantial, as the tissue comprises about 60% oftotal juvenile body mass and expands substantially between fetal andjuvenile stages ( Calnan et al., 2021 ;Hicks et al., 2021 ). As illustrated\ninFigure 1 , however, it is not the only tissue to develop this\nphenotype. Fat tissues of IUGR-born juvenile rats exhibited\ngreater gene and protein expression for TNF \u03b1and TNFR1\n(Riddle et al., 2014 ), and transcriptome analyses of pancreatic\nislets from IUGR fetal sheep indicated enriched TNF \u03b1signaling\npathways ( Kelly et al., 2017 ). Liver content of TNF \u03b1, IL-6, IL-1,\nTLR4, MyD88, phosphorylated and total NF \u03baB, phosphorylated\nI\u03baB\u03b1, and phosphorylated I \u03baB kinase were elevated in IUGR fetalsheep and newborn mice, although the latter also exhibited\ntempered hepatic TNF \u03b1production in response to acute LPS-\nstimulation ( Zarate et al., 2021 ;Zhang et al., 2021 ). Greater\nhepatic TNF \u03b1, IL-6, and TLR4 were also observed in IUGR-born\npigs at weaning and in IUGR-born rats in adulthood, whichcorresponded to greater percentages of phosphorylated I \u03baB\u03b1and\nNF\u03baB(Liu et al., 2014 ;Tarry-Adkins et al., 2016 ;He et al., 2018 ).\nIntestinal tissues of newborn IUGR piglets exhibited a paradoxicalreduction of IFN \u03b3but had increased IL-4 and the in \ufb02ammation-\nmediating transcription factor FOXO3a ( Zhong et al., 2012 ).\nIntestinal tissues from these piglets also exhibited less of the anti-\nin\ufb02ammatory cytokine, IL-10 ( Zhong et al., 2012 ). By weaning,\nintestinal gene and protein expression for cytokines and theircanonical pathways were robustly enhanced, which correspondedto greater phospho-activation and nuclear translocation of NF \u03baB\nand greater activation of the in \ufb02ammation-mediating kinase, JNK\n(Niu et al., 2021 ;Cui et al., 2022\n). Lung tissue from IUGR-born rats\nlikewise exhibited greater gene expression for in \ufb02ammatory\nFIGURE 1\nStress-induced programming of enriched in \ufb02ammatory signaling pathways in IUGR sheep tissues. Findings compiled from the literature are shown\nfor skeletal muscle ( Llovera et al., 1997 ;Bodell et al., 2009 ;Gray et al., 2009 ;Cadaret et al., 2017 ;Cadaret et al., 2019c ;Hicks and Yates, 2021 ;Posont et al.,\n2022 ), liver ( Fitzgerald et al., 2003 ;Zarate et al., 2021 ;Zhang et al., 2021 ;Wang et al., 2022 ), pancreas ( Hadjivassiliou et al., 1998 ;Andersson et al., 2005 ;\nEllingsgaard et al., 2011 ;Kelly et al., 2017 ), and adipose tissue ( Kras et al., 2000 ;Sharkey et al., 2009 ;Beer, 2022 ). Green boxes indicate signaling\ncomponents reported to be upregulated and red boxes indicate downregulated components.\nFrontiers in Physiology frontiersin.org 11White and Yates 10.3389/fphys.2023.1250134\ncytokines and reduced expression for the anti-in \ufb02ammatory IL-10,\nwhich corresponded to greater phospho-activation of thein\ufb02ammatory mediator, STAT3 ( Alejandre Alcazar et al., 2012 ).\nEven skin tissues of IUGR-born rats exhibited evidence of enhancedin\ufb02ammation, as indicated by greater macrophage in \ufb01ltration and\nincreased gene expression for the interleukin receptor, IL7R, and itscofactor, cytokine receptor-like factor 2 ( Pol\u00e1nyi et al., 2020 ). One\nnoteworthy exception for this phenotype appears to be white blood\ncells, as IUGR-born piglets and lambs had little or no change incirculating leukocyte pro \ufb01les (Zhong et al., 2012 ;Amdi et al., 2020 ;\nPosont et al., 2021 ;Cadaret et al., 2022 ). Moreover, IL-1 \u03b2production\nand proliferation by IUGR leukocytes was less responsive to LPSstimulation ( Zhong et al., 2012 ;Amdi et al., 2020 ).\nIn\ufb02ammation and oxidative stress are inherently-linked stress\nconditions. The major reactive oxygen species that mediate oxidative\nstress are listed in Figure 2 . These are physiological byproducts that\nserve important roles in cellular communication, but excessiveaccumulation causes cellular damage and increases risk forchronic in \ufb02ammatory diseases ( Pizzino et al., 2017 ). Reactive\noxygen species stimulate greater cytokine secretion from manycell types ( Bulua et al., 2011 ;Enoki et al., 2016 ). They also\ndirectly stimulate in \ufb02ammatory pathways by activating I \u03baB\nkinase, stimulating I \u03baB/NF \u03baB dissociation, and facilitating greater\nnuclear NF \u03baB dimerization ( Lugrin et al., 2014 ). Coincidentally,\nin\ufb02ammatory stimulation often increases production of reactive\noxygen species ( Floyd et al., 1999 ;Reid and Li, 2001 ;Langen\net al., 2002 ;Sriram et al., 2011 ). For example, skeletal muscle of\nIUGR-born juvenile rats overexpressed components of NADPHoxidase 2, a membrane-bound enzyme that produces reactiveoxygen species for immune signaling but is also a prominentsource for overproduction ( Chisaka et al., 2015 ;Tarry-Adkins\net al., 2016 ). The short-lived nature of reactive oxygen species\nmakes them dif \ufb01cult to measure in situ , but greater hepatic\nreduction of oxidized glutathione was indicative of severeoxidative stress in IUGR-born neonatal pigs ( Niu et al., 2019 ).\nHepatic concentrations of malondialdehyde and protein carbonyl,the primary indicators of lipid peroxidation and oxidative proteindamage, respectively, were also increased in IUGR-born adult ratsand neonatal pigs ( He et al., 2018 ;Niu et al., 2019 ). Tissues of IUGR-\nborn offspring are more susceptible to reactive oxygen species due to\nmaladaptive reductions in several intracellular antioxidantcompounds. Hepatic concentrations of the antioxidant enzymeglutathione reductase, which clears oxidized glutathione, wasreduced in IUGR-born pigs ( Niu et al., 2019 ). Glutathione\nreductase was one of several antioxidant proteins for which\nhepatic gene expression was downregulated in IUGR-born\nneonatal piglets and rats ( Tarry-Adkins et al., 2016 ;Niu et al.,\n2019 ), which culminated in an almost 50% reduction in total\nantioxidant capacity of the liver ( He et al., 2018 ;Niu et al., 2019 ).\n3 Mitigating the impact of IUGR with\n\u03c9-3 PUFA\n3.1 Overview of dietary \u03c9-3 PUFA\nNutraceutical use of two natural bioactive \u03c9-3 PUFA,\neicosapentaenoic acid (EPA; 20:5 \u03c9-3) and docosahexaenoic acid\n(DHA; 22:6 \u03c9-3), has increased in popularity as their anti-\nin\ufb02ammatory and antioxidant effects have been more \ufb01rmly\nestablished ( Shahidi and Ambigaipalan, 2018 ). Although EPA\nand DHA can be synthesized de novo from \u03b1-linolenic acid in\nmodest amounts, additional dietary sources result in health bene \ufb01ts\n(Russell and Burgin-Maunder, 2012 ). Many ocean \ufb01sh and algae\nspecies are particularly rich sources of exogenous \u03c9-3 PUFA and are\nused to produce commercial \ufb01sh oil-extract supplements ( Shahidi\nand Ambigaipalan, 2018 ). Consumer interest in \u03c9-3 PUFA has led to\nthe marketing of food products such as milk and bacon that areenriched with exogenous EPA and DHA ( Bernal-Santos et al., 2010 ;\nMeadus et al., 2010 ).\nStudies performed in vivo and in vitro report notable anti-\nin\ufb02ammatory and antioxidant effects of \u03c9-3 PUFA. Incubation of\ncultured macrophages with either EPA or DHA for only 48 hmitigated the normally robust LPS-induced secretion of TNF \u03b1,\nIL-1\u03b2, and IL-6 by up to 90% ( Weldon et al., 2007 ). This effect\nwas facilitated by stimulation of the GPR120 receptor pathway,\nFIGURE 2\nCommon stress-induced reactive oxygen species. These are natural cellular byproducts that can be damaging when overproduced during\nin\ufb02ammation or other stress conditions ( Turrens, 2003 ;Collin, 2019 ;Juan et al., 2021 ).\nFrontiers in Physiology frontiersin.org 12White and Yates 10.3389/fphys.2023.1250134\nwhich suppresses NF \u03baB binding to DNA and thus inhibits\ntranscription of additional in \ufb02ammatory factors, including\ncytokines and toll-like receptors ( Weldon et al., 2007 ;Oh et al.,\n2010 ;Block et al., 2012 ). Even in generally healthy individuals, daily\nEPA and DHA supplementation reduced circulating IL-6 and TNF-\u03b1concentrations by about 15% ( Kiecolt-Glaser et al., 2011 ;Kiecolt-\nGlaser et al., 2012 ). In mice genetically engineered to overproduce\nEPA and DHA, endotoxin-stimulated blood TNF \u03b1concentrations\nwere 5-fold less than in normal mice, and hepatic gene expressionwas reduced for several in \ufb02ammatory cytokines ( Schmocker et al.,\n2007 ). Rats supplemented \u03c9-3 PUFA via daily inhalation likewise\nhad less severe elevation of circulating in \ufb02ammatory cytokines in\nresponse to endotoxin ( Kocherlakota et al., 2022 ). Biomedical\nstudies showed that \u03c9-3 PUFA were particularly effective for\nindividuals with chronic in \ufb02ammatory conditions, including type\n2 diabetes, cancers, and cardiovascular diseases ( Natto et al., 2019 ;\nXiao et al., 2022 ;da Silva et al., 2016 ;Koppelmann et al., 2021 ).\nMoreover, DHA and EPA were shown to downregulate productionof reactive oxygen species and were effective scavengers ofsuperoxide anions ( da Silva et al., 2016 ;Richard et al., 2008 ).\nIndeed, supplementation of \u03c9-3 PUFAs mitigated both systemic\nin\ufb02ammation and excessive production of reactive oxygen species in\nacute and chronic disease states ( Li et al., 2017 ;Alorabi et al., 2022 ;\nGortan Cappellari et al., 2022 ;Khan et al., 2022 ). Although few\nstudies have investigated \u03c9-3 PUFA supplementation in IUGR\noutcomes, extensive literature documenting their antioxidant andanti-in \ufb02ammatory functions indicate their potential for\nameliorating IUGR pathologies.\n3.2 In \ufb02ammation and oxidative stress as\ntargets to improve IUGR outcomes\n3.2.1 Potential for recovering growth\nIn\ufb02ammatory cytokines are dynamic regulators of myoblast\nfunction and thus play a complex role in postnatal musclegrowth ( Bodell et al., 2009 ;Alvarez et al., 2020 ).In vitro studies\nfound that proliferation rates increased when myoblasts were\nincubated for short periods with low or moderate concentrations\nof TNF \u03b1, IL-1 \u03b2, or IL-6 ( Otis et al., 2014 ;Alvarez et al., 2020 ). For\nTNF\u03b1and IL-6 incubations, greater proliferation was coincident\nwith impaired differentiation ( Langen et al., 2001 ;Alvarez et al.,\n2020 ;Posont et al., 2022 ). Indeed, exposure to either cytokine\nsubstantially reduced the early differentiation transcription factor,myoD, and modestly reduced the later differentiation factor,myogenin ( Alvarez et al., 2020 ). However, nuclear expression of\nthe myoblast-speci \ufb01c proliferation factor, pax7, was also reduced by\nthese incubations ( Alvarez et al., 2020 ). Furthermore, high\nphysiological concentrations of IL-6 actually diminished myoblastproliferation, and incubation for longer periods of time dampenedthe inhibitory effect on differentiation ( Steyn et al., 2019 ). These\nidiosyncratic outcomes were associated with the respective up ordownregulation of IL6R by moderate or substantial IL-6 exposure(Steyn et al., 2019 ). Moreover, IL6R inhibition diminished not only\nthe effects of IL-6 but those of TNF \u03b1and IL-1 \u03b2as well ( Alvarez et al.,\n2020 ). Nevertheless, all cytokine effects were lost when myoblasts\nwere incubated with NF \u03baB inhibitors ( Otis et al., 2014 ). Disruption\nof the balance between myoblast proliferation and differentiationclearly reduces the capacity for muscle hypertrophy. To illustrate,\nintramuscular IL-6 infusion in young rats decreased muscle growthby about 10% over 2 weeks ( Bodell et al., 2009 ). This coincided with\ngreater gene expression for cytokine signaling components,including TNF \u03b1, TNFR1, and atrogin-1 ( Haddad et al., 2005 ;\nBodell et al., 2009 ). In TNF \u03b1-infused mice, an observed increase\nin muscle catabolism was attributed to greater ubiquitin-dependent\nproteolysis ( Llovera et al., 1997 ). The combination of greater relative\nmuscle catabolism and decreased myoblast-facilitated musclehypertrophy associated with experimentally-elevated cytokineexposure was comparable to the phenotype observed in theIUGR fetus ( Yates et al., 2014 ;Soto et al., 2017 ;Rozance et al.,\n2018 ;Posont et al., 2022 ).\nLike in \ufb02ammation, oxidative stress impairs skeletal muscle\nhypertrophy in similar but independent fashion ( Jang et al.,\n2020 ). Addition of even modest concentrations of reactive\noxygen species to myoblast incubations increased proliferation(Sciancalepore et al., 2012 ) and inhibited differentiation ( Langen\net al., 2002 ;\nSandiford et al., 2014 ), regardless of the presence of\nin\ufb02ammatory cytokines. When primary mouse myoblasts were\nengineered to overproduce H 2O2, only about half as many\nstained positive for myogenin, expressed myosin heavy chain\nprotein, or fused with other myoblasts ( Sandiford et al., 2014 ).\nFurthermore, accumulation of reactive oxygen species both directlyand indirectly resulted in muscle catabolism ( Jang et al., 2020 ). In\naddition to directly damaging cellular proteins, elevated reactiveoxygen species in antioxidant-de \ufb01cient mice upregulated cysteine\nproteases, which increased protein breakdown by the ubiquitin-proteasome and autophagy-lysosome systems ( Muller et al., 2006 ;\nJang et al., 2020 ). These mice were characterized by a reduction in\nmuscle mass of up to 50%, along with poor exercise performance\n(Muller et al., 2006 ).\n3.2.2 Potential for improving metabolism\nSustained exposure to elevated in \ufb02ammatory cytokines or\nreactive oxygen species dysregulates skeletal muscle glucosemetabolism and impairs insulin signaling and secretion. Briefincubations with high physiological IL-6 concentrations increased\nglucose uptake, oxidation, and incorporation into glycogen and also\nreduced lactate production in primary human and rodent muscle, aswell as in culture-derived myotubes ( Al-Khalili et al., 2006 ;Glund\net al., 2007 ;Gray et al., 2009 ;Cadaret et al., 2017 ). Glucose uptake\nwas stimulated at much lower IL-6 concentrations when its receptorwas added to the incubation in concert ( Gray et al., 2009 ). In\nprimary rat muscle and myotubes, TNF \u03b1similarly elevated\nglucose uptake and oxidation ( Yamasaki et al., 1996 ;Cadaret\net al., 2017 ). Moreover, greater glucose oxidation was observed in\nvivo when healthy young adults were infused with moderate\namounts of IL-6 over several hours ( Carey et al., 2006 ). Some of\nthese studies indicated that cytokine regulation of muscle glucoseutilization was independent of insulin and its major pathwaycomponents, IRS1 and Akt ( Yamasaki et al., 1996 ;Glund et al.,\n2007 ;Gray et al., 2009 ;Cadaret et al., 2017 ). Rather, cytokines\nappeared to stimulate translocation of sequestered Glut4 glucose\ntransporters to the membrane by activating the kinase enzyme,\nAMPK ( Al-Khalili et al., 2006 ;Carey et al., 2006 ). In fact, longer\nperiods of cytokine exposure generally disrupted insulin signaling(Rotter et al., 2003 ;Al-Khalili et al., 2006 ;Cadaret et al., 2017 ),\nFrontiers in Physiology frontiersin.org 13White and Yates 10.3389/fphys.2023.1250134\nalthough the direct effects on glucose utilization remained. This was\ndemonstrated particularly well by in vitro incubation of myoblast\ncell lines with TNF \u03b1, which increased basal glucose uptake by almost\n3-fold but reduced insulin-stimulated glucose uptake by about 75%(Yamasaki et al., 1996 ;Grzelkowska-Kowalczyk and Wieteska-\nSkrzeczynska, 2006 ;Remels et al., 2015 ). Infusion of TNF \u03b1into\nmice resulted in a 50% reduction of insulin-stimulated hindlimb\nglucose uptake but did not affect resting glucose uptake rates ( Youd\net al., 2000 ). The primary target of cytokines within the insulin\nsignaling pathway appears to be the phospho-activation of Akt, ahub that facilitates myriad insulin effects ( Ji et al., 2022 ). Incubation\nof primary rat muscle with moderate concentrations of TNF \u03b1or IL-\n6 for as little as 2 h reduced insulin-stimulated Akt phosphorylationby more than 50% ( Cadaret et al., 2017 ). Similar de \ufb01cits were\nobserved in culture-derived myotubes after 6-day incubation with\nTNF\u03b1(Grzelkowska-Kowalczyk and Wieteska-Skrzeczynska, 2006 )\nand in primary bovine adipocytes after 12 h ( Du et al., 2022 ). In\naddition to disrupting insulin signaling, cytokines also impairinsulin stimulus-secretion coupling in pancreatic islets, althoughthis effect is quite dependent upon duration of exposure. In fact,when mice were injected with IL-6, glucose-stimulated insulinsecretion was increased over the \ufb01rst 45 min, but this effect was\ngone by 1 h ( Ellingsgaard et al., 2011 ). Incubation of primary mouse\nislets with IL-1 \u03b2alone or in combination with IFN \u03b3increased\nglucose-stimulated insulin secretion for the \ufb01rst few hours but\nreduced it after 20 h ( Andersson et al., 2005 ). Likewise, 48-h\nincubation with TNF \u03b1alone or together with IL-1 \u03b2and IFN \u03b3\nhad no effect on basal insulin secretion but completely inhibitedglucose-stimulated insulin secretion in primary rat islets and in INS-1 rat \u03b2cells ( Hadjivassiliou et al., 1998 ;Zhang et al., 2022 ). This\ncombination of cytokines also reduced insulin content in primary\nhuman islets after 48 h ( Hadjivassiliou et al., 1998 ). The 40%\nreduction in glucose-stimulated insulin secretion and 25%reduction in pyruvate-stimulated insulin secretion observed inINS-1 rat \u03b2cells after 24 h with IL-1 \u03b2and IFN \u03b3coincided with\nreduced indicators of oxidative metabolism, the facilitatingmechanism for \u03b2cell stimulus-secretion coupling ( Rozance et al.,\n2007 ;Barlow et al., 2018 ).\nLike cytokines, in vitro exposure of primary rat muscle to\nreactive oxygen species for less t han 1 h increased glucose uptake\nby up to 48% and glycogen synthase activity by about 20% byenhancing canonical insulin signaling ( Kim et al., 2006 ;\nHigaki\net al., 2008 ). In fact, concurrent exposure to insulin and reactive\noxygen species for 20 min had a n additive effect on glucose\nuptake ( Higaki et al., 2008 ). Short-term oxidative stress\nre\ufb02ects the normal microenvironment of muscle and is not\nparticularly harmful, but sustained exposure becomes\ndeleterious ( Higaki et al., 2008 ;Diamond-Stanic et al., 2011 ).\nIncubation of rat muscle with high concentrations of reactiveoxygen species ceased stimulatin g basal glucose uptake after 6 h\n(Diamond-Stanic et al., 2011 ). Insulin-stimulated glucose uptake\nand Akt phosphorylation were hindered by reactive oxygenspecies after only 2 h ( Diamond-Stanic et al., 2011 ). The\nadverse effects of longer exposure on insulin signaling\ncomponents were mediated in part by p38 MAPK and were\nevident even at modest reactive oxygen species concentrations(Archuleta et al., 2009 ;Diamond-Stanic et al., 2011 ).\nInterestingly, reactive oxygen s pecies did not appear to affectfunction of primary rat or human islets after 48 h of incubation\n(Hadjivassiliou et al., 1998 ).\nIn\ufb02ammatory cytokines help to regulate lipid homeostasis and\nmetabolism by skeletal muscle in coordination with their effects onmuscle glucose utilization. Infusion of IL-6 into healthy individualsfor 3 hours increased total fatty acid oxidation rates during and for\nseveral hours after the infusion period ( van Hall et al., 2003 ). In\nprimary rat muscle, 1-h incubations with high IL-6 concentrationsincreased palmitate oxidation but not deposition, whereas 1-hincubation with TNF \u03b1increased deposition but not oxidation\n(Bruce and Dyck, 2004 ). Conversely, 3-h incubation of culture-\nderived human myotubes with IL-6 increased palmitate uptake andoxidation rates ( Al-Khalili et al., 2006 ). Greater oxidation occurred\nin the presence and absence of insulin and was mediated primarily\nby AMPK pathways ( Bruce and Dyck, 2004 ;Al-Khalili et al., 2006 ).\nTo facilitate greater lipid utilization by muscle, cytokinesconcurrently mobilize lipid deposits from adipose and othertissues. This was demonstrated by infusions of moderate or highconcentrations of IL-6 into humans, both of which elevatedcirculating NEFA and triglycerides ( van Hall et al., 2003 ).\nMoreover, blocking IL-6 signaling by administering a long-lastingIL6R antagonist reduced indicators of fatty acid mobilization in\nadult men during various degrees of physical activity and across a\nrange of body mass indices ( Trinh et al., 2021 ). In primary rat\nmuscle, IL-6 stimulated lipid mobilization in part by disruptinginsulin \u2019s lipogenic effects ( Bruce and Dyck, 2004 ). Unlike IL-6,\nTNF\u03b1had no impact on endogenous or exogenous skeletal\nmuscle fatty acid oxidation ( Bruce and Dyck, 2004 ). However,\nseveral in vitro studies have shown that even modestly elevated\nTNF\u03b1concentrations stimulated lipolysis ( Ryden et al., 2004 ;Lee\nand Fried, 2012 ;Du et al., 2022 ). This was recapitulated by 7-day\nTNF\u03b1infusion into mice, which elevated their circulating\ntriglycerides and NEFA concentrations ( Li L. et al., 2009 ).\nMoreover, both glycerol and NEFA were released fromadipocytes at greater rates when stimulated with TNF \u03b1in vitro\n(Green et al., 2004 ;Ryden et al., 2004 ). TNF \u03b1-mediated lipolysis was\nfacilitated in large part by downregulation of perilipin, a protein thatmediates hormone-sensitive lipase activity in lipid droplets ( Morin\net al., 1995 ;Wu et al., 2004 ). Studies in rats and cultured adipocytes\nfound that TNF \u03b1also reduced activity and expression of lipoprotein\nlipase, an enzyme that breaks down circulating lipoproteins fordeposition into adipocytes ( Morin et al., 1995 ;Wu et al., 2004 ). The\nincreased production of reactive oxygen species in cytokine-stimulated adipocytes further contributed to lipolysis ( Garc\u00eda\net al., 2021 ), an effect that was dampened by concurrent\ninhibition of superoxide production in culture ( Krawczyk et al.,\n2012 ;Issa et al., 2018 ). The impact of reactive oxygen species on\nadipocyte lipolysis coincided with phospho-activation of hormonesensitive lipase ( Krawczyk et al., 2012 ;Issa et al., 2018 ).\n3.3 Prenatal and perinatal supplementation\nof\u03c9-3 PUFA\n3.3.1 Potential bene \ufb01ts\nBene\ufb01ts of\u03c9-3 PUFA supplementation during critical windows\nfor fetal development on growth and metabolic outcomes have beendocumented in humans and animals. Meta-analyses of global health\nFrontiers in Physiology frontiersin.org 14White and Yates 10.3389/fphys.2023.1250134\nrecords and clinical trials indicated that dietary \u03c9-3 PUFA\nsupplementation over the 2nd half of gestation was associatedwith reductions of up to 73% in perinatal mortality rates as wellas fewer neonatal intensive care stays ( Saccone et al., 2015 ;Saccone\net al., 2016 ;Ali et al., 2017 ;Middleton et al., 2018 ). The supplements\nwere also associated with lower incidence of IUGR in many world\npopulations ( Cetin et al., 2002 ;Agostoni et al., 2005 ;Fares et al.,\n2015 ;Saccone et al., 2015 ;Gholami et al., 2020 ). In one prime\nexample, DHA supplementation in primigravidae women in Mexico\nreduced IUGR rates by half ( Ramakrishnan et al., 2010 ). Better\npregnancy outcomes coincided with positive effects onuteroplacental tissues, as clinical trials found that \u03c9-3 PUFA\nsupplements increased uterine and umbilical blood \ufb02ow and\nreduced placental apoptosis ( Wietrak et al., 2015 ;Ali et al.,\n2017 ). Moreover, dietary \u03c9-3 PUFA supplementation in pregnant\nrats reduced indicators of placental oxidative stress and increasedplacental and fetal mass ( Jones et al., 2013 ). Even direct infusion of\nEPA into the bloodstream of IUGR fetal sheep bene \ufb01tted placental\nfunction, as maternofetal glucose and O\n2gradients were improved\n(Beer et al., 2021 ). Importantly, maternal \u03c9-3 PUFA supplements\ndirectly bene \ufb01t the fetus as well as the placenta. Clinical trials found\nthat IUGR fetuses and newborns were de \ufb01cient in \u03c9-3 PUFA due to\nimpaired de novo production and that maternal supplementation\nwas effective in increasing circulating concentrations in the fetus/newborn ( Cetin et al., 2002 ;Agostoni et al., 2005 ;Llanos et al., 2005 ;\nFares et al., 2015 ;Wietrak et al., 2015 ). These \ufb01ndings were\nrecapitulated in rats, where IUGR-born neonates were found tobe DHA-de \ufb01cient, but maternal supplementation increased\ncirculating DHA concentrations in these offspring by 3.25-fold(Morand et al., 1981 ;Joss-Moore et al., 2010 ). In pigs, maternal\n\u03c9-3 PUFA supplementation increased DHA and EPA and reduced\n\u03c9-6:\u03c9-3 PUFA ratios in fetal blood and skeletal muscle near term,\nwhich coincided with greater blood glucose, less cholesterol, and areduction in the incidence of IUGR from 22% to 14% ( Heras-Molina\net al., 2021 ;Heras-Molina et al., 2022 ). These bene \ufb01ts persisted after\nbirth, as weaning-aged pigs born to \u03c9-3 PUFA-supplemented sows\nhad less circulating total cholesterol, HDL-C, and LDL-C as well asgreater total \u03c9-3 PUFA content and lower \u03c9-6:\u03c9-3 PUFA ratios in\nadipose, muscle, and liver tissues ( Heras-Molina et al., 2020 ). When\npregnant rodents carrying IUGR pregnancies were supplementedDHA, birthweight and neonatal growth of their offspring wereimproved without increased adiposity ( Bagley et al., 2013 ;Velten\net al., 2014 ). Offspring from dams supplemented DHA or \u03c9-3\nPUFA-rich \ufb01sh oil had greater circulating adiponectin, smaller\nadipocytes, and adipose tissue that expressed more PPAR \u03b3,\nadiponectin, and adiponectin receptors R1 and R2 ( Bringhenti et al.,\n2011;Bagley et al., 2013 ;Ghnaimawi et al., 2022 ). Supplementing\npregnant cows with \u03c9-3 PUFA (delivered as Ca\n2+salts for ruminal\nprotection) during late gestation increased circulating DHA in the damby 5-fold, and calves born to supplemented cows exhibited 6% \u201310%\nbetter average daily gain in the feedlot ( Marques et al., 2017 ). At harvest,\nthese calves produced marginally larg er carcasses and loin muscles with\n~10% greater marbling ( Marques et al., 2017 ). In sheep, maternal\nsupplementation of \u03c9-3 PUFA Ca\n2+salts for the \ufb01nal trimester of\ngestation had no adverse effects on dam or fetus and increased blood\nconcentrations of EPA and DHA in the ewe by ~40% and in thenewborn lamb by ~50% ( Coleman et al., 2018 ;Rosa Velazquez et al.,\n2020;Rosa-Velazquez et al., 2022 ). Greater fetal \u03c9-3 PUFA availabilityappeared to be particularly bene \ufb01cial to IUGR muscle and pancreatic\nislets. In mice, protein content for t he insulin receptor and the myogenic\ntranscription factor, myoD, as well as several genes regulatingmyogenesis were upregulated in skeletal muscle of newborn pupsborn to \u03c9-3 PUFA-supplemented dams ( Ghnaimawi et al., 2022 ).\nMoreover, 5-day infusion of EPA directly into IUGR fetal sheep\nimproved growth of several muscles, restored normal \ufb01ber type\nproportions in the semitendinosus , and modestly improved de \ufb01cits\nin muscle glucose uptake and oxidation ( Lacey, 2021 ;Lacey et al., 2021 ).\nIt also recovered about 50% of the de \ufb01cit in glucose-stimulated insulin\nsecretion ( Lacey, 2021 ;Lacey et al., 2021 ). These bene \ufb01ts coincided with\nanti-in \ufb02ammatory indicators, as EPA infus ion ameliorated the elevated\ncirculating TNF \u03b1concentrations and reduced total circulating white\nblood cells observed in IUGR fetal sheep ( Lacey, 2021 ;Lacey et al.,\n2021). Likewise, maternal \u03c9-3 PUFA supplementation reduced\no x i d a t i v es t r e s si nb r a i nt i s s u e so ff e t a lr a t sa n dr e s o l v e dt h eheightened macrophage invasion observed in lung tissues of IUGRnewborn mice pups ( Velten et al., 2014 ).\nPostnatal supplementation of \u03c9-3 PUFA to IUGR-born\noffspring is also effective in improving metabolic de \ufb01cits. For\nexample, IUGR-born rats exhibited 50% reductions in circulatingtriglycerides and 33% reductions in blood urea nitrogen when\nnursing foster dams that were fed diets high in \u03c9-3 PUFA\n(i.e., supplemented to offspring via milk) ( Voggel et al., 2022 ).\nLikewise, directly feeding \u03c9-3 PUFA-enriched diets or\nsupplementing \u03c9-3 PUFA-rich \ufb01sh oil to IUGR-born juvenile\nrats partially resolved their hyperlipidemia and reduced theiradiposity ( Wyrwoll et al., 2006 ;Bringhenti et al., 2011 ;Chen\net al., 2016 ;Chicco et al., 2016 ). It also decreased adipocyte size\nand leptin secretion, ameliorated in \ufb02ammatory markers in adipose\ntissues, and resolved elevated TNF\n\u03b1in circulation ( Wyrwoll et al.,\n2006 ;Bringhenti et al., 2011 ;Mark et al., 2014 ). Postnatal \ufb01sh oil\nsupplementation improved HOMA-estimated insulin sensitivity,glucose tolerance, and markers of systemic in \ufb02ammation in\nIUGR-born rats ( Bringhenti et al., 2011 ;Chen et al., 2016 ).\n3.3.2 Potential limitations\nAs of this writing, \ufb01sh oil and other \u03c9-3 PUFA supplements are\nconsidered safe for pregnant women by the American Pregnancy\nAssociation, which is supported by several Cochrane meta-analyses(Kar et al., 2016 ;Middleton et al., 2018 ;Wieland, 2019 ). Challenges\nregarding the use of \u03c9-3 PUFA as dietary supplements in livestock\ninclude post-ingestive feedback ( Freidin et al., 2011 ), bioavailability in\nruminants ( Chikunya et al., 2004 ), and meat sensory traits when fed at\nhigh concentrations ( B u r n e t te ta l . ,2 0 2 0 ). Reduced palatability and\nruminal microbiome cha nges associated with \ufb01sh oil can cause animals\nto eat less when too much is included in a dietary ration, and livestock\nstudies have indicated that the threshold limit is around 2% of the diet.Indeed, inclusion of \ufb01sh oil at 1% of the diet in dairy cows did not affect\nad libitum intake, but inclusion at 2% and 3% reduced intake by up to\n11% and 32%, respectively ( Donovan et al., 2000 ;Whitlock et al., 2002 ;\nAlizadeh et al., 2012 ;Kairenius et al., 2018 ). Although milk yield was\nincreased by dietary \ufb01sh oil at 1% and 2% in these cows, the large drop\nin dietary intake at 3% caused milk yield to fall ( Donovan et al., 2000 ).\nCalves fed milk replacer enriched with 0.5% \ufb01sh oil maintained their\nintake from birth to 2 months of age, which facilitated a modest increasein their average daily gain ( Melendez et al., 2022 ). Lambs fed Ca\n2+salts\nof\u03c9-3 PUFA at 1.5% also maintained dry matter intake ( Carranza\nFrontiers in Physiology frontiersin.org 15White and Yates 10.3389/fphys.2023.1250134\nMartin et al., 2018 ). In Angus feedlot steers, dry matter intake was\nreduced by dietary inclusion of \ufb01sh oil at 2.4% but not at 0.8% or 1.6%\n(Shing \ufb01eld et al., 2010 ). Limits on dietary inclusion could be\nproblematic for ruminant livestock, as bioavailability of \u03c9-3 PUFA is\nreduced by the markedly high rate s of microbial biohydrogenation\n(i.e., saturation of previously un saturated fatty acids) in the rumen\n(Jenkins et al., 2008 ). To illustrate, 93% of EPA and DHA from\nunprotected sources were absorbed unmodi \ufb01ed across the intestinal\nwall of the rat ( Chen et al., 1985 ), but as little as 7% were absorbed\nunmodi \ufb01ed in cows ( Dewhurst and Moloney, 2013 ). Similar outcomes\nwere created by the rumen m icrobiome in sheep, where\nbiohydrogenation rates were upward of 75% ( Chikunya et al., 2004 ;\nJenkins et al., 2008 ). Processing techniques for \u03c9-3 PUFA-rich feed\ningredients like \ufb02axseed increased bioavailability of EPA by 30% and\ntotal\u03c9-3 PUFA by 23% in lambs ( Kronberg et al., 2012 ). In young goats,\nheat treatment of linseed oil diets increased DHA bioavailability by 62%and total \u03c9-3 PUFA bioavailability by 19%, which corresponded with\ngreater liver and adipose tissue concentrations ( Wang et al., 2019 ).\nFreeze-drying of a microalgae-based supplement reduced ruminalbiohydrogenation of EPA in lambs from 80% to about 45% ( V\u00edtor\net al., 2021 ). Supplements utilizing Ca\n2+salts of \u03c9-3 PUFA helped\nmaintain or increase bioavailability through ruminal passage without\nproducing off-target effects such as reduced intake and milk fat\n(Casta\u00f1eda-Guti\u00e9rrez et al., 2007 ;Oyebade et al., 2020 ). It is worth\nnoting that even unprotected dietary sources still deliver meaningfulamounts of absorbable \u03c9-3 PUFA in ruminants. For example, inclusion\nof 1.1% \ufb01sh oil in a silage-based diet for dairy cows increased the\namount of EPA and DHA bypassing the rumen microbiome by 2-fold\nand 3-fold, respectively, despite 78% and 83% biohydrogenation rates\n(Kairenius et al., 2018 ). In meat animals, \u03c9-3 PUFA supplementation\nstrategies must consider the effects on product appearance and shelf life.\nLike all fatty acids, \u03c9-3 PUFA are prone to oxidation that can discolor\nthe surface of meat products ( B u r n e t te ta l . ,2 0 2 0 ). Steers fed diets with\n3%\ufb01sh oil had 1.5-fold \u20132-fold greater carcass EPA and DHA content at\nharvest ( Vatansever et al., 2000 ). Hamburger patties from these steers\nreached unacceptable discoloration 1 \u20133d a y ss o o n e rt h a nn o r m a la n d\ncooked sirloin scored about 11% lower in overall liking ,d e s p i t en o\nreduction in \ufb02avor score ( Vatansever et al., 2000 ). It should be noted\nthat most of the individual fatty acids measured in this study were\nincreased in meat from \ufb01sh oil-supplemented animals and that linseed\noil supplementation in the same study increased \u03c9-3 PUFA content\nwithout the same adverse sensory effe cts. Thus, adverse sensory traits\nm a yb ea t t r i b u t a b l em o r et ot h eu s eo fah i g hv o l u m eo f \ufb01sh oil as a\nsource than to the increase in \u03c9-3 PUFA per se . Indeed, palatability and\ntolerability of German sausag e products were not affected by\nenrichment with ~1% puri \ufb01ed EPA, DHA, and \u03b1-linolenic acid\n(K\u00f6hler et al., 2017 ). Nevertheless, \ufb01sh products are the most\ncommon source for \u03c9-3 PUFA supplements in livestock ( Burnett\net al., 2020 ), and lamb cuts from animals fed diets with 9% \ufb01sh\nmeal for 6 weeks were scored ~9% lower in juiciness by a trained\nsensory panel, although \ufb02avor, aroma, and palatability were not affected\n(Ponnampalam et al., 2002 ). Likewise, meat from lambs fed diets\nenriched with 1.5% \ufb01\nsh oil for 6 weeks was scored 14% lower in\noverall palatability, despite no r eduction in individual scores for \ufb02avor,\naroma, or juiciness and no issues with discoloration or shelf life\n(Ponnampalam et al., 2001 ;Ponnampalam et al., 2002 ). Because of\nthe potential for reduced meat sens ory traits, investigation into thebene\ufb01t of withdrawing \u03c9-3 PUFA supplements prior to harvest may be\nwarranted.\n4 Summary\nF e t a lI U G Ri sac o m m o nc o n d i t i o ni nh u m a n sa n da n i m a l st h a t\nimpacts metabolic function and growt h capacity before and after birth. It\nis most often associated with prenatal stressors during the critical windowfor placental development, which fu nctionally and structurally stunts\nplacental tissues. Placental insuf \ufb01ciency limits O\n2and nutrient delivery to\nthe growing fetus, which by late gestation can no longer keep up with fetalrequirements for growth. Consequently, the fetus undergoes a prolongedperiod of progressive hypoxemia and h ypoglycemia that in turn increases\nfetal adrenergic and in \ufb02ammatory tones and induces oxidative stress.\nThese changes drive nutrient-spar ing adaptations, which manifest in\nasymmetric fetal growth restriction and thrifty metabolic function that\npersist postnatal. Mechanisms for t hese adaptations include reduced\nadrenergic responsiveness, enhanced in \ufb02ammatory sensitivity, and\nincreased oxidative stress. IUGR adaptations aid fetal survival, buta f t e rb i r t ht h e yi n c r e a s eh e a l t hr i s k si nh u m a n sa n dr e d u c eg r o w t hef\ufb01ciency in livestock. Enhanced in \ufb02ammatory sensitivity in IUGR\nskeletal muscle and other tissues appears to be a key underlying\nfactor in growth and metabolic pa thologies. Consequently, anti-\nin\ufb02ammatory nutraceuticals such as \u03c9-3 PUFA have yielded promise\nas potential supplemental strat egies for recovering health and\nperformance outcomes in IUGR fetuses and offspring. However,several potential factors must be considered, including issues ofpalatability, bioavailability, and potential off-target effects.Nevertheless, initial proof-of-con cept studies indicate that dietary \u03c9-3\nPUFA supplements could provide the basis for recovering growth and\nmetabolic function in IUGR-born individuals.\nAuthor contributions\nMW and DY were responsible for the conceptualization and\nproduction of the manuscript. All authors contributed to the article\nand approved the submitted version.\nFunding\nThis manuscript was supported in part by the USDA National\nInstitute of Food and Agriculture Foundational Grants 2019-67015-29448 and 2020-67015-30825, the Nebraska Agricultural\nExperiment Station with funding from the Hatch Act (accession\nnumber 1009410), and Hatch Multistate Research capacity fundingprogram (accession numbers 1011055, 1009410) through the USDANational Institute of Food and Agriculture.\nCon\ufb02ict of interest\nThe authors declare that the research was conducted in the\nabsence of any commercial or \ufb01nancial relationships that could be\nconstrued as a potential con \ufb02ict of interest.\nFrontiers in Physiology frontiersin.org 16White and Yates 10.3389/fphys.2023.1250134\nPublisher \u2019s note\nAll claims expressed in this article are solely those of the authors\nand do not necessarily represent those of their af \ufb01liatedorganizations, or those of the publisher, the editors and the\nreviewers. Any product that may be evaluated in this article, orclaim that may be made by its manufacturer, is not guaranteed orendorsed by the publisher.\nReferences\nAgostoni, C., Galli, C., Riva, E., Colombo, C., Giovannini, M., and Marangoni, F.\n(2005). Reduced docosahexaenoic acid synthesis may contribute to growth restriction in\ninfants born to mothers who smoke. J. Pediatr. 147 (6), 854 \u2013856. doi:10.1016/j.jpeds.\n2005.05.040\nAl-Khalili, L., Bouzakri, K., Glund, S., Lonnqvist, F., Koistinen, H. A., and Krook, A.\n(2006). Signaling speci \ufb01city of interleukin-6 action on glucose and lipid metabolism in\nskeletal muscle. Mol. Endocrinol. 20 (12), 3364 \u20133375. doi:10.1210/me.2005-0490\nAlejandre Alcazar, M. A., Ostreicher, I., Appel, S., Rother, E., Vohlen, C., Plank, C.,\net al. (2012). Developmental regulation of in \ufb02ammatory cytokine-mediated\nStat3 signaling: the missing link between intrauterine growth restriction and\npulmonary dysfunction? J. Mol. Med. Berl. 90 (8), 945 \u2013957. doi:10.1007/s00109-012-\n0860-9\nAli, M. K., Amin, M. E., Amin, A. F., and Abd El Aal, D. E. M. (2017). Evaluation of\nthe effectiveness of low-dose aspirin and omega 3 in treatment of asymmetrically\nintrauterine growth restriction: A randomized clinical trial. Eur. J. Obstet. Gynecol.\nReprod. Biol. 210, 231 \u2013235. doi:10.1016/j.ejogrb.2017.01.002\nAlizadeh, A. R., Alikhani, M., Ghorbani, G. R., Rahmani, H. R., Rashidi, L., and Loor,\nJ. J. (2012). Effects of feeding roasted saf \ufb02ower seeds (variety IL-111) and \ufb01sh oil on dry\nmatter intake, performance and milk fatty acid pro \ufb01les in dairy cattle. J. Anim. Physiol.\nAnim. Nutr. Berl. 96 (3), 466 \u2013473. doi:10.1111/j.1439-0396.2011.01165.x\nAlkhalefah, A., Dunn, W. B., Allwood, J. W., Parry, K. L., Houghton, F. D., Ashton, N.,\net al. (2021). Maternal intermittent fasting during pregnancy induces fetal growth\nrestriction and down-regulated placental system A amino acid transport in the rat. Clin.\nSci. (Lond). 135 (11), 1445 \u20131466. doi:10.1042/CS20210137\nAllen, R. E., Merkel, R. A., and Young, R. B. (1979). Cellular aspects of muscle growth:\nmyogenic cell proliferation. J. Anim. Sci. 49 (1), 115 \u2013127. doi:10.2527/jas1979.491115x\nAlorabi, M., Mohammed, D. S., Mostafa-Hedeab, G., El-Sherbeni, S. A., Negm, W. A.,\nMohammed, A. I. A., et al. (2022). Combination treatment of omega-3 fatty acids and\nvitamin C exhibited promising therapeutic effect against oxidative impairment of the\nliver in methotrexate-intoxicated mice. Biomed. Res. Int. 2022, 4122166. doi:10.1155/\n2022/4122166\nAlvarez, A. M., DeOcesano-Pereira, C., Teixeira, C., and Moreira, V. (2020). IL-1 \u03b2\nand TNF- \u03b1modulation of proliferated and committed myoblasts: IL-6 and COX-2-\nderived prostaglandins as key actors in the mechanisms involved. Cells 9 (9), 2005.\ndoi:10.3390/cells9092005\nAmarilyo, G., Oren, A., Mimouni, F. B., Ochshorn, Y., Deutsch, V., and Mandel, D.\n(2011). Increased cord serum in \ufb02ammatory markers in small-for-gestational-age\nneonates. J. Perinatol. 31 (1), 30 \u201332. doi:10.1038/jp.2010.53\nAmdi, C., Lynegaard, J. C., Thymann, T., and Williams, A. R. (2020). Intrauterine\ngrowth restriction in piglets alters blood cell counts and impairs cytokine responses in\nperipheral mononuclear cells 24 days post-partum. Sci. Rep. 10 (1), 4683. doi:10.1038/\ns41598-020-61623-w\nAnderson, A. H., Fennessey, P. V., Meschia, G., Wilkening, R. B., and Battaglia, F. C.\n(1997). Placental transport of threonine and its utilization in the normal and growth-\nrestricted fetus. Am. J. Physiol. 272 (1), E892 \u2013E900. doi:10.1152/ajpendo.1997.272.5.\nE892\nAndersson, A. K., B\u00f6rjesson, A., Sandgren, J., and Sandler, S. (2005). Cytokines affect\nPDX-1 expression, insulin and proinsulin secretion from iNOS de \ufb01cient murine islets.\nMol. Cell Endocrinol. 240 (1-2), 50 \u201357. doi:10.1016/j.mce.2005.06.001\nArchuleta, T. L., Lemieux, A. M., Saengsirisuwan, V., Teachey, M. K., Lindborg, K. A.,\nKim, J. S., et al. (2009). Oxidant stress-induced loss of IRS-1 and IRS-2 proteins in ratskeletal muscle: role of p38 MAPK. Free Radic. Biol. Med. 47 (10), 1486 \u20131493. doi:10.\n1016/j.freeradbiomed.2009.08.014\nArmstrong, D. G. (1973). Amino acid requirements and amino acid supply in the\nsheep. Proc. Nutr. Soc. 32 (2), 107 \u2013113. doi:10.1079/pns19730023\nAssumpcao, R. P., Mucci, D. B., Fonseca, F. C. P., Marcondes, H., Sardinha, F. L. C.,\nCitelli, M., et al. (2017). Fatty acid pro \ufb01le of maternal and fetal erythrocytes and\nplacental expression of fatty acid transport proteins in normal and intrauterine growth\nrestriction pregnancies. Prostagl. Leukot. Essent. Fat. Acids 125, 24 \u201331. doi:10.1016/j.\nplefa.2017.08.011\nBacchetta, J., Harambat, J., Dubourg, L., Guy, B., Liutkus, A., Canterino, I., et al.\n(2009). Both extrauterine and intrauterine growth restriction impair renal function in\nchildren born very preterm. Kidney Int. 76 (4), 445 \u2013452. doi:10.1038/ki.2009.201\nBagley, H. N., Wang, Y., Campbell, M. S., Yu, X., Lane, R. H., and Joss-Moore, L. A.\n(2013). Maternal docosahexaenoic acid increases adiponectin and normalizes IUGR-induced changes in rat adipose deposition. J. Obes. 2013, 312153. doi:10.1155/2013/\n312153\nBarker, D. J., Eriksson, J. G., Forsen, T., and Osmond, C. (2002). Fetal origins of adult\ndisease: strength of effects and biological basis. Int. J. Epidemiol. 31 (6), 1235 \u20131239.\ndoi:10.1093/ije/31.6.1235\nBarker, D. J., Hales, C. N., Fall, C. H., Osmond, C., Phipps, K., and Clark, P. M. (1993).\nType 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia(syndrome X): relation to reduced fetal growth. Diabetologia 36 (1), 62 \u201367. doi:10.1007/\nBF00399095\nBarlow, J., Solomon, T. P. J., and Affourtit, C. (2018). Pro-in \ufb02ammatory cytokines\nattenuate glucose-stimulated insulin secretion from INS-1E insulinoma cells by\nrestricting mitochondrial pyruvate oxidation capacity - novel mechanistic insight\nfrom real-time analysis of oxidative phosphorylation. PLoS One 13 (6), e0199505.\ndoi:10.1371/journal.pone.0199505\nBassett, J. M., and Hanson, C. (1998). Catecholamines inhibit growth in fetal sheep in\nthe absence of hypoxemia. Am. J. Physiol. 274 (6), R1536 \u2013R1545. doi:10.1152/ajpregu.\n1998.274.6.R1536\nBeard, J. R., Lincoln, D., Donoghue, D., Taylor, D., Summerhayes, R., Dunn, T. M.,\net al. (2009). Socioeconomic and maternal determinants of small-for-gestational agebirths: patterns of increasing disparity. Acta Obstet. Gynecol. Scand. 88 (5), 575 \u2013583.\ndoi:10.1080/00016340902818170\nBeede, K. A., Limesand, S. W., Petersen, J. L., and Yates, D. T. (2019). Real\nsupermodels wear wool: summarizing the impact of the pregnant sheep as an\nanimal model for adaptive fetal programming. Anim. Front. 9 (3), 34 \u201343. doi:10.\n1093/af/vfz018\nBeer, H. N. (2022). Continuous video monitoring of zoo cheetahs demonstrates\ndifferential engagement patterns for six diffe rent types of environmental enrichment;\nplacental insuf \ufb01ciency indicators improve in intrauterine growth-restricted fetal\nsheep receiving daily \u03c9\n-3 polyunsaturated fatty acid infusions; investigation of\ndifferentially expressed transcripts of the adipose tissue in fetal and neonatal\nIUGR sheep . The University of Nebraska-Lincoln. doi:10.13140/RG.2.2.13682.\n58562\nBeer, H. N., Lacey, T. A., Gibbs, R. L., Most, M. S., Hicks, Z. M., Grijalva, P. C., et al.\n(2021). Placental insuf \ufb01ciency improves when intrauterine growth-restricted fetal sheep\nare administered daily \u03c9-3 polyunsaturated fatty acid infusions. Transl. Animal Sci. 5,\nS6\u2013S10. doi:10.1093/tas/txab166\nBenjamin, J. S., Culpepper, C. B., Brown, L. D., Wesolowski, S. R., Jonker, S. S., Davis,\nM. A., et al. (2017). Chronic anemic hypoxemia attenuates glucose-stimulated insulin\nsecretion in fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 312 (4), R492 \u2013R500.\ndoi:10.1152/ajpregu.00484.2016\nBerbets, A., Koval, H., Barbe, A., Albota, O., and Yuzko, O. (2021). Melatonin\ndecreases and cytokines increase in women with placental insuf \ufb01ciency. J. Matern. Fetal\nNeonatal Med. 34 (3), 373 \u2013378. doi:10.1080/14767058.2019.1608432\nBernal-Santos, G., O \u2019Donnell, A. M., Vicini, J. L., Hartnell, G. F., and Bauman, D. E.\n(2010). Hot topic: enhancing omega-3 fatty acids in milk fat of dairy cows by using\nstearidonic acid-enriched soybean oil from genetically modi \ufb01ed soybeans. J. Dairy Sci.\n93 (1), 32 \u201337. doi:10.3168/jds.2009-2711\nBlock, R. C., Dier, U., Calderonartero, P., Shearer, G. C., Kakinami, L., Larson, M. K.,\net al. (2012). The effects of EPA+DHA and aspirin on in \ufb02ammatory cytokines and\nangiogenesis factors. World J. Cardiovasc Dis. 2( 1 ) ,1 4 \u201319. doi:10.4236/wjcd.2012.\n21003\nBodell, P. W., Kodesh, E., Haddad, F., Zaldivar, F. P., Cooper, D. M., and Adams, G. R.\n(2009). Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but\npreserved by concurrent voluntary endurance exercise. J. Appl. Physiol. (1985) 106 (2),\n443\u2013453. doi:10.1152/japplphysiol.90831.2008\nBoehmer, B. H., Limesand, S. W., and Rozance, P. J. (2017). The impact of IUGR on\npancreatic islet development and beta-cell function. J. Endocrinol. 235 (2), R63 \u2013R76.\ndoi:10.1530/JOE-17-0076\nBotting, K. J., Loke, X. Y., Zhang, S., Andersen, J. B., Nyengaard, J. R., and Morrison,\nJ. L. (2018). IUGR decreases cardiomyocyte endowment and alters cardiac metabolism\nin a sex- and cause-of-IUGR-speci \ufb01c manner. Am. J. Physiol. Regul. Integr.\nComp. Physiol. 315 (1), R48 \u2013r67. doi:10.1152/ajpregu.00180.2017\nBringhenti, I., Schultz, A., Rachid, T., Bom \ufb01m, M. A., Mandarim-de-Lacerda, C. A.,\nand Aguila, M. B. (2011). An early \ufb01sh oil-enriched diet reverses biochemical, liver and\nadipose tissue alterations in male offspring from maternal protein restriction in mice.J. Nutr. Biochem. 22 (11), 1009 \u20131014. doi:10.1016/j.jnutbio.2010.08.013\nFrontiers in Physiology frontiersin.org 17White and Yates 10.3389/fphys.2023.1250134\nBrown, L. D. (2014). Endocrine regulation of fetal skeletal muscle growth: impact on\nfuture metabolic health. J. Endocrinol. 221 (2), R13 \u2013R29. doi:10.1530/JOE-13-0567\nBrown, L. D., Kohn, J. R., Rozance, P. J., Hay, W. W., Jr., and Wesolowski, S. R. (2017).\nExogenous amino acids suppress glucose oxidation and potentiate hepatic glucoseproduction in late gestation fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 312\n(5), R654 \u2013R663. doi:10.1152/ajpregu.00502.2016\nBrown, L. D., Rozance, P. J., Bruce, J. L., Friedman, J. E., Hay, W. W., Jr., and\nWesolowski, S. R. (2015). Limited capacity for glucose oxidation in fetal sheep with\nintrauterine growth restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 309 (8),\nR920 \u2013R928. doi:10.1152/ajpregu.00197.2015\nBrown, L. D., Rozance, P. J., Thorn, S. R., Friedman, J. E., and Hay, W. W., Jr. (2012).\nAcute supplementation of amino acids increases net protein accretion in IUGR fetal\nsheep. Am. J. Physiol. Endocrinol. Metab. 303 (3), E352 \u2013E364. doi:10.1152/ajpendo.\n00059.2012\nBrown, L. D., Wesolowski, S. R., Kailey, J., Bourque, S., Wilson, A., Andrews, S. E.,\net al. (2016). Chronic hyperinsulinemia increases myoblast proliferation in fetal sheepskeletal muscle. Endocrinol . 157 (6), 2447 \u20132460. doi:10.1210/en.2015-1744\nBruce, C. R., and Dyck, D. J. (2004). Cytokine regulation of skeletal muscle fatty acid\nmetabolism: effect of interleukin-6 and tumor necrosis factor-alpha. Am. J. Physiol.\nEndocrinol. Metab. 287 (4), E616 \u2013E621. doi:10.1152/ajpendo.00150.2004\nBulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K. Y., et al. (2011).\nMitochondrial reactive oxygen species promote production of proin \ufb02ammatory\ncytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS).\nJ. Exp. Med. 208 (3), 519 \u2013533. doi:10.1084/jem.20102049\nBurnett, D. D., Legako, J. F., Phelps, K. J., and Gonzalez, J. M. (2020). Biology,\nstrategies, and fresh meat consequences of manipulating the fatty acid composition of\nmeat. J. Anim. Sci. 98 (2), skaa033. doi:10.1093/jas/skaa033\nBurton, G. J., and Jauniaux, E. (2018). Pathophysiology of placental-derived fetal\ngrowth restriction. Am. J. Obstet. Gynecol. 218 (2S), S745 \u2013S761. doi:10.1016/j.ajog.2017.\n11.577\nCadaret, C. N., Beede, K. A., Riley, H. E., and Yates, D. T. (2017). Acute exposure of\nprimary rat soleus muscle to zilpaterol HCl ( \u03b22 adrenergic agonist), TNF \u03b1,o rI L - 6i n\nculture increases glucose oxidation rates independent of the impact on insulin signaling\nor glucose uptake. Cytokine 96, 107 \u2013113. doi:10.1016/j.cyto.2017.03.014\nCadaret, C. N., Merrick, E. M., Barnes, T. L., Beede, K. A., Posont, R. J., Petersen, J. L.,\net al. (2019b). Sustained maternal in \ufb02ammation during the early third-trimester yields\nintrauterine growth restriction, impaired skeletal muscle glucose metabolism, anddiminished beta-cell function in fetal sheep. J. Anim. Sci. 97 (12), 4822 \u20134833.\ndoi:10.1093/jas/skz321\nCadaret, C. N., Posont, R. J., Beede, K. A., Riley, H. E., Loy, J. D., and Yates, D. T.\n(2019a). Maternal in \ufb02ammation at midgestation impairs subsequent fetal myoblast\nfunction and skeletal muscle growth in rats, resulting in intrauterine growth restriction\nat term. Transl. Anim. Sci. 3 (2), txz037. doi:10.1093/tas/txz037\nCadaret, C. N., Posont, R. J., Swanson, R. M., Beard, J. K., Barnes, T. L., Beede, K. A.,\net al. (2019c). Intermittent maternofetal O(2) supplementation during late gestation\nrescues placental insuf \ufb01ciency-induced intrauterine growth restriction and metabolic\npathologies in the neonatal lamb. Transl. Anim. Sci. 3 (1), 1696\n\u20131700. doi:10.1093/tas/\ntxz060\nC a d a r e t ,C .N . ,P o s o n t ,R .J . ,S w a n s o n ,R .M . ,B e a r d ,J .K . ,G i b b s ,R .L . ,B a r n e s ,T .L . ,\net al. (2022). Intermittent maternofetal oxygenation during late gestation improved\nbirthweight, neonatal growth, body symmetry, and muscle metabolism inintrauterine growth-restricted lambs. J. Anim. Sci. 100 (1), skab358. doi:10.1093/\njas/skab358\nCalnan, H., Williams, A., Peterse, J., Starling, S., Cook, J., Connaughton, S., et al.\n(2021). A prototype rapid dual energy X-ray absorptiometry (DEXA) system can predict\nthe CT composition of beef carcases. Meat Sci. 173, 108397. doi:10.1016/j.meatsci.2020.\n108397\nCamacho, L. E., Davis, M. A., Kelly, A. C., Steffens, N. R., Anderson, M. J., and\nLimesand, S. W. (2022). Prenatal oxygen and glucose therapy normalizes insulin\nsecretion and action in growth-restricted fetal sheep. Endocrinol 163 (6), bqac053.\ndoi:10.1210/endocr/bqac053\nCarey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm,\nG., et al. (2006). Interleukin-6 increases insulin-stimulated glucose disposal in humans\nand glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase.\nDiabetes 55 (10), 2688 \u20132697. doi:10.2337/db05-1404\nCarranza Martin, A. C., Coleman, D. N., Garcia, L. G., Furnus, C. C., and Relling, A. E.\n(2018). Prepartum fatty acid supplementation in sheep. III. Effect of eicosapentaenoic\nacid and docosahexaenoic acid during \ufb01nishing on performance, hypothalamus gene\nexpression, and muscle fatty acids composition in lambs. J. Anim. Sci. 96 (12),\n5300\u20135310. doi:10.1093/jas/sky360\nCarver, T. D., Quick, A. A., Teng, C. C., Pike, A. W., Fennessey, P. V., and Hay, W. W.,\nJr. (1997). Leucine metabolism in chronically hypoglycemic hypoinsulinemic growth-\nrestricted fetal sheep. Am. J. Physiol. 272 (1), E107 \u2013E117. doi:10.1152/ajpendo.1997.272.\n1.E107\nCasta\u00f1eda-Guti\u00e9rrez, E., de Veth, M. J., Lock, A. L., Dwyer, D. A., Murphy, K. D., and\nBauman, D. E. (2007). Effect of supplementation with calcium salts of \ufb01sh oil on n-3\nfatty acids in milk fat. J. Dairy Sci. 90 (9), 4149 \u20134156. doi:10.3168/jds.2006-856Cetin, I., Giovannini, N., Alvino, G., Agostoni, C., Riva, E., Giovannini, M., et al.\n(2002). Intrauterine growth restriction is associated with changes in polyunsaturated\nfatty acid fetal-maternal relationships. Pediatr. Res. 52 (5), 750 \u2013755. doi:10.1203/\n00006450-200211000-00023\nChang, E. I., Rozance, P. J., Wesolowski, S. R., Nguyen, L. M., Shaw, S. C., Sclafani, R.\nA., et al. (2019b). Rates of myogenesis and myo \ufb01ber numbers are reduced in late\ngestation IUGR fetal sheep. J. Endocrinol. 244 (2), 339 \u2013352. doi:10.1530/JOE-19-0273\nChang, E. I., Wesolowski, S. R., Gilje, E. A., Baker, P. R., 2nd, Reisz, J. A.,\nD\u2019Alessandro, A., et al. (2019a). Skeletal muscle amino acid uptake is lower and\nalanine production is greater in late gestation intrauterine growth-restricted fetal\nsheep hindlimb. Am. J. Physiol. Regul. Integr. Comp. Physiol. 317 (5), R615 \u2013R629.\ndoi:10.1152/ajpregu.00115.2019\nChang, E. I., Hetrick, B., Wesolowski, S. R., McCurdy, C. E., Rozance, P. J., and\nBrown, L. D. (2021). A Two-Week insulin infusion in intrauterine growth restricted\nfetal sheep at 75% gestation increases skeletal myoblast replication but did not restoremuscle mass or increase \ufb01ber number. Front. Endocrinol. (Lausanne) 12, 785242. doi:10.\n3389/fendo.2021.785242\nChassen, S. S., Ferchaud-Roucher, V., Palmer, C., Li, C., Jansson, T., Nathanielsz, P.\nW., et al. (2020). Placental fatty acid transport across late gestation in a baboon model of\nintrauterine growth restriction. J. Physiol. 598 (12), 2469 \u20132489. doi:10.1113/JP279398\nChassen, S. S., Zemski-Berry, K., Raymond-Whish, S., Driver, C., Hobbins, J. C., and\nPowell, T. L. (2022). Altered cord blood lipid concentrations correlate with birth weight\nand Doppler velocimetry of fetal vessels in human fetal growth restriction pregnancies.\nCells 11 (19), 3110. doi:10.3390/cells11193110\nChen, I. S., Subramaniam, S., Cassidy, M. M., Sheppard, A. J., and Vahouny, G. V.\n(1985). Intestinal absorption and lipoprotein transport of (omega-3) eicosapentaenoic\nacid. J. Nutr. 115 (2), 219 \u2013225. doi:10.1093/jn/115.2.219\nChen, L. H., Liang, L., Fang, Y. L., Wang, Y. M., and Zhu, W. F. (2016). Fish oil\nimproves lipid pro \ufb01le in juvenile rats with intrauterine growth retardation by altering\nthe transcriptional expression of lipid-related hepatic genes. J. Matern. Fetal Neonatal\nMed. 29 (20), 3292 \u20133298. doi:10.3109/14767058.2015.1123244\nChen, X., Fahy, A. L., Green, A. S., Anderson, M. J., Rhoads, R. P., and Limesand, S. W.\n(2010). \u03b22-Adrenergic receptor desensitization in perirenal adipose tissue in fetuses and\nlambs with placental insuf \ufb01ciency-induced intrauterine growth restriction. J. Physiol.\n588 (18), 3539 \u20133549. doi:10.1113/jphysiol.2010.192310\nChen, X., Green, A. S., Macko, A. R., Yates, D. T., Kelly, A. C., and Limesand, S. W.\n(2014). Enhanced insulin secretion responsiveness and islet adrenergic desensitization\nafter chronic norepinephrine suppression is discontinued in fetal sheep. Am. J. Physiol.\nEndocrinol. Metab. 306 (1), E58 \u2013E64. doi:10.1152/ajpendo.00517.2013\nChen, X., Kelly, A. C., Yates, D. T., Macko, A. R., Lynch, R. M., and Limesand, S. W.\n(2017). Islet adaptations in fetal sheep persist following chronic exposure to high\nnorepinephrine. J. Endocrinol. 232 (2), 285 \u2013295. doi:10.1530/JOE-16-0445\nChicco, A., Creus, A., Illesca, P., Hein, G. J., Rodriguez, S., and Fortino, A. (2016).\nEffects of post-suckling n-3 polyunsaturated fatty acids: prevention of dyslipidemia and\nliver steatosis induced in rats by a sucrose-rich diet during pre- and post-natal life. Food\nFunct. 7 (1), 445 \u2013454. doi:10.1039/c5fo00705d\nChikunya, S., Demirel, G., Enser, M., Wood, J. D., Wilkinson, R. G., and Sinclair, L. A.\n(2004). Biohydrogenation of dietary n-3 PUFA and stability of ingested vitamin E in therumen, and their effects on microbial activity in sheep. Br. J. Nutr. 91 (4), 539 \u2013550.\ndoi:10.1079/BJN20031078\nChisaka, T., Mogi, M., Nakaoka, H., Kan-no, H., Tsukuda, K., Wang, X-L., et al.\n(2015). Low-protein diet-induced fetal growth restriction leads to exaggerated\nproliferative response to vascular injury in postnatal life. Am. J. Hypertens. 29 (1),\n54\u201362. doi:10.1093/ajh/hpv072\nCilvik, S. N., Wesolowski, S. R., Anthony, R. V., Brown, L. D., and Rozance, P. J.\n(2021). Late gestation fetal hyperglucagonaemia impairs placental function and results\nin diminished fetal protein accretion and decreased fetal growth. J. Physiol. 599 (13),\n3403\u20133427. doi:10.1113/JP281288\nColeman, D. N., Rivera-Acevedo, K. C., and Relling, A. E. (2018). Prepartum fatty acid\nsupplementation in sheep I. Eicosapentaenoic and docosahexaenoic acid\nsupplementation do not modify Ewe and lamb metabolic status and performance\nthrough weaning. J. Anim. Sci. 96 (1), 364 \u2013374. doi:10.1093/jas/skx012\nCollin, F. (2019). Chemical basis of reactive oxygen species reactivity and involvement\nin neurodegenerative diseases. Int. J. Mol. Sci. 20 (10), 2407. doi:10.3390/ijms20102407\nCree-Green, M., Scalzo, R. L., Harrall, K., Newcomer, B. R., Schauer, I. E.,\nHuebschmann, A. G., et al. (2018). Supplemental oxygen improves in vivo\nmitochondrial oxidative phosphorylation \ufb02ux in sedentary obese adults with type\n2 diabetes. Diabetes 67 (7), 1369 \u2013\n1379. doi:10.2337/db17-1124\nC u i ,C . ,W u ,C . ,W a n g ,J . ,M a ,Z . ,Z h e n g ,X . ,Z h u ,P . ,e ta l .( 2 0 2 2 ) .R e s t o r e d\nintestinal integrity, nutrients transporters, energy metabolism, antioxidative\ncapacity and decreased harmful microbi ota were associated with IUGR piglet \u2019s\ncatch-up growth before weanling. J .A n i m .S c i .B i o t e c h n o l . 13 (1), 129. doi:10.1186/\ns40104-022-00770-8\nda Silva, E. P., Jr., Nachbar, R. T., Levada-Pires, A. C., Hirabara, S. M., and\nLambertucci, R. H. (2016). Omega-3 fatty acids differentially modulate enzymatic\nanti-oxidant systems in skeletal muscle cells. Cell Stress Chaperones 21 (1), 87 \u201395.\ndoi:10.1007/s12192-015-0642-8\nFrontiers in Physiology frontiersin.org 18White and Yates 10.3389/fphys.2023.1250134\nDavis, M. A., Camacho, L. E., Pendleton, A. L., Antolic, A. T., Luna-Ramirez, R. I.,\nKelly, A. C., et al. (2021). Augmented glucose production is not contingent on high\ncatecholamines in fetal sheep with IUGR. J. Endocrinol. 249 (3), 195 \u2013207. doi:10.1530/\nJOE-21-0071\nDe Blasio, M. J., Gatford, K. L., Harland, M. L., Robinson, J. S., and Owens, J. A.\n(2012). Placental restriction reduces insulin sensitivity and expression of insulin\nsignaling and glucose transporter genes in skeletal muscle, but not liver, in young\nsheep. Endocrinol 153 (5), 2142 \u20132151. doi:10.1210/en.2011-1955\nDe Blasio, M. J., Gatford, K. L., McMillen, I. C., Robinson, J. S., and Owens, J. A.\n(2007b). Placental restriction of fetal growth increases insulin action, growth, and\nadiposity in the young lamb. Endocrinology 148 (3), 1350 \u20131358. doi:10.1210/en.2006-\n0653\nDe Blasio, M. J., Gatford, K. L., Robinson, J. S., and Owens, J. A. (2007a). Placental\nrestriction of fetal growth reduces size at birth and alters postnatal growth, feeding\nactivity, and adiposity in the young lamb. Am. J. Physiol. Regul. Integr. Comp. Physiol.\n292 (2), R875 \u2013R886. doi:10.1152/ajpregu.00430.2006\nDesai, M., Gayle, D. A., Casillas, E., Boles, J., and Ross, M. G. (2009). Early\nundernutrition attenuates the in \ufb02ammatory response in adult rat offspring.\nJ. Maternal-Fetal Neonatal Med. 22 (7), 571 \u2013575. doi:10.1080/14767050902874105\nDetmer, A., Carter, A. M., and Thomas, C. R. (1992). The metabolism of free fatty\nacids and triacylglycerols by the fetal liver in a Guinea pig model of intrauterine growth\nretardation. Pediatr. Res. 32 (4), 441 \u2013446. doi:10.1203/00006450-199210000-00014\nDewhurst, R., and Moloney, A. (2013). Modi \ufb01cation of animal diets for the\nenrichment of dairy and meat products with omega-3 fatty acids. Food Enrich.\nomega-3 Fat. acids , 257\u2013287. doi:10.1533/9780857098863.3.257\nDiamond-Stanic, M. K., Marchionne, E. M., Teachey, M. K., Durazo, D. E., Kim, J. S.,\nand Henriksen, E. J. (2011). Critical role of the transient activation of p38 MAPK in the\netiology of skeletal muscle insulin resistance induced by low-level in vitro oxidant stress.\nBiochem. Biophys. Res. Commun. 405 (3), 439 \u2013444. doi:10.1016/j.bbrc.2011.01.049\nDong, L., Zhong, X., Zhang, L., Kong, L., Kong, Y., Kou, T., et al. (2015). Impaired\nintestinal mucosal immunity is associated with the imbalance of T lymphocyte sub-\npopulations in intrauterine growth-restricted neonatal piglets. Immunobiology 220 (6),\n775\u2013781. doi:10.1016/j.imbio.2014.12.017\nDonnelly, L. E., Tudhope, S. J., Fenwick, P. S., and Barnes, P. J. (2010). Effects of\nformoterol and salmeterol on cytokine release from monocyte-derived macrophages.\nEur. Respir. J. 36 (1), 178 \u2013186. doi:10.1183/09031936.00158008\nDonovan, D. C., Schingoethe, D. J., Baer, R. J., Ryali, J., Hippen, A. R., and Franklin, S.\nT. (2000). In \ufb02uence of dietary \ufb01sh oil on conjugated linoleic acid and other fatty acids in\nmilk fat from lactating dairy cows. J. Dairy Sci. 83 (11), 2620 \u20132628. doi:10.3168/jds.\nS0022-0302(00)75155-1\nDrake, R. R., Louey, S., and Thornburg, K. L. (2022). Intrauterine growth restriction\nelevates circulating acylcarnitines and suppresses fatty acid metabolism genes in the\nfetal sheep heart. J. Physiol. 600 (3), 655 \u2013670. doi:10.1113/JP281415\nDu, X., Liu, M., Tai, W., Yu, H., Hao, X., Loor, J. J., et al. (2022). Tumor necrosis\nfactor- \u03b1promotes lipolysis and reduces insulin sensitivity by activating nuclear factor\nkappa B and c-Jun N-terminal kinase in primary bovine adipocytes. J. Dairy Sci. 105\n(10), 8426 \u20138438. doi:10.3168/jds.2022-22009\nDuan, C., Liu, M., Xu, H., Tang, W., Liu, J., Hou, L., et al. (2016). Decreased expression\nof GLUT4 in male CG-IUGR rats may play a vital role in their increased susceptibility to\ndiabetes mellitus in adulthood. Acta Biochim. Biophys. Sin. (Shanghai). 48 (10),\n872\u2013882. doi:10.1093/abbs/gmw088\nDuf\ufb01eld, J. A., Vuocolo, T., Tellam, R., McFarlane, J. R., Kauter, K. G., Muhlhausler, B.\nS., et al. (2009). Intrauterine growth restriction and the sex speci \ufb01c programming of\nleptin and peroxisome proliferator-activated receptor gamma (PPARgamma) mRNAexpression in visceral fat in the lamb. Pediatr. Res. 66 (1), 59 \u201365. doi:10.1203/PDR.\n0b013e3181a7c121\nDulloo, A. G., Jacquet, J., and Montani, J. P. (2012). How dieting makes some fatter:\nfrom a perspective of human body composition autoregulation. Proc. Nutr. Soc. 71 (3),\n379\u2013389. doi:10.1017/S0029665112000225\nDulloo, A. G., Jacquet, J., Seydoux, J., and Montani, J. P. (2006). The thrifty \u2019catch-up\nfat\u2019phenotype: its impact on insulin sensitivity during growth trajectories to obesity and\nmetabolic syndrome. Int. J. Obes. 30 (S4), S23 \u2013S35. doi:10.1038/sj.ijo.0803516\nEdwards, A. K., McKnight, S. M., Askelson, K., McKnight, J. R., Dunlap, K. A.,\nand Satter \ufb01eld, M. C. (2020). Adaptive response s to maternal nutrient restriction\nalter placental transport in ewes. Placenta 96, 1 \u20139. doi:10.1016/j.placenta.2020.\n05.002\nEllingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T.,\net al. (2011). Interleukin-6 enhances insulin secretion by increasing glucagon-like\npeptide-1 secretion from L cells and alpha cells. Nat. Med. 17 (11), 1481 \u20131489.\ndoi:10.1038/nm.2513\nElphick, M. C., Harrison, A. T., Lawlor, J. P., and Hull, D. (1978). Cord blood\nhypertriglyceridaemia as an index of fetal stress: use of a simple screening test andresults of further biochemical analysis. Br. J. Obstet. Gynaecol. 85 (4), 303 \u2013310. doi:10.\n1111/j.1471-0528.1978.tb10503.x\nEnoki, Y., Watanabe, H., Arake, R., Sugimoto, R., Imafuku, T., Tominaga, Y., et al.\n(2016). Indoxyl sulfate potentiates skeletal muscle atrophy by inducing the oxidativestress-mediated expression of myostatin and atrogin-1. Sci. Rep. 6, 32084. doi:10.1038/\nsrep32084\nFagerberg, B., Bondjers, L., and Nilsson, P. (2004). Low birth weight in combination\nwith catch-up growth predicts the occurrence of the metabolic syndrome in men at latemiddle age: the atherosclerosis and insulin resistance study. J. Intern Med. 256 (3),\n254\u2013259. doi:10.1111/j.1365-2796.2004.01361.x\nFares, S., Sethom, M. M., Kacem, S., Khouaja-Mokrani, C., Feki, M., and Kaabachi, N.\n(2015). Plasma arachidonic and docosahexaenoic acids in Tunisian very low birth\nweight infants: status and association with selected neonatal morbidities. J. Health\nPopul. Nutr. 33, 1. doi:10.1186/s41043-015-0011-3\nFelicioni, F., Pereira, A. D., Caldeira-Brant, A. L., Santos, T. G., Paula, T. M. D.,\nMagnabosco, D., et al. (2020). Postnatal development of skeletal muscle in pigs with\nintrauterine growth restriction: morphofunctional phenotype and molecular\nmechanisms. J. Anat. 236 (5), 840 \u2013853. doi:10.1111/joa.13152\nFitzgerald, K. A., Rowe, D. C., Barnes, B. J., Caffrey, D. R., Visintin, A., Latz, E., et al.\n(2003). LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adaptersTRAM and TRIF. J. Exp. Med. 198 (7), 1043\n\u20131055. doi:10.1084/jem.20031023\nFloyd, R. A., Hensley, K., Jaffery, F., Maidt, L., Robinson, K., Pye, Q., et al. (1999).\nIncreased oxidative stress brought on by pro-in \ufb02ammatory cytokines in\nneurodegenerative processes and the protective role of nitrone-based free radical\ntraps. Life Sci. 65 (18-19), 1893 \u20131899. doi:10.1016/s0024-3205(99)00443-9\nFowden, A. L., and Silver, M. (1995). Glucose and oxygen metabolism in the fetal foal\nduring late gestation. Am. J. Physiol. 269 (6 Pt 2), R1455 \u2013R1461. doi:10.1152/ajpregu.\n1995.269.6.R1455\nFreidin, E., Catanese, F., Didon\u00e9, N., and Distel, R. A. (2011). Mechanisms of intake\ninduction of a low-nutritious food in sheep ( Ovis aries ).Behav. Process. 87 (3), 246 \u2013252.\ndoi:10.1016/j.beproc.2011.04.005\nGarc\u00eda, J. G., de Miguel, C., Milagro, F. I., Zalba, G., and Ansorena, E. (2021).\nEndothelial NOX5 expression modulates thermogenesis and lipolysis in mice fed with a\nhigh-fat diet and 3T3-L1 adipocytes through an interleukin-6 dependent mechanism.\nAntioxidants (Basel) 11 (1), 30. doi:10.3390/antiox11010030\nGardner, D. S., Fletcher, A. J., Bloom \ufb01eld, M. R., Fowden, A. L., and Giussani, D. A.\n(2002). Effects of prevailing hypoxaemia, acidaemia or hypoglycaemia upon the\ncardiovascular, endocrine and metabolic responses to acute hypoxaemia in the ovine\nfetus. J. Physiol. 540 (Pt 1), 351 \u2013366. doi:10.1113/jphysiol.2001.013434\nGanguly, A., Touma, M., Thamotharan, S., De Vivo, D. C., and Devaskar, S. U. (2016).\nMaternal calorie restriction causing uteroplacental insuf \ufb01ciency differentially affects\nmammalian placental glucose and leucine transport molecular mechanisms. Endocrinol.\n157 (10), 4041 \u20134054. doi:10.1210/en.2016-1259\nGarg, M., Thamotharan, M., Oak, S. A., Pan, G., Maclaren, D. C., Lee, P. W., et al.\n(2009). Early exercise regimen improves insulin sensitivity in the intrauterine growth-\nrestricted adult female rat offspring. Am. J. Physiol. Endocrinol. Metab. 296 (2),\nE272 \u2013E281. doi:10.1152/ajpendo.90473.2008\nGarite, T. J., Clark, R., and Thorp, J. A. (2004). Intrauterine growth restriction\nincreases morbidity and mortality among premature neonates. Am. J. Obstet. Gynecol.\n191 (2), 481 \u2013487. doi:10.1016/j.ajog.2004.01.036\nGhnaimawi, S., Zhang, S., Baum, J. I., and Huang, Y. (2022). The effects of maternal\nintake of EPA and DHA enriched diet during pregnancy and lactation on offspring \u2019s\nmuscle development and energy homeostasis. Front. Physiol. 13, 881624. doi:10.3389/\nfphys.2022.881624\nGholami, N., Abotorabi, S., Lalooha, F., and Oveisi, S. (2020). Effects of \ufb01sh oil\nsupplementation on pregnancy outcomes in pregnant women referred to kosar hospital.\nIran. J. Pharm. Res. 19 (3), 241 \u2013247. doi:10.22037/ijpr.2019.13976.12041\nGibbs, R. L., Swanson, R. M., Beard, J. K., Schmidt, T. B., Petersen, J. L., and Yates, D.\nT. (2020). De \ufb01cits in growth, muscle mass, and body composition following placental\ninsuf\ufb01ciency-induced intrauterine growth restriction persisted in lambs at 60 d of age\nbut were improved by daily clenbuterol supplementation. Transl. Anim. Sci. 4 (Suppl. 1),\nS53\u2013S57. doi:10.1093/tas/txaa097\nG i b b s ,R .L . ,S w a n s o n ,R .M . ,B e a r d ,J .K . ,S c h m i d t ,T .B . ,P e t e r s e n ,J .L . ,a n dY a t e s ,D .T .\n(2021). De \ufb01cits in skeletal muscle glucose metabolism and whole-body oxidative metabolism\nin the intrauterine growth-restricted juvenile lamb are improved by daily treatment with\nclenbuterol. Transl. Anim. Sci. 5 (Suppl. 1), S20 \u2013S24. doi:10.1093/tas/txab187\nGibbs, R. L., and Yates, D. T. (2021). The price of surviving on adrenaline:\ndevelopmental programming responses to chronic fetal hypercatecholaminemia\ncontribute to poor muscle growth capacity and metabolic dysfunction in IUGR-\nborn offspring. Front. Anim. Sci. 2, 769334. doi:10.3389/fanim.2021.769334\nGlund, S., Deshmukh, A., Long, Y. C., Moller, T., Koistinen, H. A., Caidahl, K., et al.\n(2007). Interleukin-6 directly increases glucose metabolism in resting human skeletal\nmuscle. Diabetes 56 (6), 1630 \u20131637. doi:10.2337/db06-1733\nGodfray, H. C., Beddington, J. R., Crute, I. R., Haddad, L., Lawrence, D., Muir, J. F.,\net al. (2010). Food security: the challenge of feeding 9 billion people. Science 327 (5967),\n812\u2013818. doi:10.1126/science.1185383\nGoldenberg, R. L., and Culhane, J. F. (2007). Low birth weight in the United States.\nAm. J. Clin. Nutr. 85 (2), 584S \u201390S. doi:10.1093/ajcn/85.2.584S\nGortan Cappellari, G., Semolic, A., Ruozi, G., Barbetta, D., Bortolotti, F., Vinci, P.,\net al. (2022). n-3 PUFA dietary lipid replacement normalizes muscle mitochondrial\nFrontiers in Physiology frontiersin.org 19White and Yates 10.3389/fphys.2023.1250134\nfunction and oxidative stress through enhanced tissue mitophagy and protects from\nmuscle wasting in experimental kidney disease. Metabolism 133, 155242. doi:10.1016/j.\nmetabol.2022.155242\nGosby, A. K., Stanton, L. M., Maloney, C. A., Thompson, M., Briody, J., Baxter, R. C.,\net al. (2009). Postnatal nutrition alters body composition in adult offspring exposed to\nmaternal protein restriction. Br. J. Nutr. 101 (12), 1878 \u20131884. doi:10.1017/\nS0007114508135851\nGray, S. R., Ratkevicius, A., Wackerhage, H., Coats, P., and Nimmo, M. A. (2009). The\neffect of interleukin-6 and the interleukin-6 receptor on glucose transport in mouse\nskeletal muscle. Exp. Physiol. 94 (8), 899 \u2013905. doi:10.1113/expphysiol.2009.048173\nGreen, A., Rumberger, J. M., Stuart, C. A., and Ruhoff, M. S. (2004). Stimulation of\nlipolysis by tumor necrosis factor-alpha in 3T3-L1 adipocytes is glucose dependent:\nimplications for long-term regulation of lipolysis. Diabetes 53 (1), 74 \u201381. doi:10.2337/\ndiabetes.53.1.74\nGreenwood, P., Cafe, L., Hearnshaw, H., and Hennessy, D. (2005). Consequences of\nnutrition and growth retardation early in life for growth and composition of cattle andeating quality of beef. Recent Adv. Animal Nutr. Aust. 15, 183 \u2013195.\nGreenwood, P. L., and Bell, A. W. (2019). Developmental programming and growth\nof livestock tissues for meat production. Vet. Clin. North Am. Food Anim. Pract. 35 (2),\n303\u2013319. doi:10.1016/j.cvfa.2019.02.008\nGreenwood, P. L., and Cafe, L. M. (2007). Prenatal and pre-weaning growth and\nnutrition of cattle: long-term consequences for beef production. Anim 1 (9), 1283 \u20131296.\ndoi:10.1017/S175173110700050X\nGreenwood, P. L., Hunt, A. S., Hermanson, J. W., and Bell, A. W. (1998). Effects of\nbirth weight and postnatal nutrition on neonatal sheep: I. Body growth andcomposition, and some aspects of energetic ef \ufb01ciency. J. Anim. Sci. 76 (9),\n2354\u20132367. doi:10.2527/1998.7692354x\nGroenenberg, I. A., Wladimiroff, J. W., and Hop, W. C. (1989). Fetal cardiac and\nperipheral arterial \ufb02ow velocity waveforms in intrauterine growth retardation.\nCirculation 80 (6), 1711 \u20131717. doi:10.1161/01.cir.80.6.1711\nGrzelkowska-Kowalczyk, K., and Wieteska-Skrzeczynska, W. (2006). Exposure to\nTNF-alpha but not IL-1beta impairs insulin-dependent phosphorylation of protein\nkinase B and p70S6k in mouse C2C12 myogenic cells. Pol. J. Vet. Sci. 9 (1), 1 \u201310.\nGurung, S., Tong, H. H., Bryce, E., Katz, J., Lee, A. C., Black, R. E., et al. (2022). A\nsystematic review on estimating population attributable fraction for risk factors for\nsmall-for-gestational-age births in 81 low- and middle-income countries. J. Glob. Health\n12, 04024. doi:10.7189/jogh.12.04024\nHaddad, F., Zaldivar, F., Cooper, D. M., and Adams, G. R. (2005). IL-6-induced\nskeletal muscle atrophy. J. Appl. Physiol. (1985) 98 (3), 911 \u2013917. doi:10.1152/\njapplphysiol.01026.2004\nHadjivassiliou, V., Green, M. H., James, R. F., Swift, S. M., Clayton, H. A., and Green,\nI. C. (1998). Insulin secretion, DNA damage, and apoptosis in human and rat islets of\nLangerhans following exposure to nitric oxide, peroxynitrite, and cytokines. Nitric\nOxide 2 (6), 429 \u2013441. doi:10.1006/niox.1998.0203\nHales, C. N., Barker, D. J., Clark, P. M., Cox, L. J., Fall, C., Osmond, C., et al. (1991).\nFetal and infant growth and impaired glucose tolerance at age 64. Br. Med. J. 303 (6809),\n1019\u20131022. doi:10.1136/bmj.303.6809.1019\nHales, C. N., and Barker, D. J. (2001). The thrifty phenotype hypothesis. BrMedBull\n60, 5\u201320. doi:10.1093/bmb/60.1.5\nHales, C. N., and Barker, D. J. P. (1992). Type 2 (non-insulin-dependent) diabetes\nmellitus: the thrifty phenotype hypothesis. Diabetologia 35 (7), 595 \u2013601. doi:10.1007/\nBF00400248\nHam, J. N., Crutchlow, M. F., Desai, B. M., Simmons, R. A., and Stoffers, D. A. (2009).\nExendin-4 normalizes islet vascularity in intrauterine growth restricted rats: potential\nrole of VEGF. Pediatr. Res. 66 (1), 42 \u201346. doi:10.1203/PDR.0b013e3181a282a5\nHarwell, C. M., Padbury, J. F., Anand, R. S., Martinez, A. M., Ipp, E., Thio, S. L., et al.\n(1990). Fetal catecholamine responses to maternal hypoglycemia. Am. J. Physiol. 259\n(6 Pt 2), R1126 \u2013R1130. doi:10.1152/ajpregu.1990.259.6.R1126\nHe, J., Niu, Y., Wang, F., Wang, C., Cui, T., Bai, K., et al. (2018). Dietary curcumin\nsupplementation attenuates in \ufb02ammation, hepatic injury and oxidative damage in a rat\nmodel of intra-uterine growth retardation. Br. J. Nutr. 120 (5), 537 \u2013548. doi:10.1017/\nS0007114518001630\nHeras-Molina, A., Escudero, R., Pes\u00e1ntez-Pacheco, J. L., Garc\u00eda-Contreras, C.,\nV\u00e1zquez-G\u00f3mez, M., Astiz, S., et al. (2022). Maternal supplementation with\npolyphenols and omega-3 fatty acids during pregnancy: prenatal effects on fetalfatty acid composition in the iberian pig. Anim. (Basel) 12 (16), 2140. doi:10.3390/\nani12162140\nH e r a s - M o l i n a ,A . ,P e s a n t e z - P a c h e c o ,J .L . ,A s t i z ,S . ,G a r c i a - C o n t r e r a s ,C . ,\nVazquez-Gomez, M., Encin as, T., et al. (2020). Maternal supplementation with\npolyphenols and omega-3 fatty acids during pregnancy: effects on growth,\nmetabolism, and body composition of the offspring. Anim. (Basel) 10 (11),\n1946. doi:10.3390/ani10111946\nHeras-Molina, A., Pes\u00e1ntez-Pacheco, J. L., Garcia-Contreras, C., V\u00e1zquez-G\u00f3mez, M.,\nL\u00f3pez, A., Ben\u00edtez, R., et al. (2021). Maternal supplementation with polyphenols and\nomega-3 fatty acids during pregnancy: prenatal effects on growth and metabolism.\nAnim. (Basel) 11 (6), 1699. doi:10.3390/ani11061699Hicks, Z. H., Beer, H. N., Herrera, N. J., Gibbs, R. L., Lacey, T. A., Grijalva, P. C., et al.\n(2021). Hindlimb tissue composition shifts between the fetal and juvenile stages in the\nlamb. Transl. Anim. Sci. 5 (Suppl. 1), S38 \u2013S40. doi:10.1093/tas/txab164\nHicks, Z. M., and Yates, D. T. (2021). Going up in \ufb02ame: reviewing the underexplored\nrole of in \ufb02ammatory programming in stress-induced intrauterine growth restricted\nlivestock. Front. Anim. Sci. 2, 761421. doi:10.3389/fanim.2021.761421\nHigaki, Y., Mikami, T., Fujii, N., Hirshman, M. F., Koyama, K., Seino, T., et al. (2008).\nOxidative stress stimulates skeletal muscle glucose uptake through a\nphosphatidylinositol 3-kinase-dependent pathway. Am. J. Physiol. Endocrinol.\nMetab. 294 (5), E889 \u2013E897. doi:10.1152/ajpendo.00150.2007\nHuang, S., Li, N., Liu, C., Li, T., Wang, W., Jiang, L., et al. (2019). Characteristics of the\ngut microbiota colonization, in \ufb02ammatory pro \ufb01le, and plasma metabolome in\nintrauterine growth restricted piglets during the \ufb01rst 12 hours after birth.\nJ. Microbiol. 57 (9), 748 \u2013758. doi:10.1007/s12275-019-8690-x\nHudalla, H., Karenberg, K., Kuon, R-J., P\u00f6schl, J., Tschada, R., and Frommhold, D.\n(2018). LPS-induced maternal in \ufb02ammation promotes fetal leukocyte recruitment and\nprenatal organ in \ufb01ltration in mice. Pediatr. Res. 84 (5), 757 \u2013\n764. doi:10.1038/s41390-\n018-0030-z\nHyatt, M. A., Gopalakrishnan, G. S., Bispham, J., Gentili, S., McMillen, I. C., Rhind, S.\nM., et al. (2007). Maternal nutrient restriction in early pregnancy programs hepatic\nmRNA expression of growth-related genes and liver size in adult male sheep.\nJ. Endocrinol. 192 (1), 87 \u201397. doi:10.1677/joe.1.06801\nIkenoue, S., Kasuga, Y., Endo, T., Tanaka, M., and Ochiai, D. (2021). Newer insights\ninto fetal growth and body composition. Front. Endocrinol. (Lausanne) 12, 708767.\ndoi:10.3389/fendo.2021.708767\nIssa, N., Lachance, G., Bellmann, K., Laplante, M., Stadler, K., and Marette, A. (2018).\nCytokines promote lipolysis in 3T3-L1 adipocytes through induction of NADPH\noxidase 3 expression and superoxide production. J. Lipid Res. 59 (12), 2321 \u20132328.\ndoi:10.1194/jlr.M086504\nIwata, S., Kinoshita, M., Okamura, H., Tsuda, K., Saikusa, M., Harada, E., et al. (2019).\nIntrauterine growth and the maturation process of adrenal function. PeerJ 7, e6368.\ndoi:10.7717/peerj.6368\nJang, Y. C., Rodriguez, K., Lustgarten, M. S., Muller, F. L., Bhattacharya, A., Pierce, A.,\net al. (2020). Superoxide-mediated oxidative stress accelerates skeletal muscle atrophy\nby synchronous activation of proteolytic systems. Geroscience 42 (6), 1579 \u20131591. doi:10.\n1007/s11357-020-00200-5\nJansson, N., Pettersson, J., Haa \ufb01z, A., Ericsson, A., Palmberg, I., Tranberg, M., et al.\n(2006). Down-regulation of placental transport of amino acids precedes the\ndevelopment of intrauterine growth restriction in rats fed a low protein diet.\nJ. Physiol. 576 (Pt 3), 935 \u2013946. doi:10.1113/jphysiol.2006.116509\nJenkins, T. C., Wallace, R. J., Moate, P. J., and Mosley, E. E. (2008). Board-invited\nreview: recent advances in biohydrogenation of unsaturated fatty acids within the\nrumen microbial ecosystem. J. Anim. Sci. 86 (2), 397 \u2013412. doi:10.2527/jas.2007-0588\nJi, Y., Li, M., Chang, M., Liu, R., Qiu, J., Wang, K., et al. (2022). In \ufb02ammation: roles\nin skeletal muscle atrophy. Antioxidants (Basel) 11 (9), 1686. doi:10.3390/\nantiox11091686\nJoanisse, S., and Parise, G. (2016). Cytokine mediated control of muscle stem cell\nfunction. Adv. Exp. Med. Biol. 900, 27 \u201344. doi:10.1007/978-3-319-27511-6_2\nJones, A. K., Brown, L. D., Rozance, P. J., Serkova, N. J., Hay, W. W., Jr., Friedman,\nJ. E., et al. (2019). Differential effects of intrauterine growth restriction and a\nhypersinsulinemic-isoglycemic clamp on metabolic pathways and insulin action in\nthe fetal liver. Am. J. Physiol. Regul. Integr. Comp. Physiol. 316 (5), R427 \u2013R440. doi:10.\n1152/ajpregu.00359.2018\nJones, A. K., Wang, D., Goldstrohm, D. A., Brown, L. D., Rozance, P. J., Limesand, S.\nW., et al. (2022). Tissue-speci \ufb01c responses that constrain glucose oxidation and increase\nlactate production with the severity of hypoxemia in fetal sheep. Am. J. Physiol.\nEndocrinol. Metab. 322 (2), E181 \u2013E196. doi:10.1152/ajpendo.00382.2021\nJones, M. L., Mark, P. J., Mori, T. A., Keelan, J. A., and Waddell, B. J. (2013). Maternal\ndietary omega-3 fatty acid supplementation reduces placental oxidative stress and\nincreases fetal and placental growth in the rat. Biol. Reprod. 88 (2), 37. doi:10.1095/\nbiolreprod.112.103754\nJonker, S. S., Kamna, D., Loturco, D., Kailey, J., and Brown, L. D. (2018). IUGR\nimpairs cardiomyocyte growth and maturation in fetal sheep. J. Endocrinol. 239,\n253\u2013265. doi:10.1530/JOE-18-0382\nJoss-Moore, L. A., Wang, Y., Baack, M. L., Yao, J., Norris, A. W., Yu, X., et al. (2010).\nIUGR decreases PPAR \u03b3and SETD8 Expression in neonatal rat lung and these effects are\nameliorated by maternal DHA supplementation. Early Hum. Dev. 86 (12), 785 \u2013791.\ndoi:10.1016/j.earlhumdev.2010.08.026\nJuan, C. A., P\u00e9rez de la Lastra, J. M., Plou, F. J., and P\u00e9rez-Lebe\u00f1a, E. (2021). The\nchemistry of reactive oxygen species (ROS) revisited: outlining their role in biological\nmacromolecules (DNA, lipids and proteins) and induced pathologies. Int. J. Mol. Sci. 22\n(9), 4642. doi:10.3390/ijms22094642\nKairenius, P., Leskinen, H., Toivonen, V., Muetzel, S., Ahvenj\u00e4rvi, S., Vanhatalo, A.,\net al. (2018). Effect of dietary \ufb01sh oil supplements alone or in combination with\nsun\ufb02ower and linseed oil on ruminal lipid metabolism and bacterial populations in\nlactating cows. J. Dairy Sci. 101 (4), 3021 \u20133035. doi:10.3168/jds.2017-13776\nFrontiers in Physiology frontiersin.org 20White and Yates 10.3389/fphys.2023.1250134\nKar, S., Wong, M., Rogozinska, E., and Thangaratinam, S. (2016). Effects of omega-3\nfatty acids in prevention of early preterm delivery: A systematic review and meta-\nanalysis of randomized studies. Eur. J. Obstet. Gynecol. Reprod. Biol. 198, 40 \u201346. doi:10.\n1016/j.ejogrb.2015.11.033\nK e l l y ,A .C . ,B i d w e l l ,C .A . ,M c C a r t h y ,F .M . ,T a s k a ,D .J . ,A n d e r s o n ,M .J . ,C a m a c h o ,L .E . ,\net al. (2017). RNA sequencing exposes adaptive and immune responses to intrauterine\ngrowth restriction in fetal sheep islets. Endocrinol 158 (4), 743 \u2013755. doi:10.1210/en.2016-1901\nKesavan, K., and Devaskar, S. U. (2019). Intrauterine growth restriction: postnatal\nmonitoring and outcomes. Pediatr. Clin. North Am. 66 (2), 403 \u2013423. doi:10.1016/j.pcl.\n2018.12.009\nKhan, S. A., Damanhouri, G. A., Ahmed, T. J., Halawani, S. H., Ali, A., Makki, A., et al.\n(2022). Omega 3 fatty acids - potential modulators for oxidative stress and\nin\ufb02ammation in the management of sickle cell disease. J. Pediatr. (Rio J. 98 (5),\n513\u2013518. doi:10.1016/j.jped.2022.01.001\nKiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., and Glaser, R.\n(2011). Omega-3 supplementation lowers in \ufb02ammation and anxiety in medical\nstudents: A randomized controlled trial. Brain Behav. Immun. 25 (8), 1725 \u20131734.\ndoi:10.1016/j.bbi.2011.07.229\nKiecolt-Glaser, J. K., Belury, M. A., Andridge, R., Malarkey, W. B., Hwang, B. S., and\nGlaser, R. (2012). Omega-3 supplementation lowers in \ufb02ammation in healthy middle-\naged and older adults: A randomized controlled trial. Brain Behav. Immun. 26 (6),\n988\u2013995. doi:10.1016/j.bbi.2012.05.011\nKim, J. S., Saengsirisuwan, V., Sloniger, J. A., Teachey, M. K., and Henriksen, E. J.\n(2006). Oxidant stress and skeletal muscle glucose transport: roles of insulin signaling\nand p38 MAPK. Free Radic. Biol. Med. 41 (5), 818 \u2013824. doi:10.1016/j.freeradbiomed.\n2006.05.031\nKloesz, J. L., Serdikoff, C. M., Maclennan, N. K., Adibi, S. A., and Lane, R. H. (2001).\nUteroplacental insuf \ufb01ciency alters liver and skeletal muscle branched-chain amino acid\nmetabolism in intrauterine growth-restricted fetal rats. Pediatr. Res. 50 (5), 604 \u2013610.\ndoi:10.1203/00006450-200111000-00012\nKocherlakota, C., Nagaraju, B., Arjun, N., Srinath, A., Kothapalli, K. S. D., and Brenna,\nJ. T. (2022). Inhalation of nebulized omega-3 fatty acids mitigate LPS-induced acute\nlung in \ufb02ammation in rats: implications for treatment of COPD and COVID-19.\nProstagl. Leukot. Essent. Fat. Acids 179, 102426. doi:10.1016/j.plefa.2022.102426\nK\u00f6hler, A., Heinrich, J., and von Schacky, C. (2017). Bioavailability of dietary omega-3\nfatty acids added to a variety of sausages in healthy individuals. Nutrients 9 (6), 629.\ndoi:10.3390/nu9060629\nKoppelmann, T., Pollak, Y., Ben-Shahar, Y., Gorelik, G., and Sukhotnik, I. (2021). The\nmechanisms of the anti-in \ufb02ammatory and anti-apoptotic effects of omega-3\npolyunsaturated fatty acids during methotrexate-induced intestinal damage in cell\nline and in a rat model. Nutrients 13 (3), 888. doi:10.3390/nu13030888\nKrajewski, P., Sieroszewski, P., Karowicz-Bilinska, A., Kmiecik, M., Chudzik, A.,\nStrzalko-Gloskowska, B., et al. (2014). Assessment of interleukin-6, interleukin-8 and\ninterleukin-18 count in the serum of IUGR newborns. J. Maternal-Fetal Neonatal Med.\n27 (11), 1142 \u20131145. doi:10.3109/14767058.2013.851186\nKras, K. M., Hausman, D. B., and Martin, R. J. (2000). Tumor necrosis factor-alpha\nstimulates cell proliferation in adipose tissue-derived stromal-vascular cell culture:\npromotion of adipose tissue expansion by paracrine growth factors. Obes. Res. 8 (2),\n186\u2013193. doi:10.1038/oby.2000.20\nKrawczyk, S. A., Haller, J. F., Ferrante, T., Zoeller, R. A., and Corkey, B. E. (2012).\nReactive oxygen species facilitate translocation of hormone sensitive lipase to the lipiddroplet during lipolysis in human differentiated adipocytes. PLoS One 7 (4), e34904.\ndoi:10.1371/journal.pone.0034904\nKronberg, S. L., Scholljegerdes, E. J., Murphy, E. J., Ward, R. E., Maddock, T. D., and\nSchauer, C. S. (2012). Treatment of \ufb02axseed to reduce biohydrogenation of \u03b1-linolenic\nacid by ruminal microbes in sheep and cattle, and increase n-3 fatty acid concentrations\nin red meat. J. Anim. Sci. 90 (12), 4618 \u20134624. doi:10.2527/jas.2011-4774\nKuo, A. H., Li, C., Huber, H. F., Clarke, G. D., and Nathanielsz, P. W. (2018).\nIntrauterine growth restriction results in persistent vascular mismatch in adulthood.\nJ. Physiol. 596 (23), 5777 \u20135790. doi:10.1113/JP275139\nLacey, T. A. (2021). The effects of omega-3 PUFA infusions during late gestation on\ndevelopmental pathologies in the intrauterine growth restricted fetus. Theses Diss.\nAnimal Sci. 226.\nLacey, T. L., Gibbs, R. L., Most, M. S., Beer, H. N., Hicks, Z. M., Grijalva, P. C., et al.\n(2021). Decreased fetal biometrics and impaired \u03b2-cell function in IUGR fetal sheep are\nimproved by daily \u03c9-3 PUFA infusion. Transl. Anim. Sci. 5 (Suppl. ment_S1), S41 \u2013S45.\ndoi:10.1093/tas/txab168\nLacy, P., and Stow, J. L. (2011). Cytokine release from innate immune cells:\nassociation with diverse membrane traf \ufb01cking pathways. Blood 118 (1), 9 \u201318.\ndoi:10.1182/blood-2010-08-265892\nLane, R. H., Kelley, D. E., Gruetzmacher, E. M., and Devaskar, S. U. (2001a).\nUteroplacental insuf \ufb01ciency alters hepatic fatty acid-metabolizing enzymes in juvenile\nand adult rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 (1), R183 \u2013R190. doi:10.\n1152/ajpregu.2001.280.1.R183\nLane, R. H., Kelley, D. E., Ritov, V. H., Tsirka, A. E., and Gruetzmacher, E. M. (2001b).\nAltered expression and function of mitochondrial beta-oxidation enzymes in juvenileintrauterine-growth-retarded rat skeletal muscle. Pediatr. Res. 50 (1), 83 \u201390. doi:10.\n1203/00006450-200107000-00016\nLane, S. L., Doyle, A. S., Bales, E. S., Lorca, R. A., Julian, C. G., and Moore, L. G. (2020).\nIncreased uterine artery blood \ufb02ow in hypoxic murine pregnancy is not suf \ufb01cient to\nprevent fetal growth restriction \u2020.Biol. Reprod. 102 (3), 660 \u2013670. doi:10.1093/biolre/\nioz208\nLang, U., Baker, R. S., Khoury, J., and Clark, K. E. (2000). Effects of chronic reduction\nin uterine blood \ufb02ow on fetal and placental growth in the sheep. Am. J. Physiol. Regul.\nIntegr. Comp. Physiol. 279 (1), R53 \u2013R59. doi:10.1152/ajpregu.2000.279.1.R53\nLangen, R. C., Schols, A. M., Kelders, M. C., Van Der Velden, J. L., Wouters, E. F., and\nJanssen-Heininger, Y. M. (2002). Tumor necrosis factor-alpha inhibits myogenesis\nthrough redox-dependent and -independent pathways. Am. J. Physiol. Cell Physiol. 283\n(3), C714 \u2013\nC721. doi:10.1152/ajpcell.00418.2001\nLangen, R. C., Schols, A. M., Kelders, M. C., Wouters, E. F., and Janssen-Heininger, Y.\nM. (2001). In \ufb02ammatory cytokines inhibit myogenic differentiation through activation\nof nuclear factor-kappaB. FASEB J. 15 (7), 1169 \u20131180. doi:10.1096/fj.00-0463\nLapillonne, A., Peretti, N., Ho, P. S., Claris, O., and Salle, B. L. (1997). Aetiology,\nmorphology and body composition of infants born small for gestational age. Acta\nPaediatr. Suppl. 423, 173 \u2013176. ; discussion 7. doi:10.1111/j.1651-2227.1997.tb18406.x\nLaskowska, M., Laskowska, K., Leszczy \u0144ska-Gorzelak, B., and Oleszczuk, J. (2007).\nMaternal and umbilical sTNF-R1 in preeclamptic pregnancies with intrauterine normal\nand growth retarded fetus. Hypertens. Pregnancy 26 (1), 13 \u201321. doi:10.1080/\n10641950601146483\nLee, M. J., and Fried, S. K. (2012). Glucocorticoids antagonize tumor necrosis factor-\nalpha-stimulated lipolysis and resistance to the antilipolytic effect of insulin in humanadipocytes. Am. J. Physiol. Endocrinol. Metab. 303 (9), E1126 \u2013E1133. doi:10.1152/\najpendo.00228.2012\nLeos, R. A., Anderson, M. J., Chen, X., Pugmire, J., Anderson, K. A., and Limesand, S.\nW. (2010). Chronic exposure to elevated norepinephrine suppresses insulin secretion in\nfetal sheep with placental insuf \ufb01ciency and intrauterine growth restriction. Am.\nJ. Physiol. Endocrinol. Metab. 298 (4), E770 \u2013E778. doi:10.1152/ajpendo.00494.2009\nLi, C., Ramahi, E., Nijland, M. J., Choi, J., Myers, D. A., Nathanielsz, P. W., et al.\n(2013). Up-regulation of the fetal baboon hypothalamo-pituitary-adrenal axis in\nintrauterine growth restriction: coincidence with hypothalamic glucocorticoid\nreceptor insensitivity and leptin receptor down-regulation. Endocrinol 154 (7),\n2365\u20132373. doi:10.1210/en.2012-2111\nLi, L., Yang, G., Shi, S., Yang, M., Liu, H., and Boden, G. (2009b). The adipose\ntriglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-\nalpha (TNF-alpha) in vivo .Cytokine 45 (1), 12 \u201319. doi:10.1016/j.cyto.2008.10.006\nLi, Q., Yu, Q., Na, R., and Liu, B. (2017). Omega-3 polyunsaturated fatty acids prevent\nmurine dilated cardiomyopathy by reducing oxidative stress and cardiomyocyte\napoptosis. Exp. Ther. Med. 14 (6), 6152 \u20136158. doi:10.3892/etm.2017.5338\nLi, R., Huang, H., Limesand, S. W., and Chen, X. (2021). Pancreatic islets exhibit\ndysregulated adaptation of insulin secretion after chronic epinephrine exposure. Curr.\nIssues Mol. Biol. 43 (1), 240 \u2013250. doi:10.3390/cimb43010020\nLi, W., Li, B., Lv, J., Dong, L., Zhang, L., and Wang, T. (2018). Choline\nsupplementation improves the lipid metabolism of intrauterine-growth-restricted\npigs. Asian-Australas J. Anim. Sci. 31 (5), 686 \u2013695. doi:10.5713/ajas.15.0810\nLi, W., Moylan, J. S., Chambers, M. A., Smith, J., and Reid, M. B. (2009a). Interleukin-\n1 stimulates catabolism in C2C12 myotubes. Am. J. Physiol. Cell Physiol. 297 (3),\nC706 \u2013C714. doi:10.1152/ajpcell.00626.2008\nLimesand, S. W., Jensen, J., Hutton, J. C., and Hay, W. W., Jr. (2005). Diminished\nbeta-cell replication contributes to reduced beta-cell mass in fetal sheep with\nintrauterine growth restriction. Am. J. Physiol. Regul. Integr. Comp. Physiol. 288 (5),\nR1297 \u2013R1305. doi:10.1152/ajpregu.00494.2004\nLimesand, S. W., Rozance, P. J., Brown, L. D., and Hay, W. W., Jr. (2009). Effects of\nchronic hypoglycemia and euglycemic correction on lysine metabolism in fetal sheep.\nAm. J. Physiol. Endocrinol. Metab.\n296 (4), E879 \u2013E887. doi:10.1152/ajpendo.90832.2008\nLimesand, S. W., Rozance, P. J., Macko, A. R., Anderson, M. J., Kelly, A. C., and Hay,\nW. W., Jr. (2013). Reductions in insulin concentrations and beta-cell mass precede\ngrowth restriction in sheep fetuses with placental insuf \ufb01ciency. Am. J. Physiol.\nEndocrinol. Metab. 304 (5), E516 \u2013E523. doi:10.1152/ajpendo.00435.2012\nLimesand, S. W., Rozance, P. J., Smith, D., and Hay, W. W., Jr. (2007). Increased\ninsulin sensitivity and maintenance of glucose utilization rates in fetal sheep withplacental insuf \ufb01ciency and intrauterine growth restriction. Am. J. Physiol. Endocrinol.\nMetab. 293 (6), E1716 \u2013E1725. doi:10.1152/ajpendo.00459.2007\nLimesand, S. W., Rozance, P. J., Zerbe, G. O., Hutton, J. C., and Hay, W. W., Jr. (2006).\nAttenuated insulin release and storage in fetal sheep pancreatic islets with intrauterine\ngrowth restriction. Endocrinol 147 (3), 1488 \u20131497. doi:10.1210/en.2005-0900\nLiu, J., He, J., Yang, Y., Yu, J., Mao, X., Yu, B., et al. (2014). Effects of intrauterine\ngrowth retardation and postnatal high-fat diet on hepatic in \ufb02ammatory response in\npigs. Arch. Anim. Nutr. 68 (2), 111 \u2013125. doi:10.1080/1745039X.2014.897532\nLiu, T., Li, R., Luo, N., Lou, P., Limesand, S. W., Yang, Y., et al. (2022). Hepatic lipid\naccumulation and dysregulation associate with enhanced reactive oxygen species and\npro-in \ufb02ammatory cytokine in low-birth-weight goats. Anim. (Basel) 12 (6), 766. doi:10.\n3390/ani12060766\nFrontiers in Physiology frontiersin.org 21White and Yates 10.3389/fphys.2023.1250134\nLimesand, S. W., Rozance, P. J., Macko, A. R., Anderson, M. J., Kelly, A. C., Hay, W.\nW., et al. (2013). Reductions in insulin concentrations and beta-cell mass precede\ngrowth restriction in sheep fetuses with placental insuf \ufb01ciency. Am. J. Physiol.\nEndocrinol. Metab. 304 (5), E516 \u2013523. doi:10.1152/ajpendo.00435.2012\nLlanos, A., Lin, Y., Mena, P., Salem, N., Jr., and Uauy, R. (2005). Infants with\nintrauterine growth restriction have impaired formation of docosahexaenoic acid in\nearly neonatal life: A stable isotope study. Pediatr. Res. 58 (4), 735 \u2013740. doi:10.1203/01.\nPDR.0000180542.68526.A2\nLlovera, M., Garcia-Martinez, C., Agell, N., Lopez-Soriano, F. J., and Argiles, J. M.\n(1997). TNF can directly induce the expression of ubiquitin-dependent proteolytic\nsystem in rat soleus muscles. Biochem. Biophys. Res. Commun. 230 (2), 238 \u2013241. doi:10.\n1006/bbrc.1996.5827\nLugrin, J., Rosenblatt-Velin, N., Parapanov, R., and Liaudet, L. (2014). The role of\noxidative stress during in \ufb02ammatory processes. Biol. Chem. 395 (2), 203 \u2013230. doi:10.\n1515/hsz-2013-0241\nL u r b e ,E . ,C a r v a j a l ,E . ,T o r r o ,I . ,A g u i l a r ,F . ,A l v a r e z ,J . ,a n dR e d o n ,J .( 2 0 0 9 ) .\nIn\ufb02uence of concurrent obesity and low birth weight on blood pressure phenotype in\nyouth. Hypertension 53 (6), 912 \u2013917. doi:10.1161/HYPERTENSIONAHA.109.\n129155\nLy, T. T., Hewitt, J., Davey, R. J., Lim, E. M., Davis, E. A., and Jones, T. W. (2011).\nImproving epinephrine responses in hypoglycemia unawareness with real-time\ncontinuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care\n34 (1), 50 \u201352. doi:10.2337/dc10-1042\nMacko, A. R., Yates, D. T., Chen, X., Green, A. S., Kelly, A. C., Brown, L. D., et al.\n(2013). Elevated plasma norepinephrine inhibits insulin secretion, but adrenergic\nblockade reveals enhanced beta-cell responsiveness in an ovine model of placental\ninsuf\ufb01ciency at 0.7 of gestation. J. Dev. Orig. Health Dis. 4 (5), 402 \u2013410. doi:10.1017/\nS2040174413000093\nMacko, A. R., Yates, D. T., Chen, X., Shelton, L. A., Kelly, A. C., Davis, M. A., et al.\n(2016). Adrenal demedullation and oxygen supplementation independently increaseglucose-stimulated insulin concentrations in fetal sheep with intrauterine growth\nrestriction. Endocrinol 157 (5), 2104 \u20132115. doi:10.1210/en.2015-1850\nMadaro, L., Passafaro, M., Sala, D., Etxaniz, U., Lugarini, F., Proietti, D., et al. (2018).\nDenervation-activated STAT3-IL-6 signalling in \ufb01bro-adipogenic progenitors promotes\nmyo\ufb01bres atrophy and \ufb01brosis. Nat. Cell Biol. 20 (8), 917 \u2013927. doi:10.1038/s41556-018-\n0151-y\nMaier, A., McEwan, J. C., Dodds, K. G., Fischman, D. A., Fitzsimons, R. B., and Harris,\nA. J. (1992). Myosin heavy chain composition of single \ufb01bres and their origins and\ndistribution in developing fascicles of sheep tibialis cranialis muscles. J. Musc Res. Cell\nMobil. 13 (5), 551 \u2013572. doi:10.1007/BF01737997\nMaliszewski, A. M., Gadhia, M. M., O \u2019Meara, M. C., Thorn, S. R., Rozance, P. J., and\nBrown, L. D. (2012). Prolonged infusion of amino acids increases leucine oxidation in\nfetal sheep. Am. J. Physiol. Endocrinol. Metab. 302 (12), E1483\n\u2013E1492. doi:10.1152/\najpendo.00026.2012\nMark, P. J., Wyrwoll, C. S., Zulka \ufb02i, I. S., Mori, T. A., and Waddell, B. J. (2014). Rescue\nof glucocorticoid-programmed adipocyte in \ufb02ammation by omega-3 fatty acid\nsupplementation in the rat. Reprod. Biol. Endocrinol. 12, 39. doi:10.1186/1477-7827-\n12-39\nMarques, R. S., Cooke, R. F., Rodrigues, M. C., Brand\u00e3o, A. P., Schubach, K. M.,\nLippolis, K. D., et al. (2017). Effects of supplementing calcium salts of polyunsaturated\nfatty acids to late-gestating beef cows on performance and physiological responses of the\noffspring. J. Anim. Sci. 95 (12), 5347 \u20135357. doi:10.2527/jas2017.1606\nMathews, T. J., and Driscoll, A. K. (2017). Trends in infant mortality in the\nUnited States, 2005-2014. NCHS Data Brief. (279), 1 \u20138.\nMayhew, T. M., Wijesekara, J., Baker, P. N., and Ong, S. S. (2004). Morphometric\nevidence that villous development and fetoplacental angiogenesis are compromised by\nintrauterine growth restriction but not by pre-eclampsia. Placenta 25 (10), 829 \u2013833.\ndoi:10.1016/j.placenta.2004.04.011\nMeadus, W. J., Duff, P., Uttaro, B., Aalhus, J. L., Rolland, D. C., Gibson, L. L., et al.\n(2010). Production of docosahexaenoic acid (DHA) enriched bacon. J. Agric. Food\nChem. 58 (1), 465 \u2013472. doi:10.1021/jf9028078\nMelendez, P., Roeschmann, C. F., Baudo, A., Tao, S., Pinedo, P., Kalantari, A., et al.\n(2022). Effect of \ufb01sh oil and canola oil supplementation on immunological parameters,\nfeed intake, and growth of Holstein calves. J. Dairy Sci. 105 (3), 2509 \u20132520. doi:10.3168/\njds.2021-21134\nMericq, V., Ong, K. K., Bazaes, R., Pena, V., Avila, A., Salazar, T., et al. (2005).\nLongitudinal changes in insulin sensitivity and secretion from birth to age three years in\nsmall- and appropriate-for-gestational-age children. Diabetologia 48 (12), 2609 \u20132614.\ndoi:10.1007/s00125-005-0036-z\nMeyer, K. M., Koch, J. M., Ramadoss, J., Kling, P. J., and Magness, R. R. (2010). Ovine\nsurgical model of uterine space restriction: interactive effects of uterine anomalies and\nmultifetal gestations on fetal and placental growth. Biol. Reprod. 83 (5), 799 \u2013806. doi:10.\n1095/biolreprod.110.085381\nMiddleton, P., Gomersall, J. C., Gould, J. F., Shepherd, E., Olsen, S. F., and Makrides,\nM. (2018). Omega-3 fatty acid addition during pregnancy. Cochrane Database Syst. Rev.\n11 (11), CD003402. doi:10.1002/14651858.CD003402.pub3Milligan Bnf, D., and Kramer, D. L. (2002). Within-litter birth weight variation in the\ndomestic pig and its relation to pre-weaning survival, weight gain, and variation in\nweaning weights. Livest. Prod. Sci. 76 (1-2), 181 \u2013191. doi:10.1016/s0301-6226(02)\n00012-x\nMiranda, J., Paules, C., Nair, S., Lai, A., Palma, C., Scholz-Romero, K., et al. (2018).\nPlacental exosomes pro \ufb01le in maternal and fetal circulation in intrauterine growth\nrestriction - Liquid biopsies to monitoring fetal growth. Placenta 64, 34 \u201343. doi:10.1016/\nj.placenta.2018.02.006\nMorand, O., Chanez, C., Masson, M., Dumont, O., Flexor, M. A., Baumann, N., et al.\n(1981). Intrauterine growth retardation (malnutrition by vascular ligation) induces\nmodi \ufb01cations in fatty acid composition of neurons and oligodendrocytes. J. Neurochem.\n37 (4), 1057 \u20131060. doi:10.1111/j.1471-4159.1981.tb04498.x\nMorin, C. L., Schlaepfer, I. R., and Eckel, R. H. (1995). Tumor necrosis factor-alpha\neliminates binding of NF-Y and an octamer-binding protein to the lipoprotein lipase\npromoter in 3T3-L1 adipocytes. J. Clin. Invest. 95 (4), 1684 \u20131689. doi:10.1172/\nJCI117844\nMost, M. S., and Yates, D. T. (2021). In \ufb02ammatory mediation of heat stress-induced\ngrowth de \ufb01cits in livestock and its potential role as a target for nutritional interventions:\nA review. Anim. (Basel) 11 (12), 3539. doi:10.3390/ani11123539\nMuller, F. L., Song, W., Liu, Y., Chaudhuri, A., Pieke-Dahl, S., Strong, R., et al. (2006).\nAbsence of CuZn superoxide dismutase leads to elevated oxidative stress and\nacceleration of age-dependent skeletal muscle atrophy. Free Radic. Biol. Med. 40\n(11), 1993 \u20132004. doi:10.1016/j.freeradbiomed.2006.01.036\nNardozza, L. M., Caetano, A. C., Zamarian, A. C., Mazzola, J. B., Silva, C. P., Marcal,\nV. M., et al. (2017). Fetal growth restriction: current knowledge. Arch. Gynecol. Obstet.\n295 (5), 1061 \u20131077. doi:10.1007/s00404-017-4341-9\nNatto, Z. S., Yaghmoor, W., Alshaeri, H. K., and Van Dyke, T. E. (2019). Omega-3\nfatty acids effects on in \ufb02ammatory biomarkers and lipid pro \ufb01les among diabetic and\ncardiovascular disease patients: A systematic review and meta-analysis. Sci. Rep. 9 (1),\n18867. doi:10.1038/s41598-019-54535-x\nNiu, Y., He, J., Ahmad, H., Shen, M., Zhao, Y., Gan, Z., et al. (2019). Dietary curcumin\nsupplementation increases antioxidant capacity, upregulates Nrf2 and Hmox1 levels in\nthe liver of piglet model with intrauterine growth retardation. Nutrients 11 (12), 2978.\ndoi:10.3390/nu11122978\nNiu, Y., Zhao, Y., He, J., Yun, Y., Shen, M., Gan, Z., et al. (2021). Dietary\ndihydroartemisinin supplementation alleviates intestinal in \ufb02ammatory injury\nthrough TLR4/NOD/NF- \u03baB signaling pathway in weaned piglets with intrauterine\ngrowth retardation. Anim. Nutr. 7 (3), 667 \u2013678. doi:10.1016/j.aninu.2020.12.009\nOgata, Y., Nakao, T., Takahashi, K., Abe, H., Misawa, T., Urushiyama, Y., et al. (1999).\nIntrauterine growth retardation as a cause of perinatal mortality in Japanese black beef\ncalves. Zentralbl Veterinarmed A 46 (6), 327 \u2013334. doi:10.1046/j.1439-0442.1999.\n00221.x\nOh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., et al. (2010).\nGPR120 is an omega-3 fatty acid receptor mediating potent anti-in \ufb02ammatory and\ninsulin-sensitizing effects. Cell142 (5), 687 \u2013698. doi:10.1016/j.cell.2010.07.041\nOng, K. K., Ahmed, M. L., Emmett, P. M., Preece, M. A., and Dunger, D. B. (2000).\nAssociation between postnatal catch-up growth and obesity in childhood: prospective\ncohort study. BMJ 320 (7240), 967 \u2013971. doi:10.1136/bmj.320.7240.967\nOng, K. K., and Dunger, D. B. (2000). Thrifty genotypes and phenotypes in the\npathogenesis of type 2 diabetes mellitus. J. Pediatr. Endocrinol. Metab. 13 (Suppl. 6),\n1419\u20131424. doi:10.1515/jpem-2000-s616\nOtis, J. S., Niccoli, S., Hawdon, N., Sarvas, J. L., Frye, M. A., Chicco, A. J., et al. (2014).\nPro-in \ufb02ammatory mediation of myoblast proliferation. PLoS One 9 (3), e92363. doi:10.\n1371/journal.pone.0092363\nOyebade, A., Lifshitz, L., Lehrer, H., Jacoby, S., Portnick, Y., and Moallem, U. (2020).\nSaturated fat supplemented in the form of triglycerides decreased digestibility and\nreduced performance of dairy cows as compared to calcium salt of fatty acids. Anim 14\n(5), 973 \u2013982. doi:10.1017/S1751731119002465\nPadoan, A., Rigano, S., Ferrazzi, E., Beaty, B. L., Battaglia, F. C., and Galan, H. L.\n(2004). Differences in fat and lean mass proportions in normal and growth-restricted\nfetuses. Am. J. Obst Gynecol. 191 (4), 1459 \u20131464. doi:10.1016/j.ajog.2004.06.045\nPaolini, C. L., Marconi, A. M., Ronzoni, S., Di Noio, M., Fennessey, P. V., Pardi, G.,\net al. (2001). Placental transport of leucine, phenylalanine, glycine, and proline in\nintrauterine growth-restricted pregnancies. J. Clin. Endocrinol. Metab. 86 (11),\n5427\u20135432. doi:10.1210/jcem.86.11.8036\nPapandreou, V., Kavrochorianou, N., Katsoulas, T., Myrianthefs, P., Venetsanou, K.,\nand Baltopoulos, G. (2016). Adrenergic effect on cytokine release after ex vivo healthy\nvolunteers \u2019whole blood LPS stimulation. In\ufb02ammation 39 (3), 1069 \u20131075. doi:10.1007/\ns10753-016-0338-y\nPatel, D., and Kalhan, S. (1992). Glycerol metabolism and triglyceride-fatty acid\ncycling in the human newborn: effect of maternal diabetes and intrauterine growth\nretardation. Pediatr. Res. 31 (1), 52 \u201358. doi:10.1203/00006450-199201000-00010\nPecks, U., Bornemann, V., Klein, A., Segger, L., Maass, N., Alkatout, I., et al. (2019).\nEstimating fetal cholesterol synthesis rates by cord blood analysis in intrauterine growth\nrestriction and normally grown fetuses. Lipids Health Dis. 18 (1), 185. doi:10.1186/\ns12944-019-1117-1\nFrontiers in Physiology frontiersin.org 22White and Yates 10.3389/fphys.2023.1250134\nPecks, U., Brieger, M., Schiessl, B., Bauerschlag, D. O., Piroth, D., Bruno, B., et al.\n(2012). Maternal and fetal cord blood lipids in intrauterine growth restriction. J. Perinat.\nMed. 40 (3), 287 \u2013296. doi:10.1515/jpm.2011.135\nPendleton, A. L., Antolic, A. T., Kelly, A. C., Davis, M. A., Camacho, L. E., Doubleday,\nK., et al. (2020). Lower oxygen consumption and Complex I activity in mitochondria\nisolated from skeletal muscle of fetal sheep with intrauterine growth restriction. Am.\nJ. Physiol. Endocrinol. Metab. 319 (1), E67 \u2013e80. doi:10.1152/ajpendo.00057.2020\nPendleton, A. L., Humphreys, L. R., Davis, M. A., Camacho, L. E., Anderson, M. J., and\nLimesand, S. W. (2019). Increased pyruvate dehydrogenase activity in skeletal muscle of\ngrowth-restricted ovine fetuses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 317 (4),\nR513 \u2013R520. doi:10.1152/ajpregu.00106.2019\nPeterside, I. E., Selak, M. A., and Simmons, R. A. (2003). Impaired oxidative\nphosphorylation in hepatic mitochondria in growth-retarded rats. Am. J. Physiol.\nEndocrinol. Metab. 285 (6), E1258 \u2013E1266. doi:10.1152/ajpendo.00437.2002\nPhilipps, A. F., Rosenkrantz, T. S., Clark, R. M., Knox, I., Chaf \ufb01n, D. G., and Raye, J. R.\n(1991). Effects of fetal insulin de \ufb01ciency on growth in fetal lambs. Diabetes 40 (1),\n20\u201327. doi:10.2337/diab.40.1.20\nPizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., et al.\n(2017). Oxidative stress: harms and bene \ufb01ts for human health. Oxid. Med. Cell Longev.\n2017, 8416763. doi:10.1155/2017/8416763\nPol\u00e1nyi, L., Niessen, C. M., Vohlen, C., Stinn, J., Kretschmer, T., Jentgen, V., et al.\n(2020). Intrauterine growth restriction induces skin in \ufb02ammation, increases TSLP and\nimpairs epidermal barrier function. J. Mol. Med. Berl. 98 (2), 279 \u2013289. doi:10.1007/\ns00109-019-01867-w\nPonnampalam, E. N., Sinclair, A. J., Egan, A. R., Ferrier, G. R., and Leury, B. J. (2002).\nDietary manipulation of muscle long-chain omega-3 and omega-6 fatty acids and\nsensory properties of lamb meat. Meat Sci. 60 (2), 125 \u2013132. doi:10.1016/s0309-1740(01)\n00113-9\nP o n n a m p a l a m ,E .N . ,T r o u t ,G .R . ,S i n c l a i r ,A .J . ,E g a n ,A .R . ,a n dL e u r y ,B .J .\n(2001). Comparison of the color stability and lipid oxidative stability of fresh and\nvacuum packaged lamb muscle containing elevated omega-3 and omega-6 fatty acid\nlevels from dietary manipulation. Meat Sci. 58 (2), 151 \u2013161. doi:10.1016/s0309-\n1740(00)00143-1\nPosont, R. J., Cadaret, C. N., Barnes, T. L., and Yates, D. T. (2017). A potential role for\nmTORC1/2 in \u03b22 adrenergic regulation of skeletal muscle glucose oxidation in models\nof intrauterine growth restriction. Diabesity 3 (3), 9 \u201312. doi:10.15562/diabesity.2017.40\nPosont, R. J., Cadaret, C. N., Beard, J. K., Swanson, R. M., Gibbs, R. L., Marks-Nelson,\nE. S., et al. (2021). Maternofetal in \ufb02ammation induced for 2 wk in late gestation reduced\nbirth weight and impaired neonatal growth and skeletal muscle glucose metabolism in\nlambs. J. Anim. Sci. 99 (5), skab102. doi:10.1093/jas/skab102\nPosont, R. J., Most, M. S., Cadaret, C. N., Marks-Nelson, E. S., Beede, K. A., Limesand,\nS. W., et al. (2022). Primary myoblasts from intrauterine growth-restricted fetal sheep\nexhibit intrinsic dysfunction of proliferation and differentiation that coincides with\nenrichment of in \ufb02ammatory cytokine signaling pathways. J. Animal Sci. 100 (8),\nskac145. doi:10.1093/jas/skac145\nPoudel, R., McMillen, I. C., Dunn, S. L., Zhang, S., and Morrison, J. L. (2015). Impact\nof chronic hypoxemia on blood \ufb02ow to the brain, heart, and adrenal gland in the late-\ngestation IUGR sheep fetus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 308 (3),\nR151 \u2013R162. doi:10.1152/ajpregu.00036.2014\nRamakrishnan, U., Stein, A. D., Parra-Cabrera, S., Wang, M., Imhoff-Kunsch, B.,\nJuarez-Marquez, S., et al. (2010). Effects of docosahexaenoic acid supplementationduring pregnancy on gestational age and size at birth: randomized, double-blind,\nplacebo-controlled trial in Mexico. Food Nutr. Bull. 31 (2 Suppl. l), S108 \u2013S116. doi:10.\n1177/15648265100312S203\nRegnault, T. R., de Vrijer, B., Galan, H. L., Davidsen, M. L., Trembler, K. A., Battaglia,\nF. C., et al. (2003). The relationship between transplacental O2 diffusion and placental\nexpression of PlGF, VEGF and their receptors in a placental insuf \ufb01ciency model of fetal\ngrowth restriction. J. Physiol. 550 (Pt 2), 641 \u2013656. doi:10.1113/jphysiol.2003.039511\nRegnault, T. R., Orbus, R. J., de Vrijer, B., Davidsen, M. L., Galan, H. L., Wilkening, R.\nB., et al. (2002). Placental expression of VEGF, PlGF and their receptors in a model of\nplacental insuf \ufb01ciency-intrauterine growth restriction (PI-IUGR). Placenta 23 (2-3),\n132\u2013144. doi:10.1053/plac.2001.0757\nReid, M. B., and Li, Y. P. (2001). Cytokines and oxidative signalling in skeletal muscle.\nActa Physiol. Scand. 171 (3), 225 \u2013232. doi:10.1046/j.1365-201x.2001.00824.x\nRemels, A. H., Gosker, H. R., Verhees, K. J., Langen, R. C., and Schols, A. M. (2015).\nTNF- \u03b1-induced NF- \u03baB activation stimulates skeletal muscle glycolytic metabolism\nthrough activation of HIF-1 \u03b1.Endocrinol 156 (5), 1770 \u20131781. doi:10.1210/en.2014-\n1591\nRichard, D., Ke \ufb01, K., Barbe, U., Bausero, P., and Visioli, F. (2008). Polyunsaturated\nfatty acids as antioxidants. Pharmacol. Res. 57 (6), 451 \u2013455. doi:10.1016/j.phrs.2008.\n05.002\nRiddle, E. S., Campbell, M. S., Lang, B. Y., Bierer, R., Wang, Y., Bagley, H. N., et al.\n(2014). Intrauterine growth restriction increases TNF \u03b1and activates the unfolded\nprotein response in male rat pups. J. Obes. 2014, 829862. doi:10.1155/2014/829862\nRobinson, D. L., Cafe, L. M., and Greenwood, P. L. (2013). Meat science and muscle\nbiology symposium: developmental programming in cattle: consequences for growth,ef\ufb01ciency, carcass, muscle, and beef quality characteristics. J. Anim. Sci. 91 (3),\n1428\u20131442. doi:10.2527/jas.2012-5799\nRosa Velazquez, M., Batistel, F., Pinos Rodriguez, J. M., and Relling, A. E. (2020).\nEffects of maternal dietary omega-3 polyunsaturated fatty acids and methionine duringlate gestation on fetal growth, DNA methylation, and mRNA relative expression of\ngenes associated with the in \ufb02ammatory response, lipid metabolism and DNA\nmethylation in placenta and offspring \u2019s liver in sheep. J. Anim. Sci. Biotechnol. 11\n(1), 111. doi:10.1186/s40104-020-00513-7\nRosa-Velazquez, M., Pinos-Rodriguez, J. M., Parker, A. J., and Relling, A. E. (2022).\nMaternal supply of a source of omega-3 fatty acids and methionine during late gestation\non the offspring \u2019s growth, metabolism, carcass characteristic, and liver \u2019s mRNA\nexpression in sheep.\nJ. Anim. Sci. 100 (4), skac032. doi:10.1093/jas/skac032\nRosario, F. J., Kramer, A., Li, C., Galan, H. L., Powell, T. L., Nathanielsz, P. W., et al.\n(2021). Reduction of in vivo placental amino acid transport precedes the development of\nintrauterine growth restriction in the non-human primate. Nutrients 13 (8), 2892.\ndoi:10.3390/nu13082892\nRoss, J. C., Fennessey, P. V., Wilkening, R. B., Battaglia, F. C., and Meschia, G. (1996).\nPlacental transport and fetal utilization of leucine in a model of fetal growth retardation.\nAm. J. Physiol. 270 (3 Pt 1), E491 \u2013E503. doi:10.1152/ajpendo.1996.270.3.E491\nRotter, V., Nagaev, I., and Smith, U. (2003). Interleukin-6 (IL-6) induces insulin\nresistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha,\noverexpressed in human fat cells from insulin-resistant subjects. J. Biol. Chem. 278 (46),\n45777 \u201345784. doi:10.1074/jbc.M301977200\nRozance, P. J., Anderson, M., Martinez, M., Fahy, A., Macko, A. R., Kailey, J., et al.\n(2015). Placental insuf \ufb01ciency decreases pancreatic vascularity and disrupts hepatocyte\ngrowth factor signaling in the pancreatic islet endothelial cell in fetal sheep. Diabetes 64\n(2), 555 \u2013564. doi:10.2337/db14-0462\nRozance, P. J., Crispo, M. M., Barry, J. S., O \u2019Meara, M. C., Frost, M. S., Hansen, K. C.,\net al. (2009). Prolonged maternal amino acid infusion in late-gestation pregnant sheep\nincreases fetal amino acid oxidation. Am. J. Physiol. Endocrinol. Metab. 297 (3),\nE638 \u2013E646. doi:10.1152/ajpendo.00192.2009\nRozance, P. J., Limesand, S. W., and Hay, W. W., Jr (2006). Decreased nutrient\nstimulated insulin secretion in chronically hypoglycemic late gestation fetal sheep is dueto an intrinsic islet defect. Am. J. Physiol. EndocrinolMetab 291 (2), E404 \u2013E411. doi:10.\n1152/ajpendo.00643.2005\nRozance, P. J., Limesand, S. W., Zerbe, G. O., and Hay, W. W., Jr. (2007). Chronic fetal\nhypoglycemia inhibits the later steps of stimulus-secretion coupling in pancreatic beta-\ncells. Am. J. Physiol. Endocrinol. Metab. 292 (5), E1256 \u2013E1264. doi:10.1152/ajpendo.\n00265.2006\nRozance, P. J., Wesolowski, S. R., Jonker, S. S., and Brown, L. D. (2021). Anemic\nhypoxemia reduces myoblast proliferation and muscle growth in late-gestation fetal\nsheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 321 (3), R352 \u2013R363. doi:10.1152/\najpregu.00342.2020\nRozance, P. J., and Wolfsdorf, J. I. (2019). Hypoglycemia in the newborn. Pediatr.\nClin. North Am. 66 (2), 333 \u2013342. doi:10.1016/j.pcl.2018.12.004\nRozance, P. J., Zastoupil, L., Wesolowski, S. R., Goldstrohm, D. A., Strahan, B., Cree-\nGreen, M., et al. (2018). Skeletal muscle protein accretion rates and hindlimb growth are\nreduced in late gestation intrauterine growth-restricted fetal sheep. J. Physiol. 596 (1),\n67\u201382. doi:10.1113/JP275230\nRueda-Clausen, C. F., Dolinsky, V. W., Morton, J. S., Proctor, S. D., Dyck, J. R., and\nDavidge, S. T. (2011). Hypoxia-induced intrauterine growth restriction increases thesusceptibility of rats to high-fat diet-induced metabolic syndrome. Diabetes 60 (2),\n507\u2013516. doi:10.2337/db10-1239\nRussell, F. D., and Burgin-Maunder, C. S. (2012). Distinguishing health bene \ufb01ts of\neicosapentaenoic and docosahexaenoic acids. Mar. Drugs 10 (11), 2535 \u20132559. doi:10.\n3390/md10112535\nRyden, M., Arvidsson, E., Blomqvist, L., Perbeck, L., Dicker, A., and Arner, P. (2004).\nTargets for TNF-alpha-induced lipolysis in human adipocytes. Biochem. Biophys. Res.\nCommun.\n318 (1), 168 \u2013175. doi:10.1016/j.bbrc.2004.04.010\nSaccone, G., Berghella, V., Maruotti, G. M., Sarno, L., and Martinelli, P. (2015).\nOmega-3 supplementation during pregnancy to prevent recurrent intrauterine growth\nrestriction: systematic review and meta-analysis of randomized controlled trials.\nUltrasound Obstet. Gynecol. 46 (6), 659 \u2013664. doi:10.1002/uog.14910\nSaccone, G., Saccone, I., and Berghella, V. (2016). Omega-3 long-chain\npolyunsaturated fatty acids and \ufb01sh oil supplementation during pregnancy: which\nevidence? J. Matern. Fetal Neonatal Med. 29 (15), 2389 \u20132397. doi:10.3109/14767058.\n2015.1086742\nSadiq, H. F., Das, U. G., Tracy, T. F., and Devaskar, S. U. (1999). Intra-uterine growth\nrestriction differentially regulates perinatal brain and skeletal muscle glucosetransporters. Brain Res. 823 (1-2), 96 \u2013103. doi:10.1016/s0006-8993(99)01145-2\nSaker, F., Voora, D. M., Mahajan, S. D., Kilic, I., Ismail-Beigi, F., and Kalhan, S. C.\n(1999). Effect of reduced inspired oxygen on fetal growth and maternal glucosemetabolism in rat pregnancy. Metabolism 48 (6), 738 \u2013744. doi:10.1016/s0026-\n0495(99)90173-7\nSandiford, S. D., Kennedy, K. A., Xie, X., Pickering, J. G., and Li, S. S. (2014). Dual\noxidase maturation factor 1 (DUOXA1) overexpression increases reactive oxygen\nFrontiers in Physiology frontiersin.org 23White and Yates 10.3389/fphys.2023.1250134\nspecies production and inhibits murine muscle satellite cell differentiation. Cell\nCommun. Signal 12, 5. doi:10.1186/1478-811X-12-5\nSharma, R., Maimanuku, L. R., Morse, Z., and Pack, A. R. (2007). Preterm low birth\nweights associated with periodontal disease in the Fiji Islands. Int. Dent. J. 57 (4),\n257\u2013260. doi:10.1111/j.1875-595x.2007.tb00129.x\nSandoval, C., Lambo, C. A., Beason, K., Dunlap, K. A., and Satter \ufb01eld, M. C. (2020).\nEffect of maternal nutrient restriction on skeletal muscle mass and associated molecular\npathways in SGA and Non-SGA sheep fetuses. Domest. Anim. Endocrinol. 72, 106443.\ndoi:10.1016/j.domaniend.2020.106443\nSchmocker, C., Weylandt, K. H., Kahlke, L., Wang, J., Lobeck, H., Tiegs, G., et al.\n(2007). Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression\nof cytokines. Hepatology 45 (4), 864 \u2013869. doi:10.1002/hep.21626\nSciancalepore, M., Luin, E., Parato, G., Ren, E., Giniatullin, R., Fabbretti, E., et al.\n(2012). Reactive oxygen species contribute to the promotion of the ATP-mediated\nproliferation of mouse skeletal myoblasts. Free Radic. Biol. Med. 53 (7), 1392 \u20131398.\ndoi:10.1016/j.freeradbiomed.2012.08.002\nShahidi, F., and Ambigaipalan, P. (2018). Omega-3 polyunsaturated fatty acids and\ntheir health bene \ufb01ts.Annu. Rev. Food Sci. Technol. 9, 345 \u2013381. doi:10.1146/annurev-\nfood-111317-095850\nSharkey, D., Symonds, M. E., and Budge, H. (2009). Adipose tissue in \ufb02ammation:\ndevelopmental ontogeny and consequences of gestational nutrient restriction in\noffspring. Endocrinol 150 (8), 3913 \u20133920. doi:10.1210/en.2008-1784\nSharma, D., Shastri, S., Farahbakhsh, N., and Sharma, P. (2016). Intrauterine growth\nrestriction - part 1. J. Matern. Fetal Neonatal Med. 29 (24), 3977 \u20133987. doi:10.3109/\n14767058.2016.1152249\nShibata, E., Hubel, C. A., Powers, R. W., von Versen-Hoeynck, F., Gammill, H.,\nRajakumar, A., et al. (2008). Placental system A amino acid transport is reduced in\npregnancies with small for gestational age (SGA) infants but not in preeclampsia with\nSGA infants. Placenta 29 (10), 879 \u2013882. doi:10.1016/j.placenta.2008.07.001\nShing \ufb01eld, K. J., Lee, M. R., Humphries, D. J., Scollan, N. D., Toivonen, V., Reynolds,\nC. K., et al. (2010). Effect of incremental amounts of \ufb01sh oil in the diet on ruminal lipid\nmetabolism in growing steers. Br. J. Nutr. 104 (1), 56 \u201366. doi:10.1017/\nS0007114510000292\nS h o j i ,H . ,W a t a n a b e ,A . ,A w a j i ,A . ,I k e d a ,N . ,H o s o z a w a ,M . ,O h k a w a ,N . ,e ta l .\n(2020). Intrauterine growth restriction affects z-scores of anthropometric\nparameters during the \ufb01rst 6 years in very low-birth-weight-children born at\nless than 30 weeks of gestation. J. Dev. Orig. Health Dis. 11 (1), 44 \u201348. doi:10.1017/\nS2040174419000369\nSoeters, P. B., Shenkin, A., Sobotka, L., Soeters, M. R., de Leeuw, P. W., and Wolfe, R.\nR. (2021). The anabolic role of the Warburg, Cori-cycle and Crabtree effects in healthand disease. Clin. Nutr. 40 (5), 2988 \u20132998. doi:10.1016/j.clnu.2021.02.012\nSouza, L. M., Cruz, S. S., Gomes-Filho, I. S., Amico, P., Barreto, M. L, Passos-Soares, J.\nS., et al. (2016). Effect of maternal periodontitis and low birth weight \u2014a case control\nstudy.\nActa Odontol Scand 74 (1), 73 \u201380. doi:10.3109/00016357.2015.1049374\nSoto, S. M., Blake, A. C., Wesolowski, S. R., Rozance, P. J., Barthel, K. B., Gao, B., et al.\n(2017). Myoblast replication is reduced in the IUGR fetus despite maintained\nproliferative capacity in vitro .J. Endocrinol. 232 (3), 475 \u2013491. doi:10.1530/JOE-16-0123\nSriram, S., Subramanian, S., Sathiakumar, D., Venkatesh, R., Salerno, M. S.,\nMcFarlane, C. D., et al. (2011). Modulation of reactive oxygen species in skeletal\nmuscle by myostatin is mediated through NF- \u03baB.Aging Cell 10 (6), 931 \u2013948. doi:10.\n1111/j.1474-9726.2011.00734.x\nSteyn, P. J., Dzobo, K., Smith, R. I., and Myburgh, K. H. (2019). Interleukin-6 induces\nmyogenic differentiation via JAK2-STAT3 signaling in mouse C2C12 myoblast cell line\nand primary human myoblasts. Int. J. Mol. Sci. 20 (21), 5273. doi:10.3390/ijms20215273\nStremming, J., Chang, E. I., Knaub, L. A., Armstrong, M. L., Baker, P. R., 2nd,\nWesolowski, S. R., et al. (2022). Lower citrate synthase activity, mitochondrial complex\nexpression, and fewer oxidative myo \ufb01bers characterize skeletal muscle from growth-\nrestricted fetal sheep. Am. J. Physiol. Regul. Integr. Comp. Physiol. 322 (3), R228 \u2013R240.\ndoi:10.1152/ajpregu.00222.2021\nStremming, J., Heard, S., White, A., Chang, E. I., Shaw, S. C., Wesolowski, S. R., et al.\n(2021). IGF-1 infusion to fetal sheep increases organ growth but not by stimulatingnutrient transfer to the fetus. Am. J. Physiol. Endocrinol. Metab. 320 (3), E527 \u2013E538.\ndoi:10.1152/ajpendo.00453.2020\nStremming, J., Jansson, T., Powell, T. L., Rozance, P. J., and Brown, L. D. (2020).\nReduced Na(+) K(+) -ATPase activity may reduce amino acid uptake in intrauterine\ngrowth restricted fetal sheep muscle despite unchanged ex vivo amino acid transporter\nactivity. J. Physiol. 598 (8), 1625 \u20131639. doi:10.1113/JP278933\nStyrud, J., Eriksson, U. J., Grill, V., and Swenne, I. (2005). Experimental intrauterine\ngrowth retardation in the rat causes a reduction of pancreatic B-cell mass, which persists\ninto adulthood. Biol. Neonate 88 (2), 122 \u2013128. doi:10.1159/000086136\nSun, L., Zhang, H., Wang, Z., Fan, Y., Guo, Y., and Wang, F. (2018). Dietary rumen-\nprotected arginine and N-carbamylglutamate supplementation enhances fetal growth in\nunderfed ewes. Reprod. Fertil. Dev. 30 (8), 1116 \u20131127. doi:10.1071/RD17164\nSutherland, A. E., Crossley, K. J., Allison, B. J., Jenkin, G., Wallace, E. M., and Miller, S.\nL. (2012). The effects of intrauterine growth restriction and antenatal glucocorticoids on\novine fetal lung development. Pediatr. Res. 71 (6), 689 \u2013696. doi:10.1038/pr.2012.19Tang, X., and Xiong, K. (2022). Intrauterine growth retardation affects intestinal\nhealth of suckling piglets via altering intestinal antioxidant capacity, glucose uptake,\ntight junction, and immune responses. Oxid. Med. Cell Longev. 2022, 2644205. doi:10.\n1155/2022/2644205\nTarry-Adkins, J. L., Fernandez-Twinn, D. S., Hargreaves, I. P., Neergheen, V., Aiken,\nC. E., Martin-Gronert, M. S., et al. (2016). Coenzyme Q10 prevents hepatic \ufb01brosis,\nin\ufb02ammation, and oxidative stress in a male rat model of poor maternal nutrition and\naccelerated postnatal growth. Am. J. Clin. Nutr. 103 (2), 579 \u2013588. doi:10.3945/ajcn.115.\n119834\nTeasdale, F. (1984). Idiopathic intrauterine growth retardation: histomorphometry of\nthe human placenta. Placenta 5 (1), 83 \u2013\n92. doi:10.1016/s0143-4004(84)80051-x\nThaler, I., Manor, D., Itskovitz, J., Rottem, S., Levit, N., Timor-Tritsch, I., et al. (1990).\nChanges in uterine blood \ufb02ow during human pregnancy. Am. J. Obstet. Gynecol. 162 (1),\n121\u2013125. doi:10.1016/0002-9378(90)90834-t\nThorn, S. R., Brown, L. D., Rozance, P. J., Hay, W. W., Jr., and Friedman, J. E. (2013).\nIncreased hepatic glucose production in fetal sheep with intrauterine growth restrictionis not suppressed by insulin. Diabetes 62 (1), 65 \u201373. doi:10.2337/db11-1727\nT h o r n ,S .R . ,R e g n a u l t ,T .R . ,B r o w n ,L .D . ,R o z a n c e ,P .J . ,K e n g ,J . ,R o p e r ,M . ,\net al. (2009). Intrauterine growth restricti on increases fetal hepatic gluconeogenic\ncapacity and reduces messenger ribonucleic acid translation initiation and nutrient\nsensing in fetal liver and skeletal muscle. Endocrinol 150 (7), 3021 \u20133030. doi:10.\n1210/en.2008-1789\nThureen, P. J., Trembler, K. A., Meschia, G., Makowski, E. L., and Wilkening, R. B.\n(1992). Placental glucose transport in heat-induced fetal growth retardation. Am.\nJ. Physiol. 263 (3 Pt 2), R578 \u2013R585. doi:10.1152/ajpregu.1992.263.3.R578\nTracey, K. J., and Cerami, A. (1993). Tumor necrosis factor, other cytokines and\ndisease. Annu. Rev. Cell Biol. 9, 317 \u2013343. doi:10.1146/annurev.cb.09.110193.001533\nTree, K., Viemari, J. C., Cayetanot, F., and Peyronnet, J. (2016). Growth restriction\ninduced by chronic prenatal hypoxia affects breathing rhythm and its pontine\ncatecholaminergic modulation. J. Neurophysiol. 116 (4), 1654 \u20131662. doi:10.1152/jn.\n00869.2015\nTrinh, B., Peletier, M., Simonsen, C., Plomgaard, P., Karstoft, K., Klarlund Pedersen,\nB., et al. (2021). Blocking endogenous IL-6 impairs mobilization of free fatty acids\nduring rest and exercise in lean and obese men. Cell Rep. Med. 2 (9), 100396. doi:10.\n1016/j.xcrm.2021.100396\nTurrens, J. F. (2003). Mitochondrial formation of reactive oxygen species. J. Physiol.\n552 (Pt 2), 335 \u2013344. doi:10.1113/jphysiol.2003.049478\nvan Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., et al.\n(2003). Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin.\nEndocrinol. Metab. 88 (7), 3005 \u20133010. doi:10.1210/jc.2002-021687\nVatansever, L., Kurt, E., Enser, M., Nute, G., Scollan, N., Wood, J., et al. (2000). Shelf\nlife and eating quality of beef from cattle of different breeds given diets differing in n-3\npolyunsaturated fatty acid composition. Animal Sci. 71 (3), 471 \u2013482. doi:10.1017/\ns135772980005548x\nVelten, M., Britt, R. D., Jr., Heyob, K. M., Tipple, T. E., and Rogers, L. K. (2014).\nMaternal dietary docosahexaenoic acid supplementation attenuates fetal growth\nrestriction and enhances pulmonary function in a newborn mouse model of\nperinatal in \ufb02ammation. J. Nutr. 144 (3), 258 \u2013266. doi:10.3945/jn.113.179259\nVileisis, R. A. (1985). Effect of maternal oxygen inhalation on the fetus with growth\nretardation. Pediatr. Res. 19 (3), 324 \u2013327. doi:10.1203/00006450-198503000-00015\nVileisis, R. A., Fain, J., and Oh, W. (1982). Fatty acid synthesis in rat fetuses with\nintrauterine growth retardation. Metabolism 31 (3), 217 \u2013222. doi:10.1016/0026-\n0495(82)90056-7\nV\u00edtor, A. C. M., Francisco, A. E., Silva, J., Pinho, M., Huws, S. A., Santos-Silva, J., et al.\n(2021). Freeze-dried Nannochloropsis oceanica biomass protects eicosapentaenoic acid\n(EPA) from metabolization in the rumen of lambs. Sci. Rep.\n11 (1), 21878. doi:10.1038/\ns41598-021-01255-w\nV o g g e l ,J . ,F i n k ,G . ,Z e l c k ,M . ,W o h l f a r t h ,M . ,P o s t ,J .M . ,B i n d i l a ,L . ,e ta l .( 2 0 2 2 ) .\nElevated n-3/n-6 PUFA ratio in early life d iet reverses adverse intrauterine kidney\nprogramming in female rats. J. Lipid Res. 63 (11), 100283. doi:10.1016/j.jlr.2022.\n100283\nVuguin, P., Raab, E., Liu, B., Barzilai, N., and Simmons, R. (2004). Hepatic insulin\nresistance precedes the development of diabetes in a model of intrauterine growth\nretardation. Diabetes 53 (10), 2617 \u20132622. doi:10.2337/diabetes.53.10.2617\nWai, S. G., Rozance, P. J., Wesolowski, S. R., Hay, W. W., Jr., and Brown, L. D. (2018).\nProlonged amino acid infusion into intrauterine growth-restricted fetal sheep increases\nleucine oxidation rates. Am. J. Physiol. Endocrinol. Metab. 315 (6), E1143 \u2013E1153. doi:10.\n1152/ajpendo.00128.2018\nW a l l a c e ,J .M . ,B o u r k e ,D .A . ,A i t k e n ,R .P . ,M i l n e ,J .S . ,a n dH a y ,W .W . ,J r .( 2 0 0 3 ) .\nPlacental glucose transport in growth-restricted pregnancies induced by\novernourishing adolescent sheep. J. Physiol. 547 (Pt 1), 85 \u201394. doi:10.1113/\njphysiol.2002.023333\nWallace, J. M., Milne, J. S., Aitken, B. W., Aitken, R. P., and Adam, C. L. (2020). Ovine\nprenatal growth-restriction and sex in \ufb02uence fetal adipose tissue phenotype and impact\npostnatal lipid metabolism and adiposity in vivo from birth until adulthood. PLoS One\n15 (2), e0228732. doi:10.1371/journal.pone.0228732\nFrontiers in Physiology frontiersin.org 24White and Yates 10.3389/fphys.2023.1250134\nWallace, J. M., Milne, J. S., Aitken, R. P., and Adam, C. L. (2014). In \ufb02uence of birth\nweight and gender on lipid status and adipose tissue gene expression in lambs. J. Mol.\nEndocrinol. 53 (1), 131 \u2013144. doi:10.1530/JME-14-0123\nWallace, J. M., Milne, J. S., Matsuzaki, M., and Aitken, R. P. (2008). Serial\nmeasurement of uterine blood \ufb02ow from mid to late gestation in growth restricted\npregnancies induced by overnourishing adolescent sheep dams. Placenta 29 (8),\n718\u2013724. doi:10.1016/j.placenta.2008.05.006\nWallace, J. M., Regnault, T. R., Limesand, S. W., Hay, W. W., Jr., and Anthony, R. V.\n(2005). Investigating the causes of low birth weight in contrasting ovine paradigms.\nJ. Physiol. 565 (Pt 1), 19 \u201326. doi:10.1113/jphysiol.2004.082032\nWang, D. T., Yin, Y., Yang, Y. J., Lv, P. J., Shi, Y., Lu, L., et al. (2014). Resveratrol\nprevents TNF-alpha-induced muscle atrophy via regulation of Akt/mTOR/\nFoxO1 signaling in C2C12 myotubes. Int. Immunopharmacol. 19 (2), 206 \u2013213.\ndoi:10.1016/j.intimp.2014.02.002\nWang, J., Zhu, P., Zheng, X., Ma, Z., Cui, C., Wu, C., et al. (2022). Altered liver\nmetabolism, mitochondrial function, oxidative status, and in \ufb02ammatory response in\nintrauterine growth restriction piglets with different growth patterns before weaning.\nMetabolites 12 (11), 1053. doi:10.3390/metabo12111053\nWang, T., Liu, C., Feng, C., Wang, X., Lin, G., Zhu, Y., et al. (2013). IUGR alters\nmuscle \ufb01ber development and proteome in fetal pigs. Front. Biosci. (Landmark Ed. 18\n(2), 598 \u2013607. doi:10.2741/4123\nWang, X., Martin, G. B., Liu, S., Shi, B., Guo, X., Zhao, Y., et al. (2019). The\nmechanism through which dietary supplementation with heated linseed grain increases\nn-3 long-chain polyunsaturated fatty acid concentration in subcutaneous adipose tissue\nof cashmere kids. J. Anim. Sci. 97 (1), 385 \u2013397. doi:10.1093/jas/sky386\nWeldon, S. M., Mullen, A. C., Loscher, C. E., Hurley, L. A., and Roche, H. M. (2007).\nDocosahexaenoic acid induces an anti-in \ufb02ammatory pro \ufb01le in lipopolysaccharide-\nstimulated human THP-1 macrophages more effectively than eicosapentaenoic acid.\nJ. Nutr. Biochem. 18 (4), 250 \u2013258. doi:10.1016/j.jnutbio.2006.04.003\nWhitlock, L. A., Schingoethe, D. J., Hippen, A. R., Kalscheur, K. F., Baer, R. J.,\nRamaswamy, N., et al. (2002). Fish oil and extruded soybeans fed in combination\nincrease conjugated linoleic acids in milk of dairy cows more than when fed separately.\nJ. Dairy Sci. 85 (1), 234 \u2013243. doi:10.3168/jds.S0022-0302(02)74072-1\nWieland, L. S. (2019). Omega-3 fatty acid addition during pregnancy: summary of a\nCochrane review. Explore (NY) 15 (2), 168 \u2013169. doi:10.1016/j.explore.2018.12.005\nWietrak, E., Kaminski, K., Leszczynska-Gorzelak, B., and Oleszczuk, J. (2015). Effect\nof docosahexaenoic acid on apoptosis and proliferation in the placenta: preliminaryreport. Biomed. Res. Int. 2015, 482875. doi:10.1155/2015/482875\nWilson, S. J., McEwan, J. C., Sheard, P. W., and Harris, A. J. (1992). Early stages of\nmyogenesis in a large mammal: formation of successive generations of myotubes insheep tibialis cranialis muscle. J. Musc Res. Cell Mobil. 13 (5), 534 \u2013550. doi:10.1007/\nBF01737996\nWu, G., Bazer, F. W., Wallace, J. M., and Spencer, T. E. (2006). Board-invited review:\nintrauterine growth retardation: implications for the animal sciences. J. Anim. Sci. 84\n(9), 2316 \u20132337. doi:10.2527/jas.2006-156\nWu, G., Brouckaert, P., and Olivecrona, T. (2004). Rapid downregulation of adipose\ntissue lipoprotein lipase activity on food deprivation: evidence that TNF-alpha is\ninvolved. Am. J. Physiol. Endocrinol. Metab. 286 (5), E711 \u2013E717. doi:10.1152/\najpendo.00257.2003\nWyrwoll, C. S., Mark, P. J., Mori, T. A., Puddey, I. B., and Waddell, B. J. (2006).\nPrevention of programmed hyperleptinemia and hypertension by postnatal dietary\nomega-3 fatty acids. Endocrinol 147 (1), 599 \u2013606. doi:10.1210/en.2005-0748\nXiao, Y., Zhang, Q., Liao, X., Elbelt, U., and Weylandt, K. H. (2022). The effects of\nomega-3 fatty acids in type 2 diabetes: A systematic review and meta-analysis. Prostagl.\nLeukot. Essent. Fat. Acids 182, 102456. doi:10.1016/j.plefa.2022.102456\nXing, Y., Zhang, J., Wei, H., Zhang, H., Guan, Y., Wang, X., et al. (2019). Reduction of\nthe PI3K/Akt related signaling activities in skeletal muscle tissues involves insulin\nresistance in intrauterine growth restriction rats with catch-up growth. PLoS One 14 (5),\ne0216665. doi:10.1371/journal.pone.0216665\nXiao, X. M., and Li, L. P. (2005). L-Arginine treatment for asymmetric fetal growth\nrestriction. Int. J. Gynaecol. Obstet . 88 (1), 15 \u201318. doi:10.1016/j.ijgo.2004.09.017\nXu, P., Guo, H., Wang, H., Lee, S. C., Liu, M., Pan, Y., et al. (2019). Downregulations of\nplacental fatty acid transporters during cadmium-induced fetal growth restriction.\nToxicology 423, 112 \u2013122. doi:10.1016/j.tox.2019.05.013\nYamasaki, H., Yamaguchi, Y., Takino, H., Matsuo, H., Matsumoto, K., Uotani, S., et al.\n(1996). TNF-alpha stimulates glucose uptake in L6 myoblasts. Diabetes Res. Clin. Pract.\n32 (1-2), 11 \u201318. doi:10.1016/0168-8227(96)01221-1Yates, D., Green, A., and Limesand, S. W. (201 1). Catecholamines mediate multiple fetal\nadaptations during placental insuf \ufb01ciency that contribute to intrauterine growth restriction:\nlessons from hyperthermic sheep. J. pregnancy 2011, 740408. doi:10.1155/2011/740408\nYates, D. T., Macko, A. R., Chen, X., Green, A. S., Kelly, A. C., Anderson, M. J., et al.\n(2012a). Hypoxaemia-induced catecholamine secretion from adrenal chromaf \ufb01n cells\ninhibits glucose-stimulated hyperinsulinaemia in fetal sheep. J. Physiol. 590 (21),\n5439\u20135447. doi:10.1113/jphysiol.2012.237347\nYates, D., Macko, A., Nearing, M., Chen, X., Rhoads, R., and Limesand, S. W. (2012b).\nDevelopmental programming in response to intrauterine growth restriction impairs\nmyoblast function and skeletal muscle metabolism. J. pregnancy 2012, 631038. doi:10.\n1155/2012/631038\nY a t e s ,D .T . ,C a d a r e t ,C .N . ,B e e d e ,K .A . ,R i l ey, H. E., Macko, A. R., Anderson, M. J., et al.\n(2016). Intrauterine growth-restricted sh eep fetuses exhibit smaller hindlimb muscle \ufb01bers\nand lower proportions of insulin-sensitive Type I \ufb01bers near term. A m .J .P h y s i o l .R e g u l .\nIntegr. Comp. Physiol. 310 (11), R1020 \u2013R1029. doi:10.1152/ajpregu.00528.2015\nYates, D. T., Camacho, L. E., Kelly, A. C., Steyn, L. V., Davis, M. A., Antolic, A. T., et al.\n(2019). Postnatal \u03b22 adrenergic treatment improves insulin sensitivity in lambs with\nIUGR but not persistent defects in pancreatic islets or skeletal muscle. J. Physiol. 597\n(24), 5835 \u20135858. doi:10.1113/JP278726\nYates, D. T., Clarke, D. S., Macko, A. R., Anderson, M. J., Shelton, L. A., Nearing, M.,\net al. (2014). Myoblasts from intrauterine growth-restricted sheep fetuses exhibit\nintrinsic de \ufb01ciencies in proliferation that contribute to smaller semitendinosus\nmyo\ufb01bres. J. Physiol. 592 (14), 3113 \u20133125. doi:10.1113/jphysiol.2014.272591\nYates, D. T., Petersen, J. L., Schmidt, T. B., Cadaret, C. N., Barnes, T. L., Posont, R. J.,\net al. (2018). ASAS-SSR triennnial reproduction symposium: looking back and moving\nforward-how reproductive Physiology has evolved: fetal origins of impaired muscle\ngrowth and metabolic dysfunction: lessons from the heat-stressed pregnant Ewe.J. Anim. Sci. 96 (7), 2987 \u20133002. doi:10.1093/jas/sky164\nYee, J. K., Han, G., Vega, J., Lee, W. P., Ross, M. G., and Desai, M. (2016). Fatty acid de\nNovo synthesis in adult intrauterine growth-restricted offspring, and adult maleresponse to a high fat diet. Lipids 51 (12), 1339 \u20131351. doi:10.1007/s11745-016-4199-9\nYing, Z., Zhang, H., Su, W., Zhou, L., Wang, F., Li, Y., et al. (2017). Dietary\nmethionine restriction alleviates hyperglycemia in pigs with intrauterine growthrestriction by enhancing hepatic protein kinase B signaling and glycogen synthesis.\nJ. Nutr. 147 (10), 1892 \u20131899. doi:10.3945/jn.117.253427\nYoud, J. M., Rattigan, S., and Clark, M. G. (2000). Acute impairment of insulin-\nmediated capillary recruitment and glucose uptake in rat skeletal muscle in vivo by\nTNF-alpha. Diabetes 49 (11), 1904 \u20131909. doi:10.2337/diabetes.49.11.1904\nYoussef, L., Sim\u00f5es, R. V., Miranda, J., Garc\u00eda-Mart\u00edn, M. L., Paules, C., Crovetto, F.,\net al. (2021). Paired maternal and fetal metabolomics reveal a differential \ufb01ngerprint in\npreeclampsia versus fetal growth restriction. Sci. Rep. 11 (1), 14422. doi:10.1038/s41598-\n021-93936-9\nZarate, M. A., De Dios, R. K., Balasubramaniyan, D., Zheng, L., Sherlock, L. G.,\nRozance, P. J., et al. (2021). The acute hepatic NF- \u03baB-Mediated proin \ufb02ammatory\nresponse to endotoxemia is attenuated in intrauterine growth-restricted newborn mice.Front. Immunol. 12, 706774. doi:10.3389/ \ufb01mmu.2021.706774\nZhang, H., Zhang, Y., Ma, Y., Elsabagh, M., Wang, H., and Wang, M. (2021). Dietary\nrumen-protected L-arginine or N-carbamylglutamate attenuated fetal hepaticin\ufb02ammation in undernourished ewes suffering from intrauterine growth\nrestriction. Anim. Nutr. 7 (4), 1095 \u20131104. doi:10.1016/j.aninu.2021.06.004\nZhang, L., Xiao, D., and Bouslough, D. B. (1998). Long-term high-altitude hypoxia\nincreases plasma nitrate levels in pregnant ewes and their fetuses. Am. J. Obstet. Gynecol.\n179 (6 Pt 1), 1594 \u20131598. doi:10.1016/s0002-9378(98)70031-6\nZhang, Y., Jin, W., Zhang, D., Lin, C., He, H., Xie, F., et al. (2022). TNF-A antagonizes\nthe effect of leptin on insulin secretion through FOXO1-dependent transcriptional\nsuppression of LepRb in INS-1 cells. Oxid. Med. Cell Longev. 2022, 9142798. doi:10.\n1155/2022/9142798\nZhong, X., Li, W., Huang, X., Zhang, L., Yimamu, M., Raiput, N., et al. (2012).\nImpairment of cellular immunity is associated with overexpression of heat shock\nprotein 70 in neonatal pigs with intrauterine growth retardation. Cell Stress\nChaperones 17 (4), 495 \u2013505. doi:10.1007/s12192-012-0326-6\nZinkhan, E. K., Yu, B., Callaway, C. W., and McKnight, R. A. (2018). Intrauterine\ngrowth restriction combined with a maternal high-fat diet increased adiposity and\nserum corticosterone levels in adult rat offspring. J. Dev. Orig. Health Dis. 9 (3),\n315\u2013328. doi:10.1017/S2040174418000016\nZywicki, M., Blohowiak, S. E., Magness, R. R., Segar, J. L., and Kling, P. J. (2016).\nIncreasing fetal ovine number per gestation alters fetal plasma clinical chemistry values.\nPhysiol. Rep. 4 (16), e12905. doi:10.14814/phy2.12905\nFrontiers in Physiology frontiersin.org 25White and Yates 10.3389/fphys.2023.1250134\n"}
